QUARTERLY REPORT

Q3 2021 — Quarterly report

Q3 2021PDF · 79 pages666 KB
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☑ 	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended 	September 30, 2021
OR
☐ 	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____ to ____
Commission file number 	001-00035
GENERAL ELECTRIC COMPANY
(Exact name of registrant as specified in its charter)
New York 	14-0689340
(State or other jurisdiction of incorporation or organization) 	(I.R.S. Employer Identification No.)
5 Necco Street 	Boston 	MA 	02210
(Address of principal executive offices) 	(Zip Code)
(Registrant’s telephone number, including area code) 	(617) 443-3000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading Symbol(s) 	Name of each exchange on which registered
Common stock, par value $0.01 per share 	GE 	New York Stock Exchange
0.375% Notes due 2022 	GE 22A 	New York Stock Exchange
1.250% Notes due 2023 	GE 23E 	New York Stock Exchange
0.875% Notes due 2025 	GE 25 	New York Stock Exchange
1.875% Notes due 2027 	GE 27E 	New York Stock Exchange
1.500% Notes due 2029 	GE 29 	New York Stock Exchange
7 1/2% Guaranteed Subordinated Notes due 2035 	GE /35 	New York Stock Exchange
2.125% Notes due 2037 	GE 37 	New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for
the past 90 days. Yes 	þ 	No 	¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes 	þ
No 	¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an
emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in
Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer 	☑ 	Accelerated filer 	☐
Non-accelerated filer 	☐ 	Smaller reporting company 	☐
Emerging growth company 	☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 	¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes 	☐ 	No 	☑
There were 1,098,137,128 shares of common stock with a par value of $0.01 per share outstanding at September 30, 2021.

-- 1 of 79 --

TABLE OF CONTENTS
Page
Forward-Looking Statements 	3
About General Electric 	4
Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) 	4
Consolidated Results 	4
Segment Operations 	7
Corporate Items and Eliminations 	13
Other Consolidated Information 	14
Capital Resources and Liquidity 	15
Critical Accounting Estimates 	20
Other Items 	20
Non-GAAP Financial Measures 	22
Controls and Procedures 	27
Other Financial Data 	27
Financial Statements and Notes 	28
Statement of Earnings (Loss) 	28
Statement of Financial Position 	32
Statement of Cash Flows 	34
Consolidated Statement of Comprehensive Income (Loss) 	36
Consolidated Statement of Changes in Shareholders' Equity 	36
Note 1 Basis of Presentation and Summary of Significant Accounting Policies 	37
Note 2 Businesses Held for Sale and Discontinued Operations 	37
Note 3 Investment Securities 	39
Note 4 Current and Long-Term Receivables 	40
Note 5 Financing Receivables and Allowances 	42
Note 6 Inventories, Including Deferred Inventory Costs 	42
Note 7 Property, Plant and Equipment 	42
Note 8 Goodwill and Other Intangible Assets 	43
Note 9 Revenues 	43
Note 10 Contract and Other Deferred Assets & Progress Collections and Deferred Income 	45
Note 11 All Other Assets 	45
Note 12 	Borrowings 	46
Note 13 	Insurance Liabilities and Annuity Benefits 	47
Note 14 	Postretirement Benefit Plans 	48
Note 15 Current and All Other Liabilities 	48
Note 16 Income Taxes 	49
Note 17 Shareholders' Equity 	49
Note 18 Earnings Per Share Information 	50
Note 19 Financial Instruments 	50
Note 20 Variable Interest Entities 	52
Note 21 Commitments, Guarantees, Product Warranties and Other Loss Contingencies 	53
Note 22 Intercompany Transactions 	55
Note 23 Other Income 	55
Exhibits 	56
Form 10-Q Cross Reference Index 	56
Signatures 	56

-- 2 of 79 --

FORWARD-LOOKING STATEMENTS. 	Our public communications and SEC filings may contain statements related to future, not past, events. These
forward-looking statements often address our expected future business and financial performance and financial condition, and often contain words such as
"expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "estimate," "forecast," "target," "preliminary," or "range." Forward-looking
statements by their nature address matters that are, to different degrees, uncertain, such as statements about the impacts of the COVID-19 pandemic on our
business operations, financial results and financial position and on the world economy; our expected financial performance, including cash flows, revenues,
organic growth, margins, earnings and earnings per share; macroeconomic and market conditions and volatility; planned and potential business or asset
dispositions, including our plan to combine our GE Capital Aviation Services (GECAS) business with AerCap Holdings N.V. (AerCap); our de-leveraging plans,
including leverage ratios and targets, the timing and nature of actions to reduce indebtedness and our credit ratings and outlooks; GE's and GE Capital's funding
and liquidity; our businesses’ cost structures and plans to reduce costs; restructuring, goodwill impairment or other financial charges; or tax rates.
For us, particular uncertainties that could cause our actual results to be materially different than those expressed in our forward-looking statements include:
• 	the continuing severity, magnitude and duration of the COVID-19 pandemic, including impacts of the pandemic, of businesses’ and governments’ responses
to the pandemic and of individual factors such as aviation passenger confidence on our operations and personnel, and on commercial activity and demand
across our and our customers’ businesses, and on global supply chains;
• 	the extent to which the COVID-19 pandemic and related impacts, including global supply chain disruptions, will continue to adversely impact our business
operations, financial performance, results of operations, financial position, the prices of our securities and the achievement of our strategic objectives;
• 	our success in executing and completing asset dispositions or other transactions, including our plan to combine our GECAS business with AerCap and our
plan to exit our equity ownership position in Baker Hughes, the timing of closing for such transactions, the ability to satisfy closing conditions, and the
expected proceeds, consideration and benefits to GE;
• 	changes in macroeconomic and market conditions and market volatility (including developments and volatility arising from the COVID-19 pandemic),
including inflation, interest rates, the value of securities and other financial assets (including our equity ownership position in Baker Hughes and the equity
ownership position that we will hold in AerCap after completing our announced plan to combine GECAS with AerCap), oil, natural gas and other commodity
prices and exchange rates, and the impact of such changes and volatility on our financial position and businesses;
• 	our de-leveraging and capital allocation plans, including with respect to actions to reduce our indebtedness, the timing and amount of GE dividends, organic
investments, and other priorities;
• 	further downgrades of our current short- and long-term credit ratings or ratings outlooks, or changes in rating application or methodology, and the related
impact on our liquidity, funding profile, costs and competitive position;
• 	GE’s liquidity and the amount and timing of our GE Industrial cash flows and earnings, which may be impacted by customer, supplier, competitive,
contractual and other dynamics and conditions;
• 	GE Capital's capital and liquidity needs, including in connection with GE Capital’s run-off insurance operations and discontinued operations such as Bank
BPH, the amount and timing of any required capital contributions and any strategic actions that we may pursue; the impact of conditions in the financial and
credit markets on GE Capital's ability to sell financial assets; the availability and cost of funding; and GE Capital's exposure to particular counterparties and
markets, including through GECAS to the aviation sector and adverse impacts related to COVID-19;
• 	global economic trends, competition and geopolitical risks, including changes in the rates of investment or economic growth in key markets we serve, or an
escalation of sanctions, tariffs or other trade tensions between the U.S. and China or other countries, and related impacts on our businesses' global supply
chains and strategies;
• 	market developments or customer actions that may affect demand and the financial performance of major industries and customers we serve, such as
secular, cyclical and competitive pressures in our Power business; pricing, the timing of customer investment and other factors in renewable energy
markets; demand for air travel and other dynamics related to the COVID-19 pandemic; conditions in key geographic markets; and other shifts in the
competitive landscape for our products and services;
• 	operational execution by our businesses, including the operations and execution of our Power and Renewable Energy businesses, and the performance of
our Aviation business;
• 	changes in law, regulation or policy that may affect our businesses, such as trade policy and tariffs, regulation and incentives related to climate change
(including extension of the U.S. wind Production Tax Credit), and the effects of tax law changes;
• 	our decisions about investments in new products, services and platforms, and our ability to launch new products in a cost-effective manner;
• 	our ability to increase margins through implementation of operational changes, restructuring and other cost reduction measures;
• 	the impact of regulation and regulatory, investigative and legal proceedings and legal compliance risks, including the impact of Alstom and other
investigative and legal proceedings;
• 	the impact of actual or potential failures of our products or third-party products with which our products are integrated, and related reputational effects;
• 	the impact of potential information technology, cybersecurity or data security breaches at GE or third parties; and
• 	the other factors that are described in the "Risk Factors" section of our Annual Report on Form 10-K for the year ended December 31, 2020 and our
Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, as such descriptions may be updated or amended in any future reports we file with
the SEC.
These or other uncertainties may cause our actual future results to be materially different than those expressed in our forward-looking statements. We do not
undertake to update our forward-looking statements. This document includes certain forward-looking projected financial information that is based on current
estimates and forecasts. Actual results could differ materially.
2021 3Q FORM 10-Q 	3

-- 3 of 79 --

ABOUT GENERAL ELECTRIC. 	General Electric Company (General Electric, GE or the Company) is a high-tech industrial company that operates
worldwide through its four industrial segments, Aviation, Healthcare, Renewable Energy, and Power, and its financial services segment, Capital. See the
Segment Operations section within Management’s Discussion and Analysis of Financial Condition (MD&A) for segment business descriptions and product and
service offerings. See the Consolidated Results section within MD&A and Results of Operations and Note 2 to the consolidated financial statements for
information regarding our recent business portfolio actions. Results of businesses reclassified to discontinued operations have been recast for all periods
presented.
GE’s Internet address at www.ge.com, Investor Relations website at www.ge.com/investor-relations and our corporate blog at www.gereports.com, as well as
GE’s Facebook page, Twitter accounts and other social media, including @GE_Reports, contain a significant amount of information about GE, including financial
and other information for investors. GE encourages investors to visit these websites from time to time, as information is updated and new information is posted.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (MD&A).
See Note 1 for a discussion of the basis of presentation for our consolidated financial statements and this MD&A. Discussions throughout MD&A are based on
continuing operations unless otherwise noted. The MD&A should be read in conjunction with the Financial Statements and Notes to the consolidated financial
statements. For purposes of the financial statement display of sales and costs of sales in our consolidated Statement of Earnings (Loss), “goods” is required by
SEC regulations to include all sales of tangible products, and "services" must include all other sales, including other services activities. Throughout MD&A we
refer to sales under product services agreements and sales of both goods (such as spare parts and equipment upgrades) and related services (such as
monitoring, maintenance and repairs) as sales of “services,” which is an important part of our operations.
In the accompanying analysis of financial information, we sometimes use information derived from consolidated financial data but not presented in our financial
statements prepared in accordance with GAAP. Certain of these data are considered “non-GAAP financial measures” under SEC rules. See the Non-GAAP
Financial Measures section for the reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial
measures.
CONSOLIDATED RESULTS
SIGNIFICANT DEVELOPMENTS. Coronavirus Disease 2019 (COVID-19) Pandemic. The COVID-19 pandemic has impacted global economies, resulting in
workforce and travel restrictions, supply chain and production disruptions and reduced demand and spending across many sectors. Since the latter part of the
first quarter of 2020, these factors have had a material adverse impact on our operations and financial performance, as well as on the operations and financial
performance of many of the customers and suppliers in industries that we serve. While factors related directly and indirectly to the COVID-19 pandemic have
been impacting operations and financial performance at varying levels across all our businesses, the most significant impact to date has been at our Aviation
segment and our GE Capital Aviation Services (GECAS) aircraft leasing business within discontinued operations. For details about impacts related to our
businesses and actions we have taken in response, as applicable, refer to the respective segment sections within MD&A. We also continue to evaluate market
conditions as they evolve and take precautionary measures to strengthen our financial position. We ended the third quarter of 2021 with $25.0 billion of
consolidated cash, cash equivalents and restricted cash, in addition to our available credit lines of $14.5 billion. See the Capital Resources and Liquidity section
for further information. We anticipate that our operations and financial performance will continue to be impacted by the COVID-19 pandemic in future periods.
These impacts will ultimately depend on many factors that are not within our control, including the severity and duration of the pandemic; governmental, business
and individuals’ actions in response to the pandemic; and the development, availability and public acceptance of effective treatments and vaccines.
GECAS. On March 9, 2021, we announced an agreement to combine GECAS with AerCap Holdings N.V. (AerCap), for which the Company expects to receive
approximately $22.6 billion in cash, inclusive of estimated contractual closing adjustments, 111.5 million shares of AerCap common stock (approximately 46%
ownership interest) valued at approximately $6.4 billion based on the AerCap’s closing share price on September 30, 2021, and $1 billion in AerCap notes
(GECAS transaction). In connection with the signing of the transaction agreement, GE Capital recorded a non-cash after-tax charge of $3.6 billion in
discontinued operations in 2021, including a $0.2 billion gain in the third quarter driven by the increase in AerCap's share price. This was partially offset by
$1.2 billion of GECAS earnings in 2021, including $0.5 billion of earnings in the third quarter. The results of GECAS are presented in discontinued operations.
Given the economics of GECAS accrue to AerCap in conjunction with the transaction, the net impact of GECAS (loss on sale and operations) could change
materially, mainly due to fluctuations in AerCap's closing share price. In October 2021, we received final regulatory approvals and are now expecting the
transaction to be completed on November 1, 2021. See Note 2 for further information.
After completion of the transaction, we will elect to prospectively measure our investment in AerCap at fair value and expect to have continuing involvement with
AerCap, primarily through our ownership interest and ongoing sales or leases of products and services. In addition, we expect to sell our stake in an orderly
fashion over time. The remainder of GE Capital, including Energy Financial Services (EFS) and our run-off insurance operations, will be reported within
Corporate. Effective for our Annual Report on Form 10-K for the year ended December 31, 2021, we will move from three-column to one-column financial
statement reporting. At that point, while we will continue to provide the same level of Insurance disclosures, the results of our Insurance business will be
excluded from certain non-GAAP financial measures.
Liability Management Actions. 	In the second quarter of 2021, we completed a debt tender to repurchase a total of $7.3 billion of debt, comprising $4.1 billion of
GE Industrial and $3.2 billion of GE Capital debt. The total after-tax loss on the tender was $1.1 billion ($1.4 billion pre-tax), comprising $0.5 billion in GE
Industrial and $0.6 billion in GE Capital.
2021 3Q FORM 10-Q 	4

-- 4 of 79 --

Factoring. Effective April 1, 2021, the Company discontinued the majority of its factoring programs. For the six months ended September 30, 2021, the adverse
impact to GE Industrial CFOA was $3.1 billion, which primarily represents the cash that GE Industrial would have otherwise collected in the period had customer
receivables not been previously sold and is excluded from GE Industrial free cash flows*.
Reverse Stock Split. 	In the second quarter of 2021, we announced that we would proceed with the 1-for-8 reverse stock split, as approved by shareholders, and
filed an amendment to our certificate of incorporation to effectuate the reverse stock split after the close of trading on July 30, 2021. GE common stock began
trading on a split-adjusted basis on August 2, 2021. Effective this quarter, our shares of outstanding common stock and earnings per share calculation have been
retroactively restated for all periods presented.
BK Medical. 	In the third quarter of 2021, we entered into an agreement to acquire BK Medical, a leader in surgical ultrasound imaging and guidance, from Altaris
Capital Partners for a cash purchase price of $1.45 billion. The parties expect the transaction to close in 2022, subject to review by the relevant regulatory
authorities.
THIRD QUARTER 2021 RESULTS. 	Consolidated revenues were $18.4 billion, down $0.1 billion for the quarter, driven by decreased GE Industrial and GE
Capital revenues. GE Industrial revenues decreased $0.1 billion (1%), driven primarily by decreases at Renewable Energy and Healthcare. GE Capital revenues
decreased 3%.
Continuing earnings (loss) per share was $0.54. Excluding gains (losses) on equity securities, non-operating benefit costs, gains (losses) on purchases and
sales of business interests, and restructuring and other charges, Adjusted earnings per share* was $0.57.
For the three months ended September 30, 2021, GE Industrial profit was $0.9 billion and profit margins were 5.0%, up $2.2 billion, driven primarily by a higher
net gain on equity securities of $1.1 billion, higher profit at our industrial segments of $0.4 billion, the nonrecurrence of prior year asset impairments in Steam of
$0.4 billion, a decrease in non-operating benefit costs of $0.2 billion, lower GE Industrial interest and other financial charges of $0.1 billion and a decrease in
adjusted corporate operating costs of $0.1 billion. Adjusted GE Industrial organic profit* increased $0.5 billion, driven primarily by increases at Aviation and
Power, partially offset by decreases at Renewable Energy and Healthcare. Additionally, we are starting to experience inflation pressure in our supply chain as
well as delays in sourcing key materials needed for our products. The most significant impact to date has been at our Healthcare segment, which has delayed
our ability to convert remaining performance obligation (RPO) to revenue. While we are taking actions to limit this pressure, we may experience a greater impact
on our longer cycle businesses in future periods.
GE Industrial cash flows from operating activities (CFOA) were $(0.8) billion and $(3.2) billion for the nine months ended September 30, 2021 and 2020,
respectively. GE Industrial cash used for operating activities decreased primarily due to an increase in net income (after adjusting for the gain on the sale of
BioPharma, non-cash gains/losses related to our interest in Baker Hughes, non-operating benefit costs and non-operating debt extinguishment costs), and a
decrease in cash paid for income taxes, partially offset by a decrease in Aviation-related customer allowance accruals and the settlement of an Alstom legacy
legal matter in 2021. GE Industrial free cash flows (FCF)* were $1.3 billion and $(3.8) billion for the nine months ended September 30, 2021 and 2020,
respectively. GE Industrial FCF increased primarily due to a decrease in cash used for operating activities and a decrease in additions to property, plant and
equipment and internal-use software. In addition, effective April 1, 2021, the Company discontinued the majority of its factoring programs. In the second and third
quarter of 2021, the adverse impact to GE Industrial CFOA was $3.1 billion, which primarily represents the cash that GE Industrial would have otherwise
collected in the period had customer receivables not been previously sold and is excluded from GE Industrial FCF*. See the Capital Resources and Liquidity -
Statement of Cash Flows section for further information.
RPO is unfilled customer orders for products and product services (expected life of contract sales for product services) excluding any purchase order that
provides the customer with the ability to cancel or terminate without incurring a substantive penalty. Historical cancellations of customer orders have been limited
prior to the COVID-19 pandemic. In the second quarter of 2021, we voluntarily replaced our quarterly disclosures of backlog with RPO as a key metric, one
commonly used across our industries, in order to simplify our reporting and align with our peers. See Note 9 for further information.
RPO 	September 30, 2021 	December 31, 2020 	September 30, 2020
Equipment 	$ 	46,666 	$ 	45,991 	$ 	44,634
Services 	191,839 	184,608 	182,032
Total RPO 	$ 	238,505 	$ 	230,600 	$ 	226,666
As of September 30, 2021, RPO increased $7.9 billion (3%) from December 31, 2020, primarily at Aviation, from engines contracted under long-term service
agreements that have now been put into service; at Healthcare, from new contracts and renewals with large customers; and at Renewable Energy, primarily at
Offshore Wind; partially offset by a decrease at Power from sales outpacing new orders in Gas Power contractual services and the continued wind down of new
build coal business. RPO increased $11.8 billion (5%) from September 30, 2020, primarily due to the same net increases as described above.
*Non-GAAP Financial Measure
2021 3Q FORM 10-Q 	5

-- 5 of 79 --

REVENUES Three months ended September
30 	Nine months ended September 30
2021 	2020 	2021 	2020
Consolidated revenues 	$ 	18,429 	$ 	18,529 	$ 	53,826 	$ 	54,823
Equipment 	8,905 	9,625 	25,178 	26,928
Services 	8,916 	8,293 	26,459 	25,901
GE Industrial revenues 	$ 	17,821 	$ 	17,918 	$ 	51,637 	$ 	52,828
GE Capital revenues 	$ 	734 	$ 	758 	$ 	2,470 	$ 	2,455
For the three months ended September 30, 2021, 	Consolidated 	revenues were down $0.1 billion, driven by decreases in GE Industrial and GE Capital
revenues.
GE Industrial 	revenues decreased $0.1 billion (1%). Equipment revenues decreased primarily at Healthcare, driven by the nonrecurrence of the prior year order
from the U.S. Department of Health and Human Services to deliver ventilators in partnership with Ford and reductions in Life Care Solutions (LCS) for Healthcare
Systems (HCS) products; and at Power, due to decreases in Steam Power and Gas Power equipment revenues. Services revenues increased primarily at
Aviation, due to higher volume on commercial spare part shipments and increased shop visit volume; and at Power, due to increases in Steam Power services
revenues and Gas Power services revenues on strong long-term service agreement volume; partially offset by a decrease at Renewable Energy, primarily from
lower repower unit deliveries at Onshore Wind. The decrease in GE Industrial revenues included the net effects of dispositions of $0.1 billion and an increase
from foreign currency translation of $0.2 billion. Excluding the effects of acquisitions, dispositions and foreign currency translation, GE Industrial organic
revenues* decreased $0.2 billion (1%), with a decrease in equipment revenues of $0.9 billion (9%) and an increase in services revenues of $0.6 billion (7%). GE
Industrial organic revenues* decreased at Renewable Energy, Healthcare and Power, partially offset by an increase at Aviation.
GE Capital 	revenues decreased 3%, as lower factoring revenue and EFS gains were partially offset by lower marks and impairments.
For the nine months ended September 30, 2021, 	Consolidated 	revenues were down $1.0 billion, driven by a decrease in GE Industrial revenues, partially
offset by an increase in GE Capital revenues.
GE Industrial 	revenues decreased $1.2 billion (2%). Equipment revenues decreased primarily at Power, due to decreased Gas Power equipment revenues on
lower turnkey sales; at Aviation, due to fewer commercial install and spare engine unit shipments; and at Healthcare, due to the disposition of the BioPharma
business; partially offset by an increase in Renewable Energy driven by more wind turbine deliveries and higher revenue at Offshore Wind. Services revenues
increased primarily at Power, due to an increase in Gas Power services revenues; and at Healthcare, due to increased volume in Imaging and Ultrasound and a
return to pre-pandemic volume in PDx; partially offset by decreases at Renewable Energy, primarily due to lower repower unit deliveries at Onshore Wind; and at
Aviation, primarily due to our Military business. The decrease in GE Industrial revenues included the effects of acquisitions of $0.1 billion, the net effects of
dispositions of $1.4 billion and an increase from foreign currency translation of $1.0 billion. Excluding the effects of acquisitions, dispositions and foreign currency
translation, GE Industrial organic revenues* decreased $0.9 billion (2%), with equipment revenues down $1.3 billion (5%) and services revenues up $0.4 billion
(2%). GE Industrial organic revenues* decreased at Aviation, Power and Renewable Energy, partially offset by an increase at Healthcare.
GE Capital 	revenues increased 1%, primarily as a result of lower marks and impairments primarily in Insurance, partially offset by lower WCS factoring revenue
and project revenues at EFS.
EARNINGS (LOSS) AND EARNINGS (LOSS) PER SHARE Three months ended September
30 	Nine months ended September 30
(Per-share in dollars and diluted) 	2021 	2020 	2021 	2020
Continuing earnings (loss) 	$ 	603 	$ 	(1,132) 	$ 	(1) 	$ 	3,857
Continuing earnings (loss) per share 	$ 	0.54 	$ 	(1.04) 	$ 	(0.01) 	$ 	3.39
For the three months ended September 30, 2021, 	Consolidated 	continuing earnings increased $1.7 billion primarily due to an increase in GE Industrial profit,
partially offset by an increase in GE Industrial provision for income taxes and an increase in GE Capital continuing losses.
GE Industrial 	profit increased $2.2 billion driven primarily by a higher net gain on equity securities of $1.1 billion, higher profit at our industrial segments of $0.4
billion, the nonrecurrence of prior year asset impairments in Steam of $0.4 billion, a decrease in non-operating benefit costs of $0.2 billion, lower GE Industrial
interest and other financial charges of $0.1 billion and a decrease in adjusted corporate operating costs of $0.1 billion. GE Industrial profit margin was 5.0%, an
increase from (7.2)%, primarily due to the same net increases as described above. Adjusted GE Industrial profit* was $1.3 billion, an increase of $0.5 billion
organically*, due to increases at Aviation and Power, partially offset by decreases at Renewable Energy and Healthcare. Adjusted GE Industrial profit margin*
was 7.5%, an increase of 270 basis points organically*. At Aviation, the primary drivers were higher volume on commercial spare part shipments, increased shop
visit volume, the nonrecurrence of prior year charges related to lower commercial engine production volume and an impairment charge in a joint venture in the
Systems business. At Power, the primary drivers were increases in Gas Power services revenues and margins and aeroderivative sales. At Renewable Energy,
the primary drivers were lower repower volume and lower margins on new product introductions. At Healthcare, the primary drivers were lower LCS equipment
volume, and higher material, logistics and restructuring costs.
GE Capital 	continuing losses increased $0.1 billion primarily as a result of lower tax benefits, partially offset by the discontinuation of preferred dividend
payments to GE Industrial.
*Non-GAAP Financial Measure
2021 3Q FORM 10-Q 	6

-- 6 of 79 --

For the nine months ended September 30, 2021, 	Consolidated 	continuing earnings decreased $3.9 billion primarily due to a decrease in GE Industrial profit
and an increase in GE Capital continuing losses.
GE Industrial 	profit decreased $3.3 billion driven by the nonrecurrence of the prior year gain on the sale of our BioPharma business of $12.4 billion and higher
debt extinguishment costs of $0.6 billion, partially offset by a higher net gain on equity securities of $5.8 billion, higher profit at our industrial segments of $1.7
billion, decreased GE Industrial goodwill impairments of $0.7 billion, the nonrecurrence of Steam asset impairments in the prior year of $0.4 billion, a decrease in
non-operating benefit costs of $0.4 billion, lower GE Industrial interest and other financial charges of $0.3 billion, a decrease in adjusted corporate operating
costs of $0.2 billion, lower restructuring and other charges of $0.1 billion and the nonrecurrence of the legal reserves associated with the SEC investigation in the
prior year of $0.1 billion. GE Industrial profit margin was 2.0%, a decrease from 8.3%, primarily due to the same net decreases as described above. Adjusted GE
Industrial profit* was $3.1 billion, an increase of $2.2 billion organically*, due to increases at each of our industrial segments. Adjusted GE Industrial profit
margin* was 6.0%, an increase of 440 basis points organically*. At Aviation, the primary drivers were lower net unfavorable changes in estimated profitability in
long-term service agreements, operational cost reduction from the actions taken in 2020 and the first half of 2021, and the nonrecurrence of prior year charges
related to customer credit risk and lower commercial engine production volumes. At Power, the primary drivers were increases in Gas Power services revenues
and margins and aeroderivative sales and continued efforts to streamline the businesses. At Healthcare, the primary drivers were increased volume for Imaging
and Ultrasound products, increases in PDx volume as well as continued cost reduction actions. At Renewable Energy, the primary drivers were higher new unit
volume at Onshore Wind, the favorable impact of cost reduction actions, and improved project execution.
GE Capital 	continuing losses increased $0.2 billion (28%) primarily as a result of higher debt extinguishment costs, lower tax benefits and the nonrecurrence of
the tax benefit related to the BioPharma sale in the first quarter of 2020, partially offset by the discontinuation of preferred dividend payments to GE Industrial,
lower marks and impairments in Insurance and EFS, lower interest expense due to a lower debt balance and lower claims and higher terminations in Insurance.
SEGMENT OPERATIONS. 	Refer to our Annual Report on Form 10-K for the year ended December 31, 2020, for further information regarding our
determination of Industrial and Capital segment profit for continuing operations, and for our allocations of corporate costs to our segments.
SUMMARY OF REPORTABLE SEGMENTS 	Three months ended September 30 	Nine months ended September 30
2021 	2020 	V 	% 	2021 	2020 	V 	%
Aviation 	$ 	5,398 	$ 	4,919 	10 	% 	$ 	15,230 	$ 	16,196 	(6) 	%
Healthcare 	4,339 	4,565 	(5) 	% 	13,100 	13,185 	(1) 	%
Renewable Energy 	4,208 	4,525 	(7) 	% 	11,505 	11,224 	3 	%
Power 	4,026 	4,025 	— 	% 	12,242 	12,206 	— 	%
Capital 	734 	758 	(3) 	% 	2,470 	2,455 	1 	%
Total segment revenues 	18,704 	18,793 	— 	% 	54,546 	55,266 	(1) 	%
Corporate items and eliminations 	(275) 	(264) 	(4) 	% 	(720) 	(443) 	(63) 	%
Consolidated revenues 	$ 	18,429 	$ 	18,529 	(1) 	% 	$ 	53,826 	$ 	54,823 	(2) 	%
Aviation 	$ 	846 	$ 	350 	F 	$ 	1,664 	$ 	665 	F
Healthcare 	704 	738 	(5) 	% 	2,203 	2,111 	4 	%
Renewable Energy 	(151) 	(51) 	U 	(484) 	(628) 	23 	%
Power 	204 	148 	38 	% 	416 	(32) 	F
Capital 	(142) 	(29) 	U 	(887) 	(692) 	(28) 	%
Total segment profit (loss) 	1,461 	1,156 	26 	% 	2,912 	1,424 	F
Corporate items and eliminations 	(74) 	(1,515) 	95 	% 	2 	6,182 	U
GE Industrial goodwill impairments 	— 	— 	— 	% 	— 	(877) 	F
GE Industrial interest and other financial charges 	(225) 	(313) 	28 	% 	(753) 	(1,016) 	26 	%
GE Industrial debt extinguishment costs 	— 	— 	— 	% 	(645) 	(63) 	U
GE Industrial non-operating benefit costs 	(426) 	(603) 	29 	% 	(1,376) 	(1,815) 	24 	%
GE Industrial benefit (provision) for income taxes 	(81) 	143 	U 	(1) 	22 	U
GE Industrial preferred stock dividends 	(52) 	— 	U 	(139) 	— 	U
Earnings (loss) from continuing operations attributable to GE
common shareholders 	603 	(1,132) 	F 	(1) 	3,857 	U
Earnings (loss) from discontinued operations
attributable to GE common shareholders 	602 	(58) 	F 	(2,856) 	(1,070) 	U
Consolidated net earnings (loss) attributable to the GE
common shareholders 	$ 	1,205 	$ 	(1,190) 	F 	$ 	(2,857) 	$ 	2,787 	U
*Non-GAAP Financial Measure
2021 3Q FORM 10-Q 	7

-- 7 of 79 --

AVIATION. The global COVID-19 pandemic continues to have a material adverse effect on the global airline industry, although Aviation’s results in the third
quarter of 2021 reflect improvement in market fundamentals. A key underlying driver of Aviation’s commercial engine and services business is global commercial
air traffic, which in turn is driven by economic activity and consumer and business propensity to travel. Since the beginning of the pandemic in the first quarter of
2020, we have seen varied levels of recovery in global markets. Government travel restrictions, public health advisories, individuals' propensity to travel and
continued cases of the virus have all impacted the level of air travel. Aviation regularly tracks global departures, which as of September 30, 2021, were
approximately 25% below third quarter 2019. Broadly, global departures improved in the third quarter of 2021 compared to the second quarter of 2021, but levels
of recovery varied across regions due in large part to the emergence of the COVID-19 Delta variant. Aviation is closely monitoring government actions and
economic and industry forecasts. We are in frequent dialogue with our airline and airframe customers about the outlook for commercial air travel, new aircraft
production, fleet retirements, and after-market services, including shop visit and spare parts demand. Given current trends, we expect domestic travel routes
primarily served by narrowbody aircraft to recover before long-haul, international travel routes, which are primarily served by widebody aircraft. Consistent with
industry projections, Aviation continues to estimate the duration of the market recovery to be prolonged over multiple years, dependent on containing the spread
of the virus, effective inoculation programs and government collaboration to encourage travel, particularly around reducing quarantine requirements.
Aviation has taken several actions to respond to the current adverse environment. Aviation is actively monitoring the pace of demand recovery to ensure the
business is appropriately sized for the future. In addition, we continue to partner with our airline and leasing customers and collaborate with our airframe partners
on production rates for 2021 and beyond.
As it relates to the military environment, Aviation continues to forecast strong military demand creating future growth opportunities for our Military business unit
as the U.S. Department of Defense and foreign governments have continued flight operations, and have allocated budgets to upgrade and modernize their
existing fleets. During the third quarter of 2021, Aviation continued to experience supply chain challenges, which the business is actively addressing.
Total engineering, comprising company, customer and partner-funded and nonrecurring engineering costs, decreased compared to prior year in line with the
changes in the commercial environment and due to the timing of planned program expenditures. Aviation continues to be committed to investment in developing
and maturing technology that enables a more sustainable future of flight. In June 2021, Aviation and Safran announced Revolutionary Innovation for Sustainable
Engines (RISE), a technology development program targeting more than 20% lower fuel consumption and CO2 emissions compared to today’s engines. In
September 2021, Aviation’s Catalyst engine, the first clean-sheet turboprop design entering the business and general aviation market in 50 years, completed its
first flight.
Aviation is taking actions to protect its ability to serve its customers now and as the global airline industry recovers. Aviation’s deep history of innovation and
technology leadership, commercial engine installed base of approximately 37,700 units, with approximately 12,800 units under long-term service agreements,
and military engine installed base of approximately 26,500 units represents strong long-term fundamentals. Aviation expects to emerge from this crisis stronger
and drive long-term cash and profitable growth over time.
Three months ended September 30 	Nine months ended September 30
Sales in units, except where noted 	2021 	2020 	2021 	2020
Commercial Engines(a) 	377 	391 	1,119 	1,283
LEAP Engines(b) 	226 	172 	625 	622
Military Engines 	154 	107 	405 	457
Spare Parts Rate(c) 	$ 	19.3 	$ 	14.4 	$ 	15.8 	$ 	18.1
(a) Commercial Engines now includes Business and General Aviation and Aeroderivative units for all periods presented.
(b) LEAP engines are subsets of commercial engines.
(c) Commercial externally shipped spare parts and spare parts used in time and material shop visits in millions of dollars per day.
September 30, 2021 	December 31, 2020 	September 30, 2020
Equipment 	$ 	11,523 	$ 	10,597 	$ 	10,373
Services 	111,224 	103,500 	103,015
Total RPO 	$ 	122,747 	$ 	114,097 	$ 	113,388
Three months ended September 30 	Nine months ended September 30
2021 	2020 	2021 	2020
Commercial Engines & Services 	$ 	3,602 	$ 	3,087 	$ 	10,071 	$ 	10,718
Military 	1,107 	1,137 	3,104 	3,258
Systems & Other 	689 	696 	2,055 	2,220
Total segment revenues 	$ 	5,398 	$ 	4,919 	$ 	15,230 	$ 	16,196
Equipment 	$ 	1,837 	$ 	1,933 	$ 	5,549 	$ 	6,234
Services 	3,562 	2,987 	9,681 	9,961
Total segment revenues 	$ 	5,398 	$ 	4,919 	$ 	15,230 	$ 	16,196
Segment profit 	$ 	846 	$ 	350 	$ 	1,664 	$ 	665
Segment profit margin 	15.7 	% 	7.1 	% 	10.9 	% 	4.1 	%
2021 3Q FORM 10-Q 	8

-- 8 of 79 --

For the three months ended September 30, 2021, segment revenues were up $0.5 billion (10%) and segment profit was up $0.5 billion.
Revenues increased $0.5 billion (10%) organically*. Commercial Services revenues increased, primarily due to higher volume on commercial spare part
shipments and increased shop visit volume. Commercial Engines revenues decreased due to 14 fewer commercial install and spare engine unit shipments,
driven by fewer engine shipments on legacy programs, partially offset by 54 more LEAP units versus the prior year. Military revenues decreased marginally due
to lower services, partially offset by 47 more engine shipments.
Profit increased $0.5 billion organically*, primarily due to higher volume on commercial spare part shipments, increased shop visit volume and the receipt of a
payment from a partner associated with engine program activity. Profit also increased due to operational cost reduction from the actions taken in 2020 and the
first half of 2021 and the nonrecurrence of prior year charges related to lower commercial engine production volume and an impairment charge in a joint venture
in the Systems business.
For the nine months ended September 30, 2021, segment revenues were down $1.0 billion (6%) and segment profit was up $1.0 billion.
RPO as of September 30, 2021 increased $8.7 billion (8%) from December 31, 2020, due to increases in both equipment and services. Equipment increased
primarily due an increase in Military orders in the third quarter of 2021, reflecting a large order from Hindustan Aeronautics for 99 F404s, along with multiple other
T700 orders. Services increased primarily as a result of engines contracted under long-term service agreements that have now been put into service. RPO
increased $9.4 billion (8%) from September 30, 2020, due to increases in both equipment and services.
Revenues decreased $0.9 billion (6%) organically*. Commercial Engines revenues decreased, due to 164 fewer commercial install and spare engine unit
shipments, including fewer engine shipments on legacy programs, offset by three more LEAP units versus the prior year. Commercial Services revenues
increased, primarily due to higher volume on commercial spare part shipments and increased shop visit volume. Commercial Services revenues for the nine
months ended September 30, 2021, included a net unfavorable change in estimated profitability of $0.3 billion for its long-term service agreements compared to
a net unfavorable change of $0.9 billion for the same period in the prior year. Military revenues decreased due to lower services, partially offset by product mix
with 52 fewer engine shipments.
Profit increased $1.0 billion organically*, primarily due to lower net unfavorable changes in estimated profitability in long-term service agreements, operational
cost reduction from the actions taken in 2020 and the first half of 2021, and the nonrecurrence of prior year charges related to customer credit risk and lower
commercial engine production volumes. These increases in profit were partially offset by lower volume on commercial spare part shipments and an accrual for a
contract in a loss position in the long-term service agreement portfolio.
HEALTHCARE. 	We continue to see an overall recovery in hospital spending; the expectation is that this will continue in line with the worldwide COVID-19
vaccine rollout. Both HCS and PDx demand has largely recovered to pre-COVID levels. Similar to many industries, we are experiencing inflation in our supply
chain as well as delays in sourcing key materials needed for our products, such as electronics and resins, delaying our ability to convert RPO to revenue. In
response to near-term volatility and cost pressures, we have continued to execute on structural cost reductions and cash optimization actions, in order to invest
in growth and research and development.
We continue to grow and invest in precision health, with focus on creating new products and digital solutions as well as expanding uses of existing offerings that
are tailored to the different needs of our global customers. Healthcare recently launched CarestationTM Insights LIVE, a mobile application designed for
anesthesiologists overseeing operating room patients, using data from GE patient monitors and anesthesia Carestations to help clinicians view patient status and
assess how therapy is being delivered in real time. We have also launched a cloud based Edison True Picture Archive and Communication System, which offers
AI-enabled decision support to help radiologists adapt to higher workloads and increased exam complexity, and improve diagnostic accuracy. We remain
committed to innovate and invest to create more integrated, efficient, and personalized precision healthcare.
In the third quarter of 2021, we entered into an agreement to acquire BK Medical, a leader in surgical ultrasound imaging and guidance, from Altaris Capital
Partners for a cash purchase price of $1.45 billion. The parties expect the transaction to close in 2022, subject to review by the relevant regulatory authorities.
September 30, 2021 	December 31, 2020 	September 30, 2020
Equipment 	$ 	3,827 	$ 	3,465 	$ 	3,489
Services 	10,425 	9,458 	9,419
Total RPO 	$ 	14,252 	$ 	12,923 	$ 	12,908
*Non-GAAP Financial Measure
2021 3Q FORM 10-Q 	9

-- 9 of 79 --

Three months ended September 30 	Nine months ended September 30
2021 	2020 	2021 	2020
Healthcare Systems (HCS) 	$ 	3,832 	$ 	4,085 	$ 	11,572 	$ 	11,056
Pharmaceutical Diagnostics (PDx) 	507 	480 	1,528 	1,300
BioPharma 	— 	— 	— 	830
Total segment revenues 	$ 	4,339 	$ 	4,565 	$ 	13,100 	$ 	13,185
Equipment 	$ 	2,187 	$ 	2,538 	$ 	6,671 	$ 	7,287
Services 	2,151 	2,027 	6,429 	5,899
Total segment revenues 	$ 	4,339 	$ 	4,565 	$ 	13,100 	$ 	13,185
Segment profit 	$ 	704 	$ 	738 	$ 	2,203 	$ 	2,111
Segment profit margin 	16.2 	% 	16.2 	% 	16.8 	% 	16.0 	%
For the three months ended September 30, 2021, segment revenues were down $0.2 billion (5%) and segment profit was down 5%.
Revenues decreased $0.3 billion (6%) organically*, driven by the nonrecurrence of the prior year order from the U.S. Department of Health and Human Services
to deliver ventilators in partnership with Ford and reductions in LCS for HCS products, partially offset by increased volume in Imaging and Ultrasound and a
return to pre-pandemic volume in PDx.
Profit decreased $0.1 billion (10%) organically*, driven by higher inflation, supply chain and restructuring costs and lower LCS equipment volume associated with
the nonrecurrence of the prior year order from the U.S. Department of Health and Human Services to deliver ventilators in partnership with Ford, partially offset
by productivity and higher PDx volume.
For the nine months ended September 30, 2021, segment revenues were down $0.1 billion (1%) and segment profit was up $0.1 billion (4%).
RPO as of September 30, 2021 increased $1.3 billion (10%) from December 31, 2020 and $1.3 billion (10%) from September 30, 2020 primarily due to services
on new contracts and renewals with large customers and from equipment on strong orders across all regions.
Revenues increased $0.4 billion (3%) organically*, driven by increased volume in Imaging and Ultrasound and a return to pre-pandemic volume in PDx, partially
offset by reductions in LCS for HCS products.
Profit increased $0.3 billion (18%) organically*, driven by increased volume for Imaging and Ultrasound products, increases in PDx volume as well as continued
cost reduction actions.
RENEWABLE ENERGY. 	Renewable Energy includes a portfolio of business units comprising Onshore Wind (with our separate LM Wind blades business), Grid
Solutions equipment and services, Hydro Solutions, and Offshore Wind and Hybrid Solutions. These businesses are uniquely positioned to lead the energy
transition with products, services and integrated solutions by growing new renewable energy generation, lowering the cost of electricity and modernizing the grid.
Across our businesses, we have RPO of $31.4 billion together with an Onshore and Offshore Wind installed base of approximately 50,000 units, of which,
approximately half are under service agreements.
While we expect long term growth in the U.S onshore wind market, pending modifications to and extension of the Production Tax Credit (PTC) has caused
further deterioration in the market outlook and continues to drive customer uncertainty. The latest Wood Mackenzie market forecast expects the U.S onshore
market to decline from 14 gigawatts of new installations in 2021 to approximately 10 gigawatts in 2022. In the international onshore wind markets, we continue to
observe strong demand. The offshore wind industry continues to experience strong global market momentum. Customer preference continues to shift to larger,
more efficient units to drive down costs and compete with other power generation options and we are monitoring the impact across the industry from rising
inflationary costs of transportation and commodities. The Grid and Hydro business units are executing their turnaround plans and we are observing improved
operating results. Underwriting discipline, risk management and commercial selectivity of new orders remains a key priority across each of our businesses.
New product introductions remain important to our onshore and offshore customers who are demonstrating the willingness to adopt the new technology of larger
turbines that decrease the levelized cost of energy. We have observed significant market demand for our 5-6 MW Cypress and 3-4 MW Sierra Onshore units and
our 12-14 MW Haliade-X Offshore units. Our Haliade-X prototype unit is currently operating at 14MW, a first in the industry. Preparing for large scale production,
while reducing the cost of these new product platforms and blade technologies remains a key priority. At Grid Solutions, new technology such as flexible
transformers and g³ switchgears are solving for a more resilient and efficient electric grid and lower emissions, respectively.
Three months ended September 30 	Nine months ended September 30
Onshore and Offshore sales in units 	2021 	2020 	2021 	2020
Wind Turbines 	1,083 	1,170 	2,748 	2,731
Wind Turbine Gigawatts 	3.6 	3.4 	8.9 	7.8
Repower units 	27 	300 	276 	876
September 30, 2021 	December 31, 2020 	September 30, 2020
Equipment 	$ 	18,211 	$ 	18,273 	$ 	17,579
Services 	13,214 	12,531 	10,767
Total RPO 	$ 	31,425 	$ 	30,804 	$ 	28,346
*Non-GAAP Financial Measure
2021 3Q FORM 10-Q 	10

-- 10 of 79 --

Three months ended September 30 	Nine months ended September 30
2021 	2020 	2021 	2020
Onshore Wind 	$ 	3,047 	$ 	3,303 	$ 	8,048 	$ 	7,914
Grid Solutions equipment and services 	759 	936 	2,330 	2,587
Hydro 	190 	160 	549 	490
Offshore Wind and Hybrid Solutions 	211 	127 	577 	232
Total segment revenues 	$ 	4,208 	$ 	4,525 	$ 	11,505 	$ 	11,224
Equipment 	$ 	3,695 	$ 	3,771 	$ 	9,844 	$ 	9,068
Services 	512 	754 	1,661 	2,155
Total segment revenues 	$ 	4,208 	$ 	4,525 	$ 	11,505 	$ 	11,224
Segment profit (loss) 	$ 	(151) 	$ 	(51) 	$ 	(484) 	$ 	(628)
Segment profit margin 	(3.6) 	% 	(1.1) 	% 	(4.2) 	% 	(5.6) 	%
For the three months ended September 30, 2021, segment revenues were down $0.3 billion (7%) and segment losses were up $0.1 billion.
Revenues decreased $0.4 billion (9%) organically*, primarily from 273 fewer U.S. repower unit deliveries and lower volumes in Grid Solutions due to continued
commercial selectivity, in addition to 87 fewer wind turbine deliveries on a unit basis, which was largely driven by PTC uncertainty and customer site readiness in
the U.S. These decreases were partially offset by higher core Onshore services revenue and higher revenue from the Offshore EDF 6 MW project in Saint
Nazaire, France.
Segment losses increased $0.1 billion organically*, primarily from lower repower volume, lower margins on new product introductions and higher supply chain
costs at Onshore, lower volumes at Grid and higher costs at Offshore Wind from legacy projects, partially offset by the favorable impact of cost reduction actions
across our businesses and improved project execution at Grid and Hydro.
For the nine months ended September 30, 2021, segment revenues were up $0.3 billion (3%) and segment losses were down $0.1 billion (23%).
RPO as of September 30, 2021 increased $0.6 billion (2%) from December 31, 2020 primarily driven by the Offshore Vineyard Wind and Dogger Bank wind
farms and from higher Onshore services, partially offset by equipment sales exceeding new orders at Onshore and Grid. 	The decrease at Onshore Wind is
largely driven by PTC dynamics in North America, while at Grid is primarily due to increased commercial selectivity in certain 	product lines. RPO increased $3.1
billion (11%) from September 30, 2020, primarily driven by new Haliade-X orders at Offshore Wind.
Revenues decreased $0.1 billion (1%) organically*, primarily from lower repower unit deliveries at Onshore Wind and lower revenue at Grid due to increased
commercial selectivity, partially offset by 17 more wind turbine deliveries and higher revenue at Offshore Wind’s EDF 6 MW project in Saint Nazaire, France.
Segment losses decreased $0.2 billion (29%) organically*, primarily from higher new unit volume at Onshore Wind, the favorable impact of cost reduction
actions, and improved project execution. These improvements were partially offset by lower margins on new product introductions, lower repower units at
Onshore Wind and higher restructuring costs.
POWER. 	Power continues to streamline its business to better align with market demand and drive its business units with an operational rigor and discipline that
is focused on its customers’ lifecycle experience. We remain focused on our underwriting discipline, commercial selectivity and risk management to ensure we
are securing deals that meet our financial hurdles and we have a high confidence to deliver for our customers.
During the current period, global gas generation was down high-single-digits due to price-driven gas-to-coal switching. However, GE gas turbine utilization
continues to be resilient as megawatt hours grew low-single-digits. Looking ahead, we anticipate the power market to continue to be impacted by overcapacity in
the industry, continued price pressure from competition on servicing the installed base, and the uncertain timing of deal closures due to financing and the
complexities of working in emerging markets, as well as the ongoing impacts of COVID-19. Although market factors related to the energy transition such as
greater renewable energy penetration and the adoption of climate change-related policies continue to impact long-term demand, to differing degrees across
markets globally, we expect the gas market to remain stable through the next decade with gas generation continuing to grow low-single-digits. We believe gas
will play a critical role in the energy transition. We are encouraged by the growth in Gas Power Services, while at the same time, Steam Power continues to
execute on the exit of new build coal.
We continue to invest in new product development, such as our HA-Turbines. Our fundamentals remain strong with approximately $70.5 billion in RPO and a gas
turbine installed base greater than 7,000 units, including approximately 1,800 units under long-term service agreements.
Three months ended September 30 	Nine months ended September 30
Sales in units 	2021 	2020 	2021 	2020
GE Gas Turbines 	22 	11 	47 	43
Heavy-Duty Gas Turbines(a) 	14 	9 	34 	29
HA-Turbines(b) 	5 	3 	11 	12
Aeroderivatives(a) 	8 	2 	13 	14
(a) Heavy-Duty Gas Turbines and Aeroderivatives are subsets of GE Gas Turbines.
(b) HA-Turbines are a subset of Heavy-Duty Gas Turbines.
*Non-GAAP Financial Measure
2021 3Q FORM 10-Q 	11

-- 11 of 79 --

September 30, 2021 	December 31, 2020 	September 30, 2020
Equipment 	$ 	14,231 	$ 	14,991 	$ 	14,774
Services 	56,257 	58,318 	58,160
Total RPO 	$ 	70,488 	$ 	73,308 	$ 	72,934
Three months ended September 30 	Nine months ended September 30
2021 	2020 	2021 	2020
Gas Power 	$ 	2,861 	$ 	2,940 	$ 	8,739 	$ 	8,876
Steam Power 	790 	769 	2,327 	2,340
Power Conversion, Nuclear and other 	376 	316 	1,176 	990
Total segment revenues 	$ 	4,026 	$ 	4,025 	$ 	12,242 	$ 	12,206
Equipment 	$ 	1,368 	$ 	1,595 	$ 	3,680 	$ 	4,589
Services 	2,658 	2,430 	8,561 	7,617
Total segment revenues 	$ 	4,026 	$ 	4,025 	$ 	12,242 	$ 	12,206
Segment profit (loss) 	$ 	204 	$ 	148 	$ 	416 	$ 	(32)
Segment profit margin 	5.1 	% 	3.7 	% 	3.4 	% 	(0.3) 	%
For the three months ended September 30, 2021, segment revenues were flat and segment profit was up $0.1 billion (38%).
Revenues decreased 1% organically*, primarily due to decreases in Steam Power equipment revenues and decreases in Gas Power equipment revenues on
lower turnkey sales, partially offset by increases in Steam Power services revenues and Gas Power services revenues on strong long-term service agreement
volume.
Profit increased 34% organically* due to increases in Gas Power services revenues and margins and aeroderivative sales.
For the nine months ended September 30, 2021, segment revenues were flat and segment profit was up $0.4 billion.
RPO as of September 30, 2021 decreased $2.8 billion (4%) and $2.4 billion (3%) from December 31, 2020 and September 30, 2020, respectively, primarily
driven by sales outpacing new orders in Gas Power contractual services and the continued wind down of the Steam Power new build coal business.
Revenues decreased $0.2 billion (2%) organically*, primarily due to decreased Gas Power equipment revenues on lower turnkey sales, partially offset by an
increase in Gas Power services revenues.
Profit increased $0.5 billion organically* due to increases in Gas Power services revenues and margins and aeroderivative sales, continued efforts to streamline
the businesses, and a prior year charge related to an under-performing joint venture (JV) in China at Gas Power and the nonrecurrence of a quality reserve on
the legacy product line that we have since exited at Power Conversion, partially offset by unfavorable legacy project arbitration resolutions and Steam Power
project execution.
CAPITAL. 	In the first quarter of 2021, we announced an agreement to combine GECAS with AerCap, for which the Company expects to receive approximately
$22.6 billion in cash, inclusive of estimated contractual closing adjustments, 111.5 million shares of AerCap common stock (approximately 46% ownership
interest) valued at approximately $6.4 billion based on the AerCap’s closing share price of $57.81 on September 30, 2021, and $1 billion in AerCap notes. The
Company expects to transfer GECAS’ net assets, including its engine leasing and Milestone helicopter leasing business units, as well as GECAS’ more than 400
employees and its current purchase obligations, to AerCap. In addition, upon the closing of the transaction, the remainder of GE Capital will be reported within
Corporate. In October 2021, we received final regulatory approvals and are now expecting the transaction to be completed on November 1, 2021.
In connection with the signing of the transaction agreement, GE Capital recorded a total non-cash after-tax charge of $3.6 billion in discontinued operations for
the nine months ended September 30, 2021, and the results of GECAS are now presented in discontinued operations.
In the first quarter of 2021, we announced our intention to discontinue the majority of our factoring programs in WCS, which was effective April 1, 2021.
We annually perform premium deficiency testing in the aggregate across our run-off insurance portfolio in the third quarter. As a result of the testing, we identified
no premium deficiency in the third quarter of 2021. See the Other Items section and Note 13 to the consolidated financial statements for further information.
September 30, 2021 	December 31, 2020
Energy Financial Services (EFS) 	$ 	2,358 	$ 	2,385
Working Capital Solutions (WCS) 	1,337 	5,884
Insurance 	50,839 	50,824
Other continuing operations(a) 	11,762 	18,577
Total segment assets - continuing operations 	$ 	66,295 	$ 	77,670
(a) Included cash, cash equivalents and restricted cash of $6,834 million and $13,245 million and deferred income taxes of $3,595 million and $3,680 million as
of September 30, 2021 and December 31, 2020, respectively.
*Non-GAAP Financial Measure
2021 3Q FORM 10-Q 	12

-- 12 of 79 --

Three months ended September 30 	Nine months ended September 30
2021 	2020 	2021 	2020
EFS 	$ 	(75)	$ 	15$ 	(32)	$ 	77
WCS 	28 	57 	105 	270
Insurance 	770 	764 	2,348 	2,167
Other continuing operations 	11 	(78) 	49 	(59)
Total segment revenues 	$ 	734$ 	758$ 	2,470	$ 	2,455
EFS 	$ 	18$ 	18$ 	70	$ 	13
WCS 	(2) 	15 	(8) 	51
Insurance 	52 	57 	360 	78
Other continuing operations(a) 	(211) 	(119) 	(1,310) 	(834)
Total segment profit (loss) 	$ 	(142)	$ 	(29)$ 	(887)	$ 	(692)
(a) Other continuing operations primarily comprised excess interest costs from debt previously allocated to assets that have been sold, interest costs not
allocated to GE Capital businesses, and preferred stock dividend costs prior to January 2021, at which time these became a GE Industrial obligation (see
Note 17 for further information). Interest costs are allocated to GE Capital businesses based on the tenor of their assets using the market rate at the time of
origination, which differs from the asset profile when the debt was originated. As a result, actual interest expense is higher than interest expense allocated to
the remaining GE Capital businesses. We anticipate unallocated interest costs to gradually decline as debt matures and/or is refinanced.
For the three months ended September 30, 2021, segment revenues decreased 3% and segment losses increased $0.1 billion.
Capital revenues decreased 3%, as lower factoring revenue and EFS gains were partially offset by lower marks and impairments.
Capital losses increased $0.1 billion primarily as a result of lower tax benefits, partially offset by the discontinuation of preferred dividend payments to GE
Industrial.
For the nine months ended September 30, 2021, segment revenues increased 1% and segment losses increased $0.2 billion (28%).
Capital revenues increased 1%, primarily as a result of lower marks and impairments primarily in Insurance, partially offset by lower WCS factoring revenue and
project revenues at EFS.
Capital losses increased $0.2 billion (28%) primarily as a result of higher debt extinguishment costs, lower tax benefits and the nonrecurrence of the tax benefit
related to the BioPharma sale in the first quarter of 2020, partially offset by the discontinuation of preferred dividend payments to GE Industrial, lower marks and
impairments in Insurance and EFS, lower interest expense due to a lower debt balance and lower claims and higher terminations in Insurance.
CORPORATE ITEMS AND ELIMINATIONS. 	Corporate items and eliminations includes the results of our Lighting segment, through its disposition in the
second quarter of 2020, and GE Digital business for all periods presented.
Three months ended September 30 	Nine months ended September 30
2021 	2020 	2021 	2020
Revenues
Corporate revenues 	$ 	237 	$ 	251 	$ 	693 	$ 	1,039
Eliminations and other 	(512) 	(515) 	(1,412) 	(1,482)
Total Corporate Items and Eliminations 	$ 	(275) 	$ 	(264) 	$ 	(720) 	$ 	(443)
Operating profit (cost)
Gains (losses) on purchases and sales of business interests 	$ 	(156) 	$ 	28 	$ 	(159) 	$ 	12,431
Gains (losses) on equity securities 	412 	(669) 	1,256 	(4,527)
Restructuring and other charges 	(64) 	(91) 	(395) 	(523)
Steam asset impairments(a) (Notes 7 & 8) 	— 	(363) 	— 	(363)
SEC settlement charge(b) 	— 	(100) 	— 	(100)
Goodwill impairments(c) (Note 8) 	— 	— 	— 	(728)
Adjusted total corporate operating costs (Non-GAAP) 	(266) 	(321) 	(701) 	(885)
Total Corporate Items and Eliminations (GAAP) 	$ 	(74) 	$ 	(1,515) 	$ 	2 	$ 	5,305
Less: gains (losses) and restructuring & other 	192 	(1,195) 	702 	6,190
Adjusted total corporate operating costs (Non-GAAP) 	$ 	(266) 	$ 	(321) 	$ 	(701) 	$ 	(885)
Functions & operations 	$ 	(152) 	$ 	(246) 	$ 	(475) 	$ 	(709)
Environmental, health and safety (EHS) and other items 	(100) 	(21) 	(184) 	8
Eliminations 	(13) 	(54) 	(42) 	(184)
Adjusted total corporate operating costs (Non-GAAP) 	$ 	(266) 	$ 	(321) 	$ 	(701) 	$ 	(885)
(a) Included non-cash pre-tax impairment charges of $429 million, net of $65 million attributable to noncontrolling interests for the Steam business within our
Power segment in 2020.
(b) GE reached a settlement with the SEC and paid a civil penalty of $200 million in December 2020, of which $100 million was recorded and paid at Corporate
and $100 million was recorded and paid at GE Capital.
(c) Included a non-cash pre-tax impairment charge of $877 million, net of $149 million attributable to noncontrolling interest, for our Additive reporting unit within
our Aviation segment for the nine months ended September 30, 2020.
2021 3Q FORM 10-Q 	13

-- 13 of 79 --

Adjusted total corporate operating costs* excludes gains (losses) on purchases and sales of business interests, significant higher-cost restructuring programs,
gains (losses) on equity securities and goodwill impairments. We believe that adjusting corporate costs to exclude the effects of items that are not closely
associated with ongoing corporate operations provides management and investors with a meaningful measure that increases the period-to-period comparability
of our ongoing corporate costs.
For the three months ended September 30, 2021, revenues remained relatively flat year over year. Corporate operating profit increased by $1.4 billion
primarily due to a $1.1 billion change in gains/(losses) on equity securities primarily related to mark-to-market activity on our Baker Hughes shares. In addition,
Corporate operating profit also increased due to the nonrecurrence of $0.4 billion of non-cash impairment charges related to property, plant and equipment and
intangible assets at our Steam business within our Power segment, and $0.1 billion legal reserves associated with the settlement of the SEC investigation in
2020. These increases were partially offset by $0.2 billion of higher losses on purchases and sales of business interests due to a $0.2 billion held for sale loss
within our Power segment in 2021.
Adjusted total corporate operating costs* were down $0.1 billion due to lower costs associated with our Corporate functions and operations partially offset by
higher costs associated with EHS and other items.
For the nine months ended September 30, 2021, revenues decreased by $0.3 billion, primarily due to the sale of our Lighting business in June 2020, partially
offset by $0.1 billion of lower inter-segment eliminations. Corporate operating profit decreased by $5.3 billion due to $12.6 billion of lower gains on purchases and
sales of business interests primarily due to a $12.4 billion gain from the sale of our BioPharma business in 2020 and a $0.2 billion held for sale loss within our
Power segment in 2021. This decrease was partially offset by a $5.8 billion change in gains (losses) on equity securities primarily related to mark-to-market
activity on our Baker Hughes shares. In addition, Corporate operating profit increased due to the nonrecurrence of a $0.7 billion non-cash goodwill impairment
charge related to our Aviation segment, $0.4 billion of non-cash impairment charges related to property, plant and equipment and intangible assets at our Steam
business within our Power segment, and $0.1 billion legal reserves associated with the settlement of the SEC investigation in 2020. Restructuring and other
charges decreased by $0.1 billion due to lower restructuring in Aviation and Corporate, partially offset by higher restructuring in our Power segment, primarily
related to our exit from the new build coal power market.
Adjusted total corporate operating costs* decreased by $0.2 billion primarily as the result of $0.2 billion of cost reductions in our Corporate functions and
operations. Costs also decreased due to $0.1 billion of lower intercompany profit eliminations primarily as the result of lower activity from project financing
investments associated with wind energy projects in our Renewable Energy segment.
OTHER CONSOLIDATED INFORMATION
RESTRUCTURING. 	Restructuring actions are essential to our cost improvement efforts for both existing operations and those acquired. Restructuring and other
charges relate primarily to workforce reductions, facility exit costs associated with the consolidation of sales, service and manufacturing facilities, the integration
of acquisitions, and certain other asset write-downs such as those associated with product line exits. We also recognize an obligation for severance benefits that
vest or accumulate with service. We continue to closely monitor the economic environment and expect to undertake further restructuring actions to more closely
align our cost structure with earnings goals. This table is inclusive of all restructuring charges in our segments and at Corporate, and the charges are shown
below for the business where they originated. Separately, in our reported industrial segment results, significant, higher-cost restructuring programs are excluded
from measurement of segment operating performance for internal and external purposes; those excluded amounts are reported in Restructuring and other
charges for Corporate (see the Corporate Items and Eliminations section).
Three months ended September
30 	Nine months ended September 30
2021 	2020 	2021 	2020
Workforce reductions 	$ 	132 	$ 	137 	$ 	634 	$ 	630
Plant closures & associated costs and other asset write-downs 	23 	93 	87 	201
Acquisition/disposition net charges 	9 	12 	16 	57
Total restructuring and other charges 	$ 	164 	$ 	242 	$ 	736 	$ 	888
Cost of product/services 	$ 	61 	$ 	111 	$ 	349 	$ 	368
Selling, general and administrative expenses 	103 	131 	393 	520
Other income 	— 	— 	(7) 	—
Total restructuring and other charges 	$ 	164 	$ 	242 	$ 	736 	$ 	888
Aviation 	$ 	3 	$ 	65 	$ 	64 	$ 	309
Healthcare 	68 	28 	127 	104
Renewable Energy 	14 	58 	149 	142
Power 	65 	31 	341 	159
Corporate 	9 	45 	39 	154
Total GE Industrial restructuring and other charges 	$ 	160 	$ 	226 	$ 	720 	$ 	867
Capital 	4 	16 	16 	21
Total restructuring and other charges 	$ 	164 	$ 	242 	$ 	736 	$ 	888
Restructuring and other charges cash expenditures 	$ 	152 	$ 	321 	$ 	565 	$ 	856
*Non-GAAP Financial Measure
2021 3Q FORM 10-Q 	14

-- 14 of 79 --

Liabilities associated with restructuring activities were approximately $1.4 billion and $1.3 billion as of September 30, 2021 and December 31, 2020, respectively,
including actuarial determined post-employment severance benefits of $0.7 billion in both periods.
INTEREST AND OTHER FINANCIAL CHARGES Three months ended September
30 	Nine months ended September 30
2021 	2020 	2021 	2020
GE Industrial 	$ 	225 	$ 	313 	$ 	753 	$ 	1,016
GE Capital 	259 	267 	799 	821
The decrease in GE Industrial interest and other financial charges for the three months ended September 30, 2021 was primarily due to a lower debt balance
and lower financing costs on sales of receivables. The decrease in GE Industrial interest and other financial charges for the nine months ended September 30,
2021 was primarily due to a lower intercompany loan balance and lower financial costs on the sales of receivables, partially offset by a higher average interest
rate on debt. Total GE interest and other financial charges of $0.2 billion and $0.2 billion was recorded at Corporate and $0.1 billion and $0.1 billion was
recorded by the industrial segments for the three months ended September 30, 2021 and 2020, respectively, and $0.5 billion and $0.7 billion was recorded at
Corporate and $0.2 billion and $0.3 billion was recorded by the industrial segments for the nine months ended September 30, 2021 and 2020, respectively.
The decrease in GE Capital interest and other financial charges during the three and nine months ended September 30, 2021 was primarily due to lower average
borrowing balances and weighted average interest rates, partially offset by a lower allocation of interest expense to discontinued operations.
CONSOLIDATED INCOME TAXES. For the three months ended September 30, 2021, the consolidated income tax rate was 0.3% compared to 29.8% for the
three months ended September 30, 2020. The tax rate for 2020 reflects a tax benefit on a pre-tax loss.
The consolidated provision (benefit) for income taxes was an insignificant provision for the three months ended September 30, 2021 and $(0.5) billion for the
three months ended September 30, 2020. The income tax provision went from a benefit to an insignificant expense primarily due to an increase in tax associated
with pre-tax income for the three months ended September 30, 2021 compared to a pre-tax loss for the three months ended September 30, 2020, including tax
expense associated with the realized and unrealized gain on our remaining interest in Baker Hughes for the three months ended September 30, 2021, compared
to a tax benefit associated with the unrealized loss recorded for the three months ended September 30, 2020. Additionally, there was a tax expense in the third
quarter of 2021 compared to a tax benefit in the third quarter of 2020 to adjust the year-to-date tax rate to be in-line with the projected full-year rate.
The consolidated tax provision (benefit) includes $0.1 billion and $(0.1) billion for GE Industrial for the three months ended September 30, 2021 and 2020,
respectively.
For the nine months ended September 30, 2021, the consolidated income tax rate was 149.5% compared to (17.4)% for the nine months ended September
30, 2020. The tax rate for 2021 reflects a tax benefit on a pre-tax loss. The negative tax rate for 2020 reflects a tax benefit on pre-tax income.
The consolidated (benefit) for income taxes was $(0.3) billion for the nine months ended September 30, 2021 and $(0.6) billion for the nine months ended
September 30, 2020. The benefit decreased due to tax associated with the increase in pre-tax income, excluding gains on BioPharma for the nine months ended
September 30, 2021 as compared to the nine months ended September 30, 2020. The increase in pre-tax income includes realized and unrealized gain on our
remaining interest in Baker Hughes for the nine months ended September 30, 2021, compared to unrealized loss for the nine months ended September 30,
2020. Partially offsetting these items was the nonrecurrence of the tax expense associated with the disposition of the BioPharma business in the first quarter of
2020, as well as tax benefits associated with internal restructurings to recognize historical losses due to decreases in fair value.
The consolidated tax provision (benefit) includes an insignificant amount for GE Industrial in both the nine months ended September 30, 2021 and 2020,
respectively.
DISCONTINUED OPERATIONS 	primarily comprise our GECAS business, our mortgage portfolio in Poland, and other trailing assets and liabilities associated
with prior dispositions. See Notes 2 and 21 for further financial information.
CAPITAL RESOURCES AND LIQUIDITY
FINANCIAL POLICY. We intend to maintain a disciplined financial policy, targeting a sustainable long-term credit rating in the Single-A range, achieving a GE
Industrial net debt*-to-EBITDA ratio of less than 2.5x over the next few years and a dividend in line with our peers over time. In addition to net debt*-to-EBITDA,
we also evaluate other leverage measures, including gross debt-to-EBITDA, and we will ultimately size our deleveraging actions across a range of measures to
ensure we are operating the Company based on a strong balance sheet.
Following the closing of the GECAS transaction, the Company intends to use the transaction proceeds and its existing cash sources to significantly reduce debt.
*Non-GAAP Financial Measure
2021 3Q FORM 10-Q 	15

-- 15 of 79 --

LIQUIDITY POLICY. 	We maintain a strong focus on liquidity and define our liquidity risk tolerance based on sources and uses to maintain a sufficient liquidity
position to meet our obligations under both normal and stressed conditions. At both GE Industrial and GE Capital, we manage our liquidity to provide access to
sufficient funding to meet our business needs and financial obligations, as well as capital allocation and growth objectives, throughout business cycles.
At GE Capital, we continue to hold cash levels to cover at least 12 months of long-term debt maturities.
We believe that our consolidated liquidity and availability under our revolving credit facilities will be sufficient to meet our liquidity needs.
CONSOLIDATED LIQUIDITY. 	Following is a summary of cash, cash equivalents and restricted cash at September 30, 2021.
September 30, 2021 	September 30, 2021
GE Industrial 	$ 	17,995 	U.S. 	$ 	12,801
GE Capital 	6,960 	Non-U.S. 	12,154
Consolidated 	$ 	24,955 	Consolidated 	$ 	24,955
Cash held in non-U.S. entities has generally been reinvested in active foreign business operations; however, substantially all of our unrepatriated earnings were
subject to U.S. federal tax and, if there is a change in reinvestment, we would expect to be able to repatriate available cash (excluding amounts held in countries
with currency controls) without additional federal tax cost. Any foreign withholding tax on a repatriation to the U.S. would potentially be partially offset by a U.S.
foreign tax credit.
GE INDUSTRIAL LIQUIDITY. 	GE Industrial's primary sources of liquidity consist of cash and cash equivalents, free cash flows from our operating businesses,
remaining receivable monetization programs, and short-term borrowing facilities, including revolving credit facilities. Cash generation can be subject to variability
based on many factors, including seasonality, receipt of down payments on large equipment orders, timing of billings on long-term contracts, market conditions
and our ability to execute dispositions. Additionally, in connection with the program we launched in 2020 to fully monetize our Baker Hughes position over
approximately three years, we received proceeds of $1.3 billion in the third quarter of 2021 and expect to receive approximately $1.2 billion in the fourth quarter
of 2021.
GE Industrial cash, cash equivalents and restricted cash totaled $18.0 billion at September 30, 2021, including $2.2 billion of cash held in countries with currency
control restrictions and $0.3 billion of restricted use cash. Cash held in countries with currency controls represents amounts held in countries that may restrict the
transfer of funds to the U.S. or limit our ability to transfer funds to the U.S. without incurring substantial costs. Restricted use cash represents amounts that are
not available to fund operations, and primarily comprised funds restricted in connection with certain ongoing litigation matters.
In the first quarter of 2021, we announced our intention to discontinue the majority of our factoring programs, which was effective April 1, 2021. The estimated
adverse impact to GE Industrial CFOA for 2021 is expected to be approximately $3.5 billion, including a total of $3.1 billion in the second and third quarters of
2021, which primarily represents the cash that GE Industrial would have otherwise collected in the period had customer receivables not been previously sold and
is excluded from GE Industrial free cash flows*.
GE CAPITAL LIQUIDITY. 	GE Capital’s primary sources of liquidity consist of cash and cash equivalents, cash generated from asset sales (including the
expected proceeds from the GECAS transaction) and cash flows from our businesses, as well as GE Industrial repayments of intercompany loans and capital
contributions from GE Industrial. We expect to maintain a sufficient liquidity position to fund our insurance obligations, debt maturities and other obligations. See
the Segment Operations - Capital section for further information regarding allocation of GE Capital interest expense to the GE Capital businesses.
GE Capital cash, cash equivalents and restricted cash totaled $7.0 billion at September 30, 2021, excluding $0.8 billion of cash in Insurance, which was
classified as All other assets on the GE Capital Statement of Financial Position.
GE Capital provided capital contributions to its insurance subsidiaries of $2.0 billion, $2.0 billion, $1.9 billion and $3.5 billion in the first quarters of 2021, 2020,
2019 and 2018, respectively, and expects to provide further capital contributions of approximately $5.5 billion through 2024. These contributions are subject to
ongoing monitoring by Kansas Insurance Department (KID), and the total amount to be contributed could increase or decrease, or the timing could be
accelerated, based upon the results of reserve adequacy testing or a decision by KID to modify the schedule of contributions set forth in January 2018. GE is
required to maintain specified capital levels at these insurance subsidiaries under capital maintenance agreements. Going forward, we anticipate funding any
capital needs for Insurance through a combination of GE Capital liquidity, GE Capital asset sales, GE Capital future earnings and capital contributions from GE
Industrial.
BORROWINGS. 	Consolidated total borrowings were $62.9 billion and $74.9 billion at September 30, 2021 and December 31, 2020, respectively, a decrease of
$12.0 billion ($12.4 billion excluding intercompany eliminations). See the following table for a summary of GE Industrial and GE Capital borrowings.
*Non-GAAP Financial Measure
2021 3Q FORM 10-Q 	16

-- 16 of 79 --

GE Industrial September 30,
2021 December 31,
2020 	GE Capital September 30,
2021 December 31,
2020
GE Industrial senior notes 	$ 	14,663 	$ 	18,994 	Senior and subordinated notes 	$ 	28,719 	$ 	30,987
Senior and subordinated notes
assumed by GE Industrial 	18,106 	22,390
Intercompany loans from
GE Capital 	3,177 	3,177
Intercompany loans to
GE Industrial 	(3,177) 	(3,177)
Other GE Industrial borrowings 898 	1,352 Other GE Capital
borrowings 	717 	1,779
Total GE Industrial 	Total GE Capital
adjusted borrowings(a)(b) 	$ 	18,738 	$ 	23,523 	adjusted borrowings(a)(b) 	$ 	44,366 	$ 	51,979
(a) Consolidated total borrowings of $62,888 million and $74,902 million at September 30, 2021 and December 31, 2020, respectively, are net of intercompany
eliminations of $216 million and $600 million, respectively, of other GE Industrial borrowings from GE Capital, primarily related to timing of cash settlements
associated with GE Industrial receivables monetization programs.
(b) Included $3,788 million and $5,687 million at September 30, 2021 and December 31, 2020, respectively, of fair value adjustments for debt in fair value hedge
relationships. See Note 19 for further information.
The reduction in GE Industrial adjusted borrowings at September 30, 2021 compared to December 31, 2020 was driven by debt repurchases of $4.1 billion, net
repayments and maturities of other debt of $0.5 billion and $0.3 billion related to changes in foreign exchange rates.
GE Industrial net debt* was $31.3 billion and $32.3 billion at September 30, 2021 and December 31, 2020, respectively. The decrease was driven primarily by a
lower debt balance of $4.8 billion, partially offset by a decrease in the net cash deduction of $3.9 billion due to a lower cash balance, mainly due to debt
repurchases.
The reduction in GE Capital adjusted borrowings at September 30, 2021 compared to December 31, 2020 was driven primarily by debt repurchases of $3.2
billion, long-term debt maturities of $1.8 billion, lower non-recourse borrowings of $0.9 billion, and $1.6 billion of fair value adjustments for debt in fair value
hedge relationships.
Liability Management Actions. 	In the second quarter of 2021, we completed a debt tender to repurchase a total of $7.3 billion of debt, comprising $4.1 billion of
GE Industrial debt with maturities ranging from 2022 through 2050, and $3.2 billion of GE Capital debt with maturities ranging from 2021 through 2039.
The following table provides a reconciliation of total short- and long-term borrowings as reported on the respective GE Industrial and GE Capital Statements of
Financial Position to borrowings adjusted for assumed debt and intercompany loans:
September 30, 2021 	GE Industrial 	GE Capital 	Consolidated
Total short- and long-term borrowings 	$ 	33,667 	$ 	29,437 	$ 	62,888
Debt assumed by GE Industrial from GE Capital(a) 	(18,106) 	18,106 	—
Intercompany loans with right of offset(a) 	3,177 	(3,177) 	—
Total intercompany payable (receivable) between GE Industrial and GE Capital 	(14,929) 	14,929 	—
Total borrowings adjusted for assumed debt and intercompany loans 	$ 	18,738 	$ 	44,366 	$ 	62,888
(a) See the Capital Resources and Liquidity section of our Annual Report on Form 10-K for the year ended December 31, 2020 for further details on the
assumed debt and intercompany loans with right of offset.
The intercompany loans from GE Capital to GE Industrial bear the right of offset against amounts owed by GE Capital to GE Industrial under the assumed debt
agreement and can be prepaid by GE Industrial at any time, in whole or in part, without premium or penalty. These loans are priced at market terms and have a
collective weighted average interest rate of 3.7% and term of approximately 15.2 years at September 30, 2021.
GE Industrial has in place committed revolving credit facilities totaling $14.5 billion at September 30, 2021, comprising a $10.0 billion unused back-up revolving
syndicated credit facility and a total of $4.5 billion of bilateral revolving credit facilities.
Under the terms of an agreement between GE Capital and GE Industrial, GE Capital has the right to compel GE Industrial to borrow under the $10.0 billion
unused back-up revolving syndicated credit facility. Under this agreement, GE Industrial would transfer the proceeds to GE Capital as intercompany loans, which
would be subject to the same terms and conditions as those between GE Industrial and the lending banks. GE Capital has not exercised this right.
CREDIT RATINGS AND CONDITIONS. 	We have relied, and may continue to rely, on the short- and long-term debt capital markets to fund, among other things,
a significant portion of our operations. The cost and availability of debt financing is influenced by our credit ratings. Moody’s Investors Service (Moody’s),
Standard and Poor’s Global Ratings (S&P), and Fitch Ratings (Fitch) currently issue separate ratings on GE Industrial and GE Capital short- and long-term debt.
The credit ratings of GE Industrial and GE Capital as of the date of this filing are set forth in the table below.
*Non-GAAP Financial Measure
2021 3Q FORM 10-Q 	17

-- 17 of 79 --

Moody's 	S&P 	Fitch
GE Industrial 	Outlook 	Negative 	CreditWatch Negative 	Stable
Short term 	P-2 	A-2 	F3
Long term 	Baa1 	BBB+ 	BBB
GE Capital 	Outlook 	Negative 	CreditWatch Negative 	Stable
Short term 	P-2 	A-2 	F3
Long term 	Baa1 	BBB+ 	BBB
In the first quarter of 2021, Moody’s and Fitch affirmed their respective credit ratings, and S&P announced that they have placed us on CreditWatch with negative
implications and currently expect to lower our credit ratings by one notch upon the closing of the GECAS transaction.
We are disclosing our credit ratings and any current quarter updates to these ratings to enhance understanding of our sources of liquidity and the effects of our
ratings on our costs of funds and access to liquidity. Our ratings may be subject to a revision or withdrawal at any time by the assigning rating organization, and
each rating should be evaluated independently of any other rating. For a description of some of the potential consequences of a reduction in our credit ratings,
see the Financial Risks section of Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2020.
Following the close of the GECAS transaction, we expect that GE Capital will no longer receive separate credit ratings on its short- or long-term debt, and as a
result our credit ratings will be issued on a consolidated basis for the Company.
Substantially all of the Company's debt agreements in place at September 30, 2021 do not contain material credit rating covenants. GE’s unused back-up
revolving syndicated credit facility and certain of our bilateral revolving credit facilities contain a customary net debt-to-EBITDA financial covenant, which GE
satisfied at September 30, 2021.
The Company may from time to time enter into agreements that contain minimum ratings requirements. The following table provides a summary of the maximum
estimated liquidity impact in the event of further downgrades below each stated ratings level.
Triggers Below 	At September 30, 2021
BBB+/A-2/P-2 	$ 	59
BBB/A-3/P-3 	576
BBB- 	986
BB+ and below 	457
Our most significant contractual ratings requirements are related to ordinary course commercial activities, our receivables sales programs, and our derivatives
portfolio. The timing within the quarter of the potential liquidity impact of these areas may differ, as can the remedies to resolving any potential breaches of
required ratings levels.
FOREIGN EXCHANGE. 	As a result of our global operations, we generate and incur a significant portion of our revenues and expenses in currencies other than
the U.S. dollar. Such principal currencies include the euro, the Chinese renminbi, the British pound sterling and the Indian rupee, among others. The effects of
foreign currency fluctuations on earnings, excluding the earnings impact of the underlying hedged item, was less than $0.1 billion for both the three and nine
months ended September 30, 2021 and 2020. This analysis excludes any offsetting effect from the forecasted future transactions that are economically hedged.
See Note 19 for further information about our risk exposures, our use of derivatives, and the effects of this activity on our financial statements.
STATEMENT OF CASH FLOWS – NINE MONTHS ENDED SEPTEMBER 30, 2021 VERSUS 2020. 	We manage the cash flow performance of our industrial and
financial services businesses separately, in order to enable us and our investors to evaluate the cash from operating activities of our industrial businesses
separately from the cash flows of our financial services business.
Transactions between GE Industrial and GE Capital are reported in the respective columns of our Statement of Cash Flows, but are eliminated in deriving our
consolidated Statement of Cash Flows. See the GE Industrial Working Capital Transactions section and Notes 4 and 22 for further information regarding certain
transactions affecting our consolidated Statement of Cash Flows.
GE INDUSTRIAL CASH FLOWS FROM CONTINUING OPERATIONS. 	The most significant source of cash in GE Industrial CFOA is customer-related activities,
the largest of which is collecting cash resulting from product or services sales. The most significant operating use of cash is to pay our suppliers, employees, tax
authorities, contribute to post retirement plans and pay others for a wide range of material, services and taxes.
GE Industrial cash used for operating activities 	was $0.8 billion in 2021, a decrease of $2.3 billion compared with 2020, primarily due to: an increase in net
income (after adjusting for the gain on the sale of BioPharma, non-cash losses related to our interest in Baker Hughes, non-operating benefit costs and non-
operating debt extinguishment costs, which are adjusted through All other operating activities) primarily due to COVID-19 impacts in our Aviation segment in
2020; a decrease in cash paid for income taxes of $0.7 billion; partially offset by a lower increase in Aviation related customer allowance accruals of $0.2 billion
and the settlement of an Alstom legacy legal matter of $0.2 billion in 2021 (components of All other operating activities). All other operating activities included
$0.5 billion and $0.8 billion increase in Aviation related customer allowance accruals and decreases in employee benefit liabilities of $0.2 billion and $0.3 billion
in 2021 and 2020, respectively.
2021 3Q FORM 10-Q 	18

-- 18 of 79 --

Changes in working capital compared to prior year were as follows: current receivables of $(1.4) billion, driven by a higher decrease in sales of receivables to
discontinued factoring programs of $(2.8) billion, partially offset by a prior year decrease in sales of receivables to our continuing unconsolidated receivables
facility of $1.1 billion which did not reoccur in 2021 and higher net collections; inventories, including deferred inventory, of $(0.7) billion, driven by lower
liquidations; current contract assets of $(0.4) billion, driven by lower net unfavorable changes in estimated profitability at Aviation; accounts payable and
equipment project accruals of $2.7 billion, driven by lower disbursements related to purchases of materials in prior periods; and progress collections and current
deferred income of $(0.2) billion, driven by higher net liquidations. Progress collections and current deferred income included lower early payments received at
our Aviation Military equipment business of $0.3 billion from a foreign government in 2021 compared to $0.7 billion from the U.S. Department of Defense in 2020.
GE Industrial cash from investing activities 	was $2.2 billion in 2021, a decrease of $17.1 billion compared with 2020, primarily due to: the nonrecurrence of
proceeds from the 2020 sale of our BioPharma business of $20.3 billion; partially offset by proceeds from the 2021 sales of a portion of our retained ownership
interest in Baker Hughes of $3.0 billion. Cash used for additions to property, plant and equipment and internal-use software, which are components of GE
Industrial free cash flows*, was $1.0 billion in 2021, down $0.5 billion compared with 2020.
GE Industrial cash used for financing activities 	was $6.5 billion in 2021, a decrease of $2.9 billion compared with 2020, primarily due to: the nonrecurrence of
repayments of commercial paper of $3.0 billion in 2020; partially offset by an increase of $0.5 billion in debt tender offers. GE Industrial paid cash to repurchase
long term debt of $4.8 billion and $4.3 billion, including debt extinguishment costs of $0.6 billion and $0.1 billion (a component of All other financing activities) in
2021 and 2020, respectively.
GE CAPITAL CASH FLOWS FROM CONTINUING OPERATIONS. GE Capital cash used for operating activities 	was $3.0 billion in 2021, an increase of
$3.6 billion compared with 2020, primarily due to: cash collateral paid, which is a standard market practice to minimize derivative counterparty exposures, and
settlements received on derivative contracts (components of All other operating activities) of $1.4 billion in 2021, compared with collateral and settlements
received of $2.2 billion in 2020.
GE Capital cash from investing activities 	was $4.0 billion in 2021, a decrease of $5.2 billion compared with 2020, primarily due to: the nonrecurrence of the
repayment of GE Capital intercompany loans of $7.5 billion by GE Industrial in 2020; a decrease in cash of $1.3 billion related to our current receivables and
supply chain finance programs with GE Industrial; partially offset by higher net collections of financing receivables of $3.7 billion, mainly driven by the
discontinuation of certain factoring programs.
GE Capital cash used for financing activities 	was $7.0 billion in 2021, a decrease of $6.8 billion compared with 2020, primarily due to: lower net repayments
of borrowings of $7.5 billion, partially offset by higher debt tender incentive and fees of $0.9 billion. GE Capital paid cash to repurchase long term debt of $3.9
billion and $10.0 billion, including debt tender incentive and fees of $1.1 billion and $0.2 billion (a component of All other financing activities), excluding a non-
cash debt basis adjustment of $0.3 billion and an insignificant amount in 2021 and 2020, respectively.
GE CAPITAL CASH FLOWS FROM DISCONTINUED OPERATIONS. 	GE Capital cash from operating activities relates primarily to cash generated from
earnings (loss) from discontinued operations in our GECAS business. GE Capital cash used for investing activities increased primarily due to an increase in net
purchases of plant, property and equipment, partially offset by an increase in net collections of financing receivables.
GE INDUSTRIAL WORKING CAPITAL TRANSACTIONS. Sales of Receivables. 	In order to manage short-term liquidity and credit exposure, GE Industrial
may sell current customer receivables to GE Capital and other third parties. These transactions are made on arms-length terms and any discount related to time
value of money is recognized within the respective GE Industrial business in the period these receivables were sold to GE Capital or third parties. See Note 4 for
further information.
Supply Chain Finance Programs. GE Industrial facilitates voluntary supply chain finance programs with third parties, which provide participating GE Industrial
suppliers the opportunity to sell their GE Industrial receivables to third parties at the sole discretion of both the suppliers and the third parties.
At September 30, 2021 and December 31, 2020, included in GE Industrial's accounts payable was $3.5 billion and $2.9 billion, respectively, of supplier invoices
that are subject to the third-party programs. Total GE Industrial supplier invoices paid through these third-party programs were $4.9 billion and $3.8 billion for the
nine months ended September 30, 2021 and 2020, respectively.
INTERCOMPANY TRANSACTIONS BETWEEN GE INDUSTRIAL AND GE CAPITAL. 	Transactions between related companies are made on arms-length
terms and are reported in the GE Industrial and GE Capital columns of our financial statements, which we believe provide useful supplemental information to our
consolidated financial statements. See Note 22 for further information.
GE Capital Finance Transactions. 	During the nine months ended September 30, 2021 and 2020, GE Capital acquired from third parties 24 aircraft with a list
price totaling $1.9 billion and eight aircraft with a list price totaling $0.8 billion, respectively, that will be leased to others and are powered by engines
manufactured by GE Aviation and affiliates. GE Capital also made payments to GE Aviation and affiliates related to spare engines and engine parts of an
insignificant amount and $0.2 billion, which included an insignificant amount and $0.1 billion to CFM International during the nine months ended September 30,
2021 and 2020, respectively. Additionally, GE Capital had $2.0 billion and $2.1 billion of net book value of engines, originally manufactured by GE Aviation and
affiliates and subsequently leased back to GE Aviation and affiliates at September 30, 2021 and December 31, 2020, respectively.
*Non-GAAP Financial Measure
2021 3Q FORM 10-Q 	19

-- 19 of 79 --

Also, during the nine months ended September 30, 2021 and 2020, GE Industrial recognized equipment revenues of $1.6 billion and $1.9 billion, respectively,
from customers within our Power and Renewable Energy segments in which GE Capital is an investee or is committed to be an investee in the underlying
projects. At September 30, 2021, GE Capital had funded related investments of $0.2 billion.
For certain of these investments, in order to meet its underwriting criteria, GE Capital may obtain a direct guarantee from GE Industrial related to the
performance of the third party. GE Industrial guarantees include direct performance or payment guarantees, return on investment guarantees and asset value
guarantees. As of September 30, 2021, GE Industrial had outstanding guarantees to GE Capital on $0.7 billion of funded exposure and an insignificant amount
of unfunded commitments, which included guarantees issued by industrial businesses. The recorded contingent liability for these guarantees was insignificant as
of September 30, 2021 and is based on individual transaction level defaults, losses and/or returns.
CRITICAL ACCOUNTING ESTIMATES. 	Please refer to the Critical Accounting Estimates and Other Items sections within MD&A and Note 1 to the
consolidated financial statements of our Annual Report on Form 10-K for the year ended December 31, 2020 for a discussion of our accounting policies and
critical accounting estimates.
OTHER ITEMS
INSURANCE. 	At September 30, 2021, our insurance liabilities and annuity benefits of $37.7 billion were primarily supported by investment securities of $41.7
billion, commercial mortgage loans of $1.8 billion, net of their allowance for losses, and equity method and other investments of $1.3 billion. The insurance
liabilities and annuity benefits primarily comprise a liability for future policy benefits for those insurance contract claims not yet incurred and claim reserves for
claims that have been incurred or are estimated to have been incurred but not yet reported.
2021 Premium Deficiency Testing. We completed our annual premium deficiency testing in the aggregate across our run-off insurance portfolio in the third
quarter of 2021. These procedures included updating experience studies since our last test completed in the third quarter of 2020, independent actuarial analysis
(principally on long-term care insurance exposures) and review of industry benchmarks. Our 2021 premium deficiency testing started with the positive margin of
less than 2% of the recorded future policy benefit reserves that resulted from our 2020 premium deficiency testing. Using updated assumptions, the 2021
premium deficiency testing results indicated a significant increase in the positive margin to approximately 11% of the related future policy benefit reserves
recorded at September 30, 2021. As a result, the assumptions updated in connection with the premium deficiency recognized in 2019 remain locked-in and will
remain so unless another premium deficiency occurs in the future.
The significant increase in the premium deficiency testing margin resulting from our 2021 premium deficiency testing was largely attributable to an increase in the
overall discount rate to a weighted average rate of 6.15% compared to 5.70% in 2020 ($2.2 billion). This increase in the discount rate from 2020 reflects further
development of our previously communicated investment portfolio realignment strategy, that includes increased amounts allocated to growth assets, consisting
of private equity, equity-like securities and select high yield credit strategies, from our current target of approximately 8% up to approximately 15%. These
amounts are expected to be funded over the next 5 to 7 years from the remaining projected capital contribution of approximately $5.5 billion through 2024 and
regular portfolio cash flows while maintaining an overall A-rated fixed income portfolio. The 2021 discount rate assumptions also reflect a lower expected
reinvestment rate on fixed-income investments versus that applied in 2020, due to lower prevailing benchmark interest rates in the U.S, grading to a lower
expected long-term average investment yield over a shorter period and slightly lower actual yields on our fixed-income investment security portfolio. As a result
of this increased allocation to higher-yielding assets, our run-off insurance operations may experience future earnings volatility due to investments carried at fair
value with changes in fair values reported in earnings and changes in the allowance for credit losses, and temporary elevated amounts of unfunded investment
commitments.
While our observed long-term care insurance claim experience has shown some modest favorable emerging morbidity experience in the period since the 2017
reconstruction of our future claim cost projections, it remains largely in-line with those reconstructed projections. Based on the application of professional
actuarial judgment to the factors discussed above, we have made no substantial change to our assumptions concerning morbidity, morbidity improvement,
mortality, mortality improvement, terminations, or long-term care insurance premium rate increases in 2021. As with all assumptions underlying our premium
deficiency testing, we will continue to monitor these factors, which may result in future changes in our assumptions.
Since our premium deficiency testing performed in 2020, we have implemented approximately $0.2 billion of previously approved long-term care insurance
premium rate increase actions and made no substantial changes to the amount of projected future premium rate increase approvals. Our 2021 premium
deficiency test includes approximately $1.7 billion of anticipated future premium increases or benefit reductions associated with future in-force rate actions, of
which approximately $0.9 billion has been approved and not yet implemented. This represents a decrease of $0.2 billion from our 2020 premium deficiency test
to account for actions that are: (a) approved and not yet implemented, (b) filed but not yet approved, and (c) estimated on future filings through 2030 and
includes the effects of the higher discount rate mentioned above and longer anticipated timing to achieve and implement certain premium rate approvals.
2021 3Q FORM 10-Q 	20

-- 20 of 79 --

As a result of exposure period cut-off dates to permit experience to develop and lags in ceding company data reporting from our ceding companies, the impact of
COVID-19 was generally not reflected in the experience studies data used in our 2021 premium deficiency testing. However, we assessed certain scenarios to
better understand potential impacts associated with COVID-19 and, due to the currently observed insignificance and perceived short-term nature of such
uncertain future impacts, including the natural offsets from mortality in the aggregate across our run-off insurance products (i.e., for life insurance products,
higher mortality increases the present value of expected future benefit payments, while for annuity and long-term care insurance contracts, higher mortality
decreases the present value of expected future benefit payments), concluded adjustments to our primary assumptions used in the premium deficiency testing
were not warranted.
When results of the premium deficiency testing indicate overall reserves are sufficient, we are also required to assess whether additional future policy benefit
reserves are required to be accrued over time in the future. Such an accrual would be required if profits are projected in earlier future periods followed by losses
projected in later future years (i.e., profits followed by losses). When this pattern of profits followed by losses is projected, we would be required to accrue a
liability in the expected profitable years by the amount necessary to offset projected losses in later future years. We noted our projections as of third quarter 2021
indicate the present value of projected earnings in each future year to be positive, and therefore, no further adjustments to our future policy benefit reserves were
required at this time.
GAAP Reserve Sensitivities. The results of our premium deficiency testing are sensitive to the assumptions described above. Considering the results of the
2021 premium deficiency test which resulted in a margin, any future net adverse changes in our assumptions, may reduce the margin or result in a premium
deficiency requiring an increase to future policy benefit reserves. For example, adverse changes in key assumptions related to our future policy benefits
reserves, holding all other assumptions constant, would have the following effects on the projected present value of future cash flows as presented in the table
below. Any future net favorable changes to these assumptions could result in a lower projected present value of future cash flows and additional margin in our
premium deficiency test and higher income over the remaining duration of the portfolio, including higher investment income. The assumptions within our future
policy benefit reserves are subject to significant uncertainties, including those inherent in the complex nature of our reinsurance treaties. Many of our
assumptions are interdependent and require evaluation individually and in the aggregate across all insurance products. Small changes in the amounts used in
the sensitivities, the use of different factors or effect from converting to modeling future cash flow projections for our long-term insurance exposures to a "first
principles" model based on more granular assumptions of expected future claim experience could result in materially different outcomes from those reflected
below.
2020 assumption 	2021 assumption
Hypothetical change in 2021
assumption
Estimated increase to
projected present value of
future cash flows
(In millions, pre-tax)
Long-term care insurance
morbidity improvement
1.25% per year over 12 to 20
years
1.25% per year over 12 to 20
years
25 basis point reduction
No morbidity improvement
$500
$2,700
Long-term care insurance
morbidity
Based on company
experience
Based on company
experience
5% increase in dollar amount of
paid claims
$900
Long-term care insurance
mortality improvement
0.5% per year for 10 years
with annual improvement
graded to 0% over next 10
years
0.5% per year for 10 years
with annual improvement
graded to 0% over next 10
years
1.0% per year for 10 years with
annual improvement graded to
0% over next 10 years
$400
Total terminations:
Long-term care insurance
mortality
Based on company
experience
Based on company
experience
Any change in termination
assumptions that reduce total
terminations by 10%
$900
Long-term care insurance lapse
rate
Varies by block, attained age
and benefit period; average
0.5% - 1.15%
Varies by block, attained age
and benefit period; average
0.5% -1.15%
Long-term care insurance
benefit exhaustion
Based on company
experience
Based on company
experience
Long-term care insurance future
premium rate increases
Varies by block based on filing
experience
Varies by block based on filing
experience
25% adverse change in
premium rate increase success
rate
$400
Discount rate:
Overall discount rate 	5.70% 	6.15% 	25 basis point reduction 	$800
Reinvestment rate 	2.70%; grading to a long-term
average investment yield of
5.8%
2.60%; grading to a long-term
average investment yield of
5.1%
25 basis point reduction; grading
to a long-term average
investment yield of 5.1%
Less than $100
Structured settlement annuity
mortality
Based on company
experience
Based on company
experience
5% decrease in mortality 	$100
Life insurance mortality 	Based on company
experience
Based on company
experience
5% increase in mortality 	$300
2021 3Q FORM 10-Q 	21

-- 21 of 79 --

Statutory Considerations. Our run-off insurance subsidiaries are required to prepare statutory financial statements in accordance with statutory accounting
practices. Statutory accounting practices, not GAAP, determine the minimum required statutory capital levels of our insurance legal entities. We annually perform
statutory asset adequacy testing and expect our December 31, 2021 testing process to be completed in the first quarter of 2022, the results of which may affect
the amount or timing of capital contributions from GE Capital to the insurance legal entities.
See Other Items - New Accounting Standards, Note 12 and Other Items within MD&A in our Annual Report on Form 10-K for the year ended December 31, 2020
for further information related to our run-off insurance operations.
NEW ACCOUNTING STANDARDS. 	The Financial Accounting Standards Board issued new guidance on accounting for long-duration insurance contracts that is
effective for our interim and annual periods beginning January 1, 2023, with an election to adopt early, and restatement of prior periods presented. We intend to
adopt the new guidance effective January 1, 2023, using the modified retrospective transition method where permitted. We are evaluating the effect of the new
guidance on our consolidated financial statements and anticipate that its adoption will significantly change the accounting for measurements of our long-duration
insurance liabilities. The new guidance requires cash flow assumptions used in the measurement of various insurance liabilities to be reviewed at least annually
and updated if actual experience or other evidence indicates previous assumptions need to be revised with any required changes recorded in earnings. Under
the current accounting guidance, the discount rate is based on expected investment yields, while under the new guidance the discount rate will be equivalent to
the upper-medium grade (i.e., single A) fixed-income instrument yield reflecting the duration characteristics of the liability and is required to be updated in each
reporting period with changes recorded in other comprehensive income. We expect that the single-A rate under the new guidance at the transition date will be
lower than our current discount rate. In measuring the insurance liabilities under the new guidance, contracts shall not be grouped together from different issue
years. These changes will result in the elimination of premium deficiency testing and shadow adjustments. While we continue to evaluate the effect of the new
guidance on our ongoing financial reporting, we anticipate that its adoption will materially affect our financial statements and require changes to certain of our
processes, systems, and controls. As the new guidance is only applicable to the measurements of our long-duration insurance liabilities under GAAP, it will not
affect the accounting for our insurance reserves or the levels of capital and surplus under statutory accounting practices.
NON-GAAP FINANCIAL MEASURES. 	We believe that presenting non-GAAP financial measures provides management and investors useful measures to
evaluate performance and trends of the total company and its businesses. This includes adjustments in recent periods to GAAP financial measures to increase
period-to-period comparability following actions to strengthen our overall financial position and how we manage our business.
In addition, management recognizes that certain non-GAAP terms may be interpreted differently by other companies under different circumstances. In various
sections of this report we have made reference to the following non-GAAP financial measures in describing our (1) revenues, specifically GE Industrial organic
revenues by segment; GE Industrial organic revenues, and GE Industrial equipment and services organic revenues, (2) profit, specifically GE Industrial organic
profit and profit margin by segment; Adjusted GE Industrial profit and profit margin (excluding certain items); Adjusted GE Industrial organic profit and profit
margin; Adjusted earnings (loss); and Adjusted earnings (loss) per share (EPS), (3) cash flows, specifically GE Industrial free cash flows (FCF), and (4) debt
balances, specifically GE Industrial net debt.
The reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial measures follow.
GE INDUSTRIAL ORGANIC REVENUES, PROFIT (LOSS) AND PROFIT MARGIN BY SEGMENT (NON-GAAP)
Revenues 	Segment profit (loss) 	Profit margin
Three months ended September 30 	2021 	2020 	V% 	2021 	2020 	V% 	2021 	2020 	V pts
Aviation (GAAP) 	$ 	5,398 	$ 	4,919 	10 	% 	$ 	846 	$ 	350 	F 	15.7 	% 	7.1 	% 	8.6pts
Less: acquisitions 	— 	— 	— 	—
Less: business dispositions 	— 	12 	— 	(12)
Less: foreign currency effect 	(9) 	— 	(13) 	—
Aviation organic (Non-GAAP) 	$ 	5,408 	$ 	4,908 	10 	% 	$ 	858 	$ 	362 	F 	15.9 	% 	7.4 	% 	8.5pts
Healthcare (GAAP) 	$ 	4,339 	$ 	4,565 	(5)% 	$ 	704 	$ 	738 	(5)% 	16.2 	% 	16.2 	% 	—pts
Less: acquisitions 	— 	(23) 	(9) 	(13)
Less: business dispositions 	— 	21 	— 	(2)
Less: foreign currency effect 	49 	— 	31 	—
Healthcare organic (Non-GAAP) 	$ 	4,289 	$ 	4,567 	(6)% 	$ 	681 	$ 	753 	(10)% 	15.9 	% 	16.5 	% 	(0.6)pts
Renewable Energy (GAAP) 	$ 	4,208 	$ 	4,525 	(7)% 	$ 	(151) 	$ 	(51) 	U 	(3.6)% 	(1.1)% 	(2.5)pts
Less: acquisitions 	— 	— 	— 	—
Less: business dispositions 	— 	— 	— 	—
Less: foreign currency effect 	101 	— 	(4) 	—
Renewable Energy organic (Non-GAAP) 	$ 	4,106 	$ 	4,525 	(9)% 	$ 	(147) 	$ 	(51) 	U 	(3.6)% 	(1.1)% 	(2.5)pts
Power (GAAP) 	$ 	4,026 	$ 	4,025 	— 	% 	$ 	204 	$ 	148 	38 	% 	5.1 	% 	3.7 	% 	1.4pts
Less: acquisitions 	— 	— 	— 	—
Less: business dispositions 	— 	— 	— 	—
Less: foreign currency effect 	39 	— 	6 	—
Power organic (Non-GAAP) 	$ 	3,988 	$ 	4,025 	(1)% 	$ 	198 	$ 	148 	34 	% 	5.0 	% 	3.7 	% 	1.3pts
2021 3Q FORM 10-Q 	22

-- 22 of 79 --

GE INDUSTRIAL ORGANIC REVENUES, PROFIT (LOSS) AND PROFIT MARGIN BY SEGMENT (NON-GAAP)
Revenues 	Segment profit (loss) 	Profit margin
Nine months ended September 30 	2021 	2020 	V% 	2021 	2020 	V% 	2021 	2020 	V pts
Aviation (GAAP) 	$ 	15,230 	$ 	16,196 	(6)% 	$ 	1,664 	$ 	665 	F 	10.9 	% 	4.1 	% 	6.8pts
Less: acquisitions 	— 	— 	— 	—
Less: business dispositions 	— 	48 	— 	(48)
Less: foreign currency effect 	13 	— 	(28) 	—
Aviation organic (Non-GAAP) 	$ 	15,217 	$ 	16,148 	(6)% 	$ 	1,691 	$ 	713 	F 	11.1 	% 	4.4 	% 	6.7pts
Healthcare (GAAP) 	$ 	13,100 	$ 	13,185 	(1)% 	$ 	2,203 	$ 	2,111 	4 	% 	16.8 	% 	16.0 	% 	0.8pts
Less: acquisitions 	18 	(73) 	(5) 	(35)
Less: business dispositions 	— 	911 	— 	373
Less: foreign currency effect 	335 	— 	110 	—
Healthcare organic (Non-GAAP) 	$ 	12,747 	$ 	12,348 	3 	% 	$ 	2,098 	$ 	1,773 	18 	% 	16.5 	% 	14.4 	% 	2.1pts
Renewable Energy (GAAP) 	$ 	11,505 	$ 	11,224 	3 	% 	$ 	(484) 	$ 	(628) 	23 	% 	(4.2)% 	(5.6)% 	1.4pts
Less: acquisitions 	— 	— 	— 	—
Less: business dispositions 	— 	33 	— 	(4)
Less: foreign currency effect 	438 	— 	(41) 	—
Renewable Energy organic (Non-GAAP) 	$ 	11,066 	$ 	11,191 	(1)% 	$ 	(443) 	$ 	(624) 	29 	% 	(4.0)% 	(5.6)% 	1.6pts
Power (GAAP) 	$ 	12,242 	$ 	12,206 	— 	% 	$ 	416 	$ 	(32) 	F 	3.4 	% 	(0.3)% 	3.7pts
Less: acquisitions 	— 	— 	— 	—
Less: business dispositions 	— 	15 	— 	2
Less: foreign currency effect 	237 	— 	(25) 	—
Power organic (Non-GAAP) 	$ 	12,005 	$ 	12,191 	(2)% 	$ 	441 	$ 	(34) 	F 	3.7 	% 	(0.3)% 	4pts
We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established,
ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, as these activities can obscure underlying trends. We also believe
presenting organic revenues* and organic profit* separately for our industrial businesses provides management and investors with useful information about the
trends of our industrial businesses and enables a more direct comparison to other non-financial companies.
GE INDUSTRIAL ORGANIC REVENUES (NON-GAAP) 	Three months ended September 30 	Nine months ended September 30
2021 	2020 	V% 	2021 	2020 	V%
GE Industrial revenues (GAAP) 	$ 	17,821 	$ 	17,918 	(1)% 	$ 	51,637 	$ 	52,828 	(2)%
Less: acquisitions 	— 	(15) 	18 	(61)
Less: business dispositions(a) 	— 	57 	— 	1,393
Less: foreign currency effect(b) 	185 	— 	1,042 	—
GE Industrial organic revenues (Non-GAAP) 	$ 	17,636 	$ 	17,876 	(1)% 	$ 	50,577 	$ 	51,496 	(2)%
(a) Dispositions impact in 2020 primarily related to our BioPharma business, with revenues of $830 million.
(b) Foreign currency impact in 2021 was primarily driven by U.S. Dollar appreciation against euro, British pound, and Chinese renminbi.
GE INDUSTRIAL EQUIPMENT AND SERVICES 	Three months ended September 30 	Nine months ended September 30
ORGANIC REVENUES (NON-GAAP) 	2021 	2020 	V% 	2021 	2020 	V%
GE Industrial equipment revenues (GAAP) 	$ 	8,905 	$ 	9,625 	(7)% 	$ 	25,178 	$ 	26,928 	(6)%
Less: acquisitions 	— 	— 	— 	—
Less: business dispositions 	— 	— 	— 	1,124
Less: foreign currency effect 	133 	— 	702 	—
GE Industrial equipment organic revenues (Non-GAAP) 	$ 	8,772 	$ 	9,625 	(9)% 	$ 	24,477 	$ 	25,803 	(5)%
GE Industrial services revenues (GAAP) 	$ 	8,916 	$ 	8,293 	8 	% 	$ 	26,459 	$ 	25,901 	2 	%
Less: acquisitions 	— 	(15) 	18 	(61)
Less: business dispositions 	— 	57 	— 	269
Less: foreign currency effect 	51 	— 	340 	—
GE Industrial services organic revenues (Non-GAAP) 	$ 	8,865 	$ 	8,251 	7 	% 	$ 	26,100 	$ 	25,693 	2 	%
We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established,
ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, as these activities can obscure underlying trends.
*Non-GAAP Financial Measure
2021 3Q FORM 10-Q 	23

-- 23 of 79 --

ADJUSTED GE INDUSTRIAL PROFIT AND PROFIT MARGIN 	Three months ended September 30 	Nine months ended September 30
(EXCLUDING CERTAIN ITEMS) (NON-GAAP) 	2021 	2020 	V% 	2021 	2020 	V%
GE Industrial total revenues (GAAP) 	$ 	17,821 	$ 	17,918 	(1) 	% 	$ 	51,637 	$ 	52,828 	(2) 	%
Costs
GE Industrial total costs and expenses (GAAP) 	$ 	17,347 	$ 	18,705 	(7) 	% 	$ 	52,348 	$ 	56,943 	(8) 	%
Less: GE Industrial interest and other financial charges 	225 	313 	753 	1,016
Less: debt extinguishment costs 	— 	— 	645 	63
Less: non-operating benefit costs 	426 	603 	1,376 	1,815
Less: restructuring & other(a) 	64 	91 	402 	523
Less: Steam asset impairment 	— 	363 	— 	363
Less: SEC settlement charge 	— 	100 	— 	100
Less: goodwill impairments 	— 	— 	— 	728
Add: noncontrolling interests 	16 	(51) 	22 	(161)
Adjusted GE Industrial costs (Non-GAAP) 	$ 	16,648 	$ 	17,185 	(3) 	% 	$ 	49,194 	$ 	52,174 	(6) 	%
Other Income
GE Industrial other income (GAAP) 	$ 	420 	$ 	(509) 	F 	$ 	1,760 	$ 	8,481 	(79) 	%
Less: gains (losses) on equity securities(a) 	412 	(669) 	1,256 	(4,527)
Less: restructuring & other 	— 	— 	7 	—
Less: gains (losses) on purchases and sales of business
interests(a) 	(156) 	28 	(159) 	12,431
Adjusted GE Industrial other income (Non-GAAP) 	$ 	165 	$ 	132 	25 	% 	$ 	656 	$ 	577 	14 	%
GE Industrial profit (loss) (GAAP) 	$ 	894 	$ 	(1,296) 	F 	$ 	1,048 	$ 	4,366 	(76) 	%
GE Industrial profit (loss) margin (GAAP) 	5.0 	% 	(7.2)% 	12.2pts 	2.0 	% 	8.3 	% 	(6.3)pts
Adjusted GE Industrial profit (loss) (Non-GAAP) 	$ 	1,337 	$ 	865 	55 	% 	$ 	3,099 	$ 	1,231 	F
Adjusted GE Industrial profit (loss) margin (Non-GAAP) 	7.5 	% 	4.8 	% 	2.7pts 	6.0 	% 	2.3 	% 	3.7pts
(a) See the Corporate Items and Eliminations section for further information.
We believe that adjusting industrial profit to exclude the effects of items that are not closely associated with ongoing operations provides management and
investors with a meaningful measure that increases the period-to-period comparability. Gains (losses) and restructuring and other items are impacted by the
timing and magnitude of gains associated with dispositions, and the timing and magnitude of costs associated with restructuring and other activities.
ADJUSTED GE INDUSTRIAL ORGANIC PROFIT 	Three months ended September 30 	Nine months ended September 30
(NON-GAAP) 	2021 	2020 	V% 	2021 	2020 	V%
Adjusted GE Industrial profit (loss) (Non-GAAP) 	$ 	1,337 	$ 	865 	55 	% 	$ 	3,099 	$ 	1,231 	F
Less: acquisitions 	(9) 	5 	(5) 	22
Less: business dispositions 	— 	(2) 	— 	354
Less: foreign currency effect 	24 	— 	30 	—
Adjusted GE Industrial organic profit (loss) (Non-GAAP) 	$ 	1,322 	$ 	861 	54 	% 	$ 	3,074 	$ 	855 	F
Adjusted GE Industrial profit (loss) margin (Non-GAAP) 	7.5 	% 	4.8 	% 	2.7pts 	6.0 	% 	2.3 	% 	3.7pts
Adjusted GE Industrial organic profit (loss) margin
(Non-GAAP) 	7.5 	% 	4.8 	% 	2.7pts 	6.1 	% 	1.7 	% 	4.4pts
We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established,
ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, as these activities can obscure underlying trends.
2021 3Q FORM 10-Q 	24

-- 24 of 79 --

ADJUSTED EARNINGS (LOSS) (NON-GAAP) 	Three months ended September 30 	Nine months ended September 30
2021 	2020 	V% 	2021 	2020 	V%
Consolidated earnings (loss) from continuing operations attributable to GE
common shareholders (GAAP)(a) 	$ 	603 	$ 	(1,132) 	F 	$ 	(2) 	$ 	3,848 	U
Add: Accretion of redeemable noncontrolling interests (RNCI) 	(9) 	(6) 	(9) 	(141)
Less: GE Capital earnings (loss) from continuing operations attributable to GE
common shareholders (GAAP) 	(142) 	(29) 	(887) 	(692)
GE Industrial earnings (loss) (Non-GAAP) 	$ 	735 	$ 	(1,109) 	F 	$ 	877 	$ 	4,399 	(80)%
Non-operating benefits costs (pre-tax) (GAAP) 	(426) 	(603) 	(1,376) 	(1,815)
Tax effect on non-operating benefit costs 	90 	127 	289 	381
Less: non-operating benefit costs (net of tax) 	(337) 	(476) 	(1,087) 	(1,434)
Gains (losses) on purchases and sales of business interests (pre-tax)(b) 	(156) 	28 	(159) 	12,431
Tax effect on gains (losses) on purchases and sales of business interests 	30 	(25) 	31 	(1,253)
Less: gains (losses) on purchases and sales of business interests (net of tax) 	(126) 	3 	(128) 	11,178
Restructuring & other (pre-tax)(b) 	(64) 	(91) 	(395) 	(523)
Tax effect on restructuring & other 	7 	27 	36 	118
Less: restructuring & other (net of tax) 	(57) 	(63) 	(359) 	(405)
Steam asset impairments (pre-tax) 	— 	(363) 	— 	(363)
Tax effect on Steam asset impairments 	— 	37 	— 	37
Less: Steam asset impairments (net of tax) 	— 	(326) 	— 	(326)
Gains (losses) on equity securities (pre-tax)(b) 	412 	(669) 	1,256 	(4,527)
Tax effect on gains (losses) on equity securities(c) 	78 	122 	155 	934
Less: gains (losses) on equity securities (net of tax) 	490 	(547) 	1,411 	(3,593)
Goodwill impairments (pre-tax)(b) 	— 	— 	— 	(728)
Tax effect on goodwill impairments 	— 	— 	— 	(23)
Less: goodwill impairments (net of tax) 	— 	— 	— 	(751)
Debt extinguishment costs (pre-tax) 	— 	— 	(645) 	(63)
Tax effect on debt extinguishment costs 	— 	— 	135 	13
Less: debt extinguishment costs (net of tax) 	— 	— 	(510) 	(50)
Less: SEC settlement charge (pre-tax and net of tax) 	— 	(100) 	— 	(100)
Less: Accretion of RNCI (pre-tax and net of tax) 	(9) 	(6) 	(9) 	(141)
Less: GE Industrial U.S. tax reform enactment adjustment 	— 	(51) 	— 	(51)
Adjusted GE Industrial earnings (loss) (Non-GAAP) 	$ 	775 	$ 	458 	69 	% 	$ 	1,559 	$ 	73 	F
GE Capital earnings (loss) from continuing operations attributable to GE
common shareholders (GAAP) 	$ 	(142) 	$ 	(29) 	U 	$ 	(887) 	$ 	(692) 	(28)%
Debt extinguishment costs (pre-tax) 	— 	— 	(771) 	(143)
Tax effect on debt extinguishment costs 	— 	— 	162 	24
Less: debt extinguishment costs (net of tax) 	— 	— 	(609) 	(119)
Less: GE Capital tax benefit related to BioPharma sale 	— 	8 	— 	96
Less: GE Capital tax loss related to GECAS sale 	— 	— 	(44) 	—
Less: GE Capital U.S. tax reform enactment adjustment 	— 	2 	8 	2
Adjusted GE Capital earnings (loss) (Non-GAAP) 	$ 	(142) 	$ 	(39) 	U 	$ 	(243) 	$ 	(671) 	64 	%
Adjusted GE Industrial earnings (loss) (Non-GAAP) 	$ 	775 	$ 	458 	69 	% 	$ 	1,559 	$ 	73 	F
Add: Adjusted GE Capital earnings (loss) (Non-GAAP) 	(142) 	(39) 	U 	(243) 	(671) 	64 	%
Adjusted earnings (loss) (Non-GAAP) 	$ 	633 	$ 	419 	51 	% 	$ 	1,316 	$ 	(598) 	F
(a) See Note 18 for further information.
(b) See the Corporate Items and Eliminations section for further information.
(c) Included tax benefits available to offset the tax on gains in equity securities.
2021 3Q FORM 10-Q 	25

-- 25 of 79 --

ADJUSTED EARNINGS (LOSS) PER SHARE (EPS) 	Three months ended September 30 	Nine months ended September 30
(NON-GAAP) 	(In dollars) 	2021 	2020 	V% 	2021 	2020 	V%
Consolidated EPS from continuing operations attributable to GE common
shareholders (GAAP) 	$ 	0.55 	$ 	(1.03) 	F 	$ 	— 	$ 	3.52 	U
Add: Accretion of redeemable noncontrolling interests (RNCI) 	(0.01) 	(0.01) 	(0.01) 	(0.13)
Less: GE Capital EPS from continuing operations attributable to GE common
shareholders (GAAP) 	(0.13) 	(0.03) 	(0.81) 	(0.63)
GE Industrial EPS (Non-GAAP) 	$ 	0.67 	$ 	(1.01) 	F 	$ 	0.80 	$ 	4.02 	(80)%
Non-operating benefits costs (pre-tax) (GAAP) 	(0.39) 	(0.55) 	(1.25) 	(1.66)
Tax effect on non-operating benefit costs 	0.08 	0.12 	0.26 	0.35
Less: non-operating benefit costs (net of tax) 	(0.30) 	(0.43) 	(0.99) 	(1.31)
Gains (losses) on purchases and sales of business interests (pre-tax) 	(0.14) 	0.03 	(0.14) 	11.36
Tax effect on gains (losses) on purchases and sales of business interests 	0.03 	(0.02) 	0.03 	(1.14)
Less: gains (losses) on purchases and sales of business interests (net of tax) 	(0.11) 	— 	(0.12) 	10.21
Restructuring & other (pre-tax) 	(0.06) 	(0.08) 	(0.36) 	(0.48)
Tax effect on restructuring & other 	0.01 	0.03 	0.03 	0.11
Less: restructuring & other (net of tax) 	(0.05) 	(0.06) 	(0.33) 	(0.37)
Steam asset impairments (pre-tax) 	— 	(0.33) 	— 	(0.33)
Tax effect on Steam asset impairments 	— 	0.03 	— 	0.03
Less: Steam asset impairments (net of tax) 	— 	(0.30) 	— 	(0.30)
Gains (losses) on equity securities (pre-tax) 	0.37 	(0.61) 	1.14 	(4.14)
Tax effect on gains (losses) on equity securities 	0.07 	0.11 	0.14 	0.85
Less: gains (losses) on equity securities (net of tax) 	0.44 	(0.50) 	1.29 	(3.28)
Goodwill impairments (pre-tax) 	— 	— 	— 	(0.67)
Tax effect on goodwill impairments 	— 	— 	— 	(0.02)
Less: goodwill impairments (net of tax) 	— 	— 	— 	(0.69)
Debt extinguishment costs (pre-tax) 	— 	— 	(0.59) 	(0.06)
Tax effect on debt extinguishment costs 	— 	— 	0.12 	0.01
Less: debt extinguishment costs (net of tax) 	— 	— 	(0.46) 	(0.05)
Less: SEC settlement charge (pre-tax and net of tax) 	— 	(0.09) 	— 	(0.09)
Less: Accretion of RNCI (pre-tax and net of tax) 	(0.01) 	(0.01) 	(0.01) 	(0.13)
Less: GE Industrial U.S. tax reform enactment adjustment 	— 	(0.05) 	— 	(0.05)
Adjusted GE Industrial EPS (Non-GAAP) 	$ 	0.70 	$ 	0.42 	67 	% 	$ 	1.42 	$ 	0.07 	F
GE Capital EPS from continuing operations attributable to GE common
shareholders (GAAP) 	$ 	(0.13) 	$ 	(0.03) 	U 	$ 	(0.81) 	$ 	(0.63) 	(29)%
Debt extinguishment costs (pre-tax) 	— 	— 	(0.70) 	(0.13)
Tax effect on debt extinguishment costs 	— 	— 	0.15 	0.02
Less: debt extinguishment costs (net of tax) 	— 	— 	(0.55) 	(0.11)
Less: GE Capital tax benefit related to BioPharma sale 	— 	0.01 	— 	0.09
Less: GE Capital tax loss related to GECAS sale 	— 	— 	(0.04) 	—
Less: GE Capital U.S. tax reform enactment adjustment 	— 	— 	0.01 	—
Adjusted GE Capital EPS (Non-GAAP) 	$ 	(0.13) 	$ 	(0.04) 	U 	$ 	(0.22) 	$ 	(0.61) 	64 	%
Adjusted GE Industrial EPS (Non-GAAP) 	$ 	0.70 	$ 	0.42 	67 	% 	$ 	1.42 	$ 	0.07 	F
Add: Adjusted GE Capital EPS (Non-GAAP) 	(0.13) 	(0.04) 	U 	(0.22) 	(0.61) 	64 	%
Adjusted EPS (Non-GAAP) 	$ 	0.57 	$ 	0.38 	50 	% 	$ 	1.20 	$ 	(0.55) 	F
Earnings-per-share amounts are computed independently. As a result, the sum of per-share amounts may not equal the total.
The service cost of our pension and other benefit plans are included in adjusted earnings (loss)*, which represents the ongoing cost of providing pension
benefits to our employees. The components of non-operating benefit costs are mainly driven by capital allocation decisions and market performance, and we
manage these separately from the operational performance of our businesses. Gains (losses) and restructuring and other items are impacted by the timing and
magnitude of gains associated with dispositions, and the timing and magnitude of costs associated with restructuring and other activities. We believe that the
retained costs in Adjusted earnings (loss)* provides management and investors a useful measure to evaluate the performance of the total company, and
increases period-to-period comparability. We believe that presenting Adjusted Industrial earnings (loss)* separately for our financial services businesses also
provides management and investors with useful information about the relative size of our industrial and financial services businesses in relation to the total
company.
*Non-GAAP Financial Measure
2021 3Q FORM 10-Q 	26

-- 26 of 79 --

GE INDUSTRIAL FREE CASH FLOWS (FCF) (NON-GAAP) Nine months ended September
30
2021 	2020
GE Industrial CFOA (GAAP) 	$ 	(832) 	$ 	(3,175)
Add: gross additions to property, plant and equipment 	(896) 	(1,302)
Add: gross additions to internal-use software 	(76) 	(121)
Less: CFOA impact from factoring programs discontinued as of April 1, 2021 	(3,067) 	—
Less: taxes related to business sales 	(6) 	(837)
GE Industrial free cash flows (Non-GAAP) 	$ 	1,270 	$ 	(3,761)
We believe investors may find it useful to compare GE's Industrial free cash flows* performance without the effects of cash used for taxes related to business
sales and the factoring program discontinuation. The CFOA impact from factoring programs discontinued as of April 1, 2021 of $(3,067) million represents the
cash that GE Industrial would have otherwise collected in the six months ended September 30, 2021 had customer receivables not been previously sold to GE
Capital or third parties in those discontinued programs. The CFOA impact associated with this activity in factoring programs that have now been discontinued
was $(3,832) million and $(1,022) million in the nine months ended September 30, 2021 and 2020, respectively, an increase of $(2,810) million. The CFOA
impact for the three months ended September 30, 2020 was $613 million. We believe this measure will better allow management and investors to evaluate the
capacity of our industrial operations to generate free cash flows.
GE INDUSTRIAL NET DEBT (NON-GAAP) 	September 30, 2021 	December 31, 2020
Total GE Industrial short- and long-term borrowings (GAAP) 	$ 	33,667 	$ 	42,736
Less: GE Capital short- and long-term debt assumed by GE Industrial 	18,106 	22,390
Add: intercompany loans from GE Capital 	3,177 	3,177
Total adjusted GE Industrial borrowings 	$ 	18,738 	$ 	23,523
Pension and principal retiree benefit plan liabilities (pre-tax)(a) 	25,492 	25,492
Less: taxes at 21% 	5,353 	5,353
Pension and principal retiree benefit plan liabilities (net of tax) 	$ 	20,139 	$ 	20,139
GE Industrial operating lease liabilities 	2,948 	3,133
GE Industrial preferred stock 	5,933 	5,918
Less: 50% of GE Industrial preferred stock 	2,966 	2,959
50% of preferred stock 	$ 	2,966 	$ 	2,959
Deduction for total GE Industrial cash, cash equivalents and restricted cash 	(17,995) 	(23,209)
Less: 25% of GE Industrial cash, cash equivalents and restricted cash 	(4,499) 	(5,802)
Deduction for 75% of GE Industrial cash, cash equivalents and restricted cash 	$ 	(13,496) 	$ 	(17,407)
Total GE Industrial net debt (Non-GAAP) 	$ 	31,295 	$ 	32,347
(a) Represents the sum of the net deficit of principal pension, other pension and principal retiree benefit plans at December 31, 2020. The funded status of our
benefit plans is updated annually in the fourth quarter.
In this document we use GE Industrial net debt*, which is calculated based on rating agency methodologies. We are including the calculation of GE Industrial
net debt* to provide investors more clarity regarding how the credit rating agencies measure GE Industrial leverage.
CONTROLS AND PROCEDURES. 	Under the direction of our Chief Executive Officer and Chief Financial Officer, we evaluated our disclosure controls
and procedures and internal control over financial reporting and concluded that (i) our disclosure controls and procedures were effective as of September 30,
2021, and (ii) no change in internal control over financial reporting occurred during the quarter ended September 30, 2021, that has materially affected, or is
reasonably likely to materially affect, such internal control over financial reporting.
OTHER FINANCIAL DATA. 	GE did not repurchase any equity securities during the three months ended September 30, 2021.
*Non-GAAP Financial Measure
2021 3Q FORM 10-Q 	27

-- 27 of 79 --

STATEMENT OF EARNINGS (LOSS) 	Three months ended September 30
(UNAUDITED) 	Consolidated
(In millions; per-share amounts in dollars) 	2021 	2020
Sales of goods 	$ 	11,530 	$ 	12,306
Sales of services 	6,283 	5,560
GE Capital revenues from services 	616 	663
Total revenues (Note 9) 	18,429 	18,529
Cost of goods sold 	9,127 	10,555
Cost of services sold 	4,275 	3,486
Selling, general and administrative expenses 	2,747 	3,215
Research and development 	627 	595
Interest and other financial charges 	462 	526
Debt extinguishment costs 	— 	—
Insurance losses and annuity benefits 	643 	624
Goodwill impairments (Note 8) 	— 	—
Non-operating benefit costs 	427 	605
Other costs and expenses 	28 	25
Total costs and expenses 	18,337 	19,632
Other income (Note 23) 	491 	(517)
Earnings (loss) from continuing operations before income taxes 	584 	(1,620)
Benefit (provision) for income taxes 	(2) 	483
Earnings (loss) from continuing operations 	582 	(1,137)
Earnings (loss) from discontinued operations, net of taxes (Note 2) 	602 	(58)
Net earnings (loss) 	1,184 	(1,195)
Less net earnings (loss) attributable to noncontrolling interests 	(73) 	(51)
Net earnings (loss) attributable to the Company 	1,257 	(1,144)
Preferred stock dividends 	(52) 	(46)
Net earnings (loss) attributable to GE common shareholders 	$ 	1,205 	$ 	(1,190)
Amounts attributable to GE common shareholders
Earnings (loss) from continuing operations 	$ 	582 	$ 	(1,137)
Less net earnings (loss) attributable to noncontrolling interests,
continuing operations 	(73) 	(51)
Earnings (loss) from continuing operations attributable to the Company 	655 	(1,087)
Preferred stock dividends 	(52) 	(46)
Earnings (loss) from continuing operations attributable
to GE common shareholders 	603 	(1,132)
Earnings (loss) from discontinued operations attributable
to GE common shareholders 	602 	(58)
Net earnings (loss) attributable to GE common shareholders 	$ 	1,205 	$ 	(1,190)
Earnings (loss) per share from continuing operations (Note 18)
Diluted earnings (loss) per share 	$ 	0.54 	$ 	(1.04)
Basic earnings (loss) per share 	$ 	0.54 	$ 	(1.04)
Net earnings (loss) per share (Note 18)
Diluted earnings (loss) per share 	$ 	1.08 	$ 	(1.09)
Basic earnings (loss) per share 	$ 	1.09 	$ 	(1.09)
2021 3Q FORM 10-Q 	28

-- 28 of 79 --

STATEMENT OF EARNINGS (LOSS) (CONTINUED) 	Three months ended September 30
(UNAUDITED) 	GE Industrial 	GE Capital
(In millions) 	2021 	2020 	2021 	2020
Sales of goods 	$ 	11,532 	$ 	12,314 	$ 	— 	$ 	—
Sales of services 	6,289 	5,604 	— 	—
GE Capital revenues from services 	— 	— 	734 	758
Total revenues 	17,821 	17,918 	734 	758
Cost of goods sold 	9,129 	10,564 	— 	—
Cost of services sold 	4,276 	3,525 	5 	5
Selling, general and administrative expenses 	2,665 	3,105 	96 	133
Research and development 	627 	595 	— 	—
Interest and other financial charges 	225 	313 	259 	267
Debt extinguishment costs 	— 	— 	1 	—
Insurance losses and annuity benefits 	— 	— 	645 	635
Goodwill impairments (Note 8) 	— 	— 	— 	—
Non-operating benefit costs 	426 	603 	— 	2
Other costs and expenses 	— 	— 	39 	38
Total costs and expenses 	17,347 	18,705 	1,044 	1,081
Other income (Note 23) 	420 	(509) 	— 	—
Earnings (loss) from continuing operations before income taxes 	894 	(1,296) 	(311) 	(323)
Benefit (provision) for income taxes 	(81) 	143 	79 	340
Earnings (loss) from continuing operations 	813 	(1,153) 	(231) 	16
Earnings (loss) from discontinued operations, net of taxes (Note 2) 	(8) 	(10) 	611 	(48)
Net earnings (loss) 	804 	(1,163) 	380 	(32)
Less net earnings (loss) attributable to noncontrolling interests 	16 	(51) 	(89) 	—
Net earnings (loss) attributable to the Company 	788 	(1,112) 	469 	(32)
Preferred stock dividends 	(52) 	— 	— 	(46)
Net earnings (loss) attributable to GE common shareholders 	$ 	737 	$ 	(1,112) 	$ 	469 	$ 	(78)
Amounts attributable to GE common shareholders:
Earnings (loss) from continuing operations 	$ 	813 	$ 	(1,153) 	$ 	(231) 	$ 	16
Less net earnings (loss) attributable to noncontrolling interests,
continuing operations 	16 	(51) 	(89) 	—
Earnings (loss) from continuing operations attributable to the Company 	797 	(1,103) 	(142) 	16
Preferred stock dividends 	(52) 	— 	— 	(46)
Earnings (loss) from continuing operations attributable
to GE common shareholders 	745 	(1,103) 	(142) 	(29)
Earnings (loss) from discontinued operations attributable
to GE common shareholders 	(8) 	(10) 	611 	(48)
Net earnings (loss) attributable to GE common shareholders 	$ 	737 	$ 	(1,112) 	$ 	469 	$ 	(78)
2021 3Q FORM 10-Q 	29

-- 29 of 79 --

STATEMENT OF EARNINGS (LOSS) 	Nine months ended September 30
(UNAUDITED) 	Consolidated
(In millions; per-share amounts in dollars) 	2021 	2020
Sales of goods 	$ 	32,983 	$ 	35,365
Sales of services 	18,615 	17,340
GE Capital revenues from services 	2,228 	2,118
Total revenues (Note 9) 	53,826 	54,823
Cost of goods sold 	26,892 	30,272
Cost of services sold 	12,666 	11,829
Selling, general and administrative expenses 	8,504 	9,344
Research and development 	1,792 	1,929
Interest and other financial charges 	1,450 	1,648
Debt extinguishment costs 	1,416 	206
Insurance losses and annuity benefits 	1,680 	1,824
Goodwill impairments (Note 8) 	— 	877
Non-operating benefit costs 	1,374 	1,821
Other costs and expenses 	91 	114
Total costs and expenses 	55,866 	59,863
Other income (Note 23) 	1,824 	8,430
Earnings (loss) from continuing operations before income taxes 	(216) 	3,390
Benefit (provision) for income taxes 	323 	589
Earnings (loss) from continuing operations 	107 	3,979
Earnings (loss) from discontinued operations, net of taxes (Note 2) 	(2,856) 	(1,072)
Net earnings (loss) 	(2,748) 	2,907
Less net earnings (loss) attributable to noncontrolling interests 	(72) 	(161)
Net earnings (loss) attributable to the Company 	(2,677) 	3,068
Preferred stock dividends 	(180) 	(280)
Net earnings (loss) attributable to GE common shareholders 	$ 	(2,857) 	$ 	2,787
Amounts attributable to GE common shareholders
Earnings (loss) from continuing operations 	$ 	107 	$ 	3,979
Less net earnings (loss) attributable to noncontrolling interests,
continuing operations 	(72) 	(159)
Earnings (loss) from continuing operations attributable to the Company 	179 	4,138
Preferred stock dividends 	(180) 	(280)
Earnings (loss) from continuing operations attributable
to GE common shareholders 	(1) 	3,857
Earnings (loss) from discontinued operations attributable
to GE common shareholders 	(2,856) 	(1,070)
Net earnings (loss) attributable to GE common shareholders 	$ 	(2,857) 	$ 	2,787
Earnings (loss) per share from continuing operations (Note 18)
Diluted earnings (loss) per share 	$ 	(0.01) 	$ 	3.39
Basic earnings (loss) per share 	$ 	(0.01) 	$ 	3.39
Net earnings (loss) per share (Note 18)
Diluted earnings (loss) per share 	$ 	(2.61) 	$ 	2.41
Basic earnings (loss) per share 	$ 	(2.61) 	$ 	2.41
2021 3Q FORM 10-Q 	30

-- 30 of 79 --

STATEMENT OF EARNINGS (LOSS) (CONTINUED) 	Nine months ended September 30
(UNAUDITED) 	GE Industrial 	GE Capital
(In millions; per-share amounts in dollars) 	2021 	2020 	2021 	2020
Sales of goods 	$ 	32,989 	$ 	35,401 	$ 	— 	$ 	—
Sales of services 	18,648 	17,427 	— 	—
GE Capital revenues from services 	— 	— 	2,470 	2,455
Total revenues 	51,637 	52,828 	2,470 	2,455
Cost of goods sold 	26,899 	30,308 	— 	—
Cost of services sold 	12,683 	11,901 	15 	15
Selling, general and administrative expenses 	8,200 	9,033 	318 	396
Research and development 	1,792 	1,929 	— 	—
Interest and other financial charges 	753 	1,016 	799 	821
Debt extinguishment costs 	645 	63 	771 	143
Insurance losses and annuity benefits 	— 	— 	1,706 	1,866
Goodwill impairments (Note 8) 	— 	877 	— 	—
Non-operating benefit costs 	1,376 	1,815 	(2) 	6
Other costs and expenses 	— 	— 	127 	185
Total costs and expenses 	52,348 	56,943 	3,734 	3,432
Other income (Note 23) 	1,760 	8,481 	— 	—
Earnings (loss) from continuing operations before income taxes 	1,048 	4,366 	(1,264) 	(976)
Benefit (provision) for income taxes 	(1) 	22 	324 	566
Earnings (loss) from continuing operations 	1,047 	4,389 	(940) 	(410)
Earnings (loss) from discontinued operations, net of taxes (Note 2) 	(4) 	(33) 	(2,851) 	(1,039)
Net earnings (loss) 	1,042 	4,355 	(3,791) 	(1,449)
Less net earnings (loss) attributable to noncontrolling interests 	22 	(163) 	(94) 	2
Net earnings (loss) attributable to the Company 	1,021 	4,518 	(3,698) 	(1,451)
Preferred stock dividends 	(139) 	— 	(41) 	(280)
Net earnings (loss) attributable to GE common shareholders 	$ 	882 	$ 	4,518 	$ 	(3,739) 	$ 	(1,731)
Amounts attributable to GE common shareholders:
Earnings (loss) from continuing operations 	$ 	1,047 	$ 	4,389 	$ 	(940) 	$ 	(410)
Less net earnings (loss) attributable to noncontrolling interests,
continuing operations 	22 	(161) 	(94) 	2
Earnings (loss) from continuing operations attributable to the Company 	1,025 	4,549 	(846) 	(412)
Preferred stock dividends 	(139) 	— 	(41) 	(280)
Earnings (loss) from continuing operations attributable
to GE common shareholders 	886 	4,549 	(887) 	(692)
Earnings (loss) from discontinued operations attributable
to GE common shareholders 	(4) 	(31) 	(2,851) 	(1,039)
Net earnings (loss) attributable to GE common shareholders 	$ 	882 	$ 	4,518 	$ 	(3,739) 	$ 	(1,731)
2021 3Q FORM 10-Q 	31

-- 31 of 79 --

STATEMENT OF FINANCIAL POSITION (UNAUDITED) 	Consolidated
(In millions, except share amounts) 	September 30, 2021 	December 31, 2020
Cash, cash equivalents and restricted cash(a) 	$ 	24,955 	$ 	36,530
Investment securities (Note 3) 	5,300 	7,319
Current receivables (Note 4) 	14,874 	16,691
Financing receivables – net (Note 5) 	271 	326
Inventories, including deferred inventory costs (Note 6) 	16,790 	15,890
Other GE Capital receivables 	1,186 	1,549
Receivable from GE Capital 	— 	—
Current contract assets (Note 10) 	5,238 	5,764
All other current assets (Note 11) 	1,191 	1,109
Assets of discontinued operations (Note 2) 	33,782 	—
Current assets 	103,587 	85,180
Investment securities (Note 3) 	42,394 	42,549
Other GE Capital receivables 	4,668 	4,661
Property, plant and equipment – net (Note 7) 	15,873 	16,699
Receivable from GE Capital 	— 	—
Goodwill (Note 8) 	25,333 	25,524
Other intangible assets – net (Note 8) 	9,187 	9,671
Contract and other deferred assets (Note 10) 	6,119 	5,888
All other assets (Note 11) 	12,651 	11,038
Deferred income taxes (Note 16) 	14,466 	14,253
Assets of discontinued operations (Note 2) 	2,855 	40,749
Total assets 	$ 	237,133 	$ 	256,211
Short-term borrowings (Note 12) 	$ 	5,459 	$ 	4,713
Short-term borrowings assumed by GE (Note 12) 	— 	—
Accounts payable and equipment project accruals 	16,172 	16,458
Progress collections and deferred income (Note 10) 	16,909 	18,371
All other current liabilities (Note 15) 	14,349 	15,071
Liabilities of discontinued operations (Note 2) 	4,788 	—
Current liabilities 	57,676 	54,613
Deferred income (Note 10) 	1,839 	1,801
Long-term borrowings (Note 12) 	57,429 	70,189
Long-term borrowings assumed by GE (Note 12) 	— 	—
Insurance liabilities and annuity benefits (Note 13) 	37,705 	42,191
Non-current compensation and benefits 	28,415 	29,677
All other liabilities (Note 15) 	14,999 	15,484
Liabilities of discontinued operations (Note 2) 	109 	5,182
Total liabilities 	198,172 	219,138
Preferred stock (5,939,875 shares outstanding at both September 30, 2021
and December 31, 2020) 	6 	6
Common stock (1,098,137,128 and 1,095,686,581 shares outstanding
at September 30, 2021 and December 31, 2020, respectively)(b) 	15 	702
Accumulated other comprehensive income (loss) – net attributable to GE 	(5,078) 	(9,749)
Other capital 	34,751 	34,307
Retained earnings 	89,098 	92,247
Less common stock held in treasury 	(81,314) 	(81,961)
Total GE shareholders’ equity 	37,477 	35,552
Noncontrolling interests 	1,484 	1,522
Total equity 	38,961 	37,073
Total liabilities and equity 	$ 	237,133 	$ 	256,211
(a) Excluded $807 million and $455 million at September 30, 2021 and December 31, 2020, respectively, in Insurance, which is subject to regulatory restrictions.
This balance is included in All other assets. See Note 11 for further information.
(b) Reduction of $687 million in common stock represents the change in par value of issued shares from $0.06 to $0.01 with the offsetting change in Other
capital.
2021 3Q FORM 10-Q 	32

-- 32 of 79 --

STATEMENT OF FINANCIAL POSITION (CONTINUED) 	GE Industrial 	GE Capital
(UNAUDITED) 	(In millions, except share amounts) September 30,
2021 December 31,
2020 September 30,
2021 December 31,
2020
Cash, cash equivalents and restricted cash 	$ 	17,995 	$ 	23,209 	$ 	6,960 	$ 	13,322
Investment securities (Note 3) 	5,300 	7,319 	— 	—
Current receivables (Note 4) 	14,368 	13,442 	— 	—
Financing receivables – net (Note 5) 	— 	— 	1,300 	4,172
Inventories, including deferred inventory costs (Note 6) 	16,790 	15,890 	— 	—
Other GE Capital receivables 	— 	— 	1,544 	3,280
Receivable from GE Capital 	2,346 	2,432 	— 	—
Current contract assets (Note 10) 	5,238 	5,764 	— 	—
All other current assets (Note 11) 	839 	835 	362 	543
Assets of discontinued operations (Note 2) 	— 	— 	33,782 	—
Current assets 	62,876 	68,892 	43,948 	21,317
Investment securities (Note 3) 	150 	36 	42,246 	42,515
Other GE Capital receivables 	— 	— 	5,056 	5,076
Property, plant and equipment – net (Note 7) 	15,635 	16,433 	241 	271
Receivable from GE Capital 	12,583 	16,780 	— 	—
Goodwill (Note 8) 	25,333 	25,524 	— 	—
Other intangible assets – net (Note 8) 	9,155 	9,632 	32 	39
Contract and other deferred assets (Note 10) 	6,119 	5,921 	— 	—
All other assets (Note 11) 	8,709 	7,948 	4,170 	3,354
Deferred income taxes (Note 16) 	10,082 	9,154 	4,384 	5,099
Assets of discontinued operations (Note 2) 	123 	144 	2,732 	40,587
Total assets 	$ 	150,765 	$ 	160,462 	$ 	102,809 	$ 	118,257
Short-term borrowings (Note 12) 	$ 	1,468 	$ 	918 	$ 	1,862 	$ 	1,963
Short-term borrowings assumed by GE (Note 12) 	2,346 	2,432 	2,346 	2,432
Accounts payable and equipment project accruals 	15,929 	16,380 	760 	918
Progress collections and deferred income (Note 10) 	16,936 	18,371 	— 	—
All other current liabilities (Note 15) 	13,385 	14,131 	1,164 	2,288
Liabilities of discontinued operations (Note 2) 	— 	— 	4,788 	—
Current liabilities 	50,064 	52,232 	10,919 	7,602
Deferred income (Note 10) 	1,839 	1,801 	— 	—
Long-term borrowings (Note 12) 	14,093 	19,428 	27,575 	30,803
Long-term borrowings assumed by GE (Note 12) 	15,761 	19,957 	12,583 	16,780
Insurance liabilities and annuity benefits (Note 13) 	— 	— 	38,090 	42,565
Non-current compensation and benefits 	28,108 	29,291 	299 	379
All other liabilities (Note 15) 	14,794 	15,072 	379 	539
Liabilities of discontinued operations (Note 2) 	124 	139 	(15) 	5,058
Total liabilities 	124,784 	137,921 	89,830 	103,726
Preferred stock (5,939,875 shares outstanding at both
September 30, 2021 and December 31, 2020) 	6 	6 	— 	6
Common stock (1,098,137,128 and 1,095,686,581 shares outstanding at
September 30, 2021 and December 31, 2020, respectively) 	15 	702 	5 	—
Accumulated other comprehensive income (loss) – net attributable to GE 	(6,437) 	(8,945) 	1,359 	(804)
Other capital 	16,827 	16,466 	17,920 	17,835
Retained earnings 	95,500 	94,910 	(6,402) 	(2,663)
Less common stock held in treasury 	(81,314) 	(81,961) 	— 	—
Total GE shareholders’ equity 	24,596 	21,179 	12,881 	14,373
Noncontrolling interests 	1,386 	1,363 	97 	159
Total equity 	25,982 	22,542 	12,979 	14,531
Total liabilities and equity 	$ 	150,765 	$ 	160,462 	$ 	102,809 	$ 	118,257
2021 3Q FORM 10-Q 	33

-- 33 of 79 --

STATEMENT OF CASH FLOWS 	Nine months ended September 30
(UNAUDITED) 	Consolidated
(In millions) 	2021 	2020
Net earnings (loss) 	$ 	(2,748) 	$ 	2,907
(Earnings) loss from discontinued operations 	2,856 	1,072
Adjustments to reconcile net earnings (loss)
to cash provided from operating activities
Depreciation and amortization of property, plant and equipment (Note 7) 	1,390 	1,664
Amortization of intangible assets (Note 8) 	860 	1,036
Goodwill impairments (Note 8) 	— 	877
(Gains) losses on purchases and sales of business interests (Note 23) 	155 	(12,446)
(Gains) losses on equity securities (Note 23) 	(1,035) 	4,781
Principal pension plans cost (Note 14) 	1,990 	2,681
Principal pension plans employer contributions 	(232) 	(226)
Other postretirement benefit plans (net) 	(772) 	(712)
Provision (benefit) for income taxes 	(323) 	(589)
Cash recovered (paid) during the year for income taxes 	(1,048) 	(1,138)
Changes in operating working capital:
Decrease (increase) in current receivables 	874 	(1,665)
Decrease (increase) in inventories, including deferred inventory costs 	(1,184) 	(432)
Decrease (increase) in current contract assets 	498 	855
Increase (decrease) in accounts payable and equipment project accruals 	(167) 	(1,208)
Increase (decrease) in progress collections and current deferred income 	(1,509) 	(1,247)
All other operating activities 	(1,132) 	1,912
Cash from (used for) operating activities – continuing operations 	(1,527) 	(1,876)
Cash from (used for) operating activities – discontinued operations 	2,427 	1,816
Cash from (used for) operating activities 	900 	(60)
Additions to property, plant and equipment 	(895) 	(1,302)
Dispositions of property, plant and equipment 	128 	134
Additions to internal-use software 	(78) 	(125)
Net decrease (increase) in financing receivables 	66 	(32)
Proceeds from principal business dispositions 	1 	20,577
Net cash from (payments for) principal businesses purchased 	(27) 	(10)
Sales of retained ownership interests 	2,961 	—
Net (purchases) dispositions of GE Capital investment securities 	(1,158) 	(1,292)
All other investing activities 	1,912 	1,719
Cash from (used for) investing activities – continuing operations 	2,909 	19,667
Cash from (used for) investing activities – discontinued operations 	(2,683) 	(1,966)
Cash from (used for) investing activities 	226 	17,702
Net increase (decrease) in borrowings (maturities of 90 days or less) 	(390) 	(4,198)
Newly issued debt (maturities longer than 90 days) 	364 	14,452
Repayments and other debt reductions (maturities longer than 90 days) 	(10,210) 	(24,486)
Dividends paid to shareholders 	(431) 	(412)
All other financing activities 	(1,836) 	(369)
Cash from (used for) financing activities – continuing operations 	(12,502) 	(15,014)
Cash from (used for) financing activities – discontinued operations 	101 	(24)
Cash from (used for) financing activities 	(12,401) 	(15,038)
Effect of currency exchange rate changes on cash, cash equivalents and restricted cash 	(136) 	(11)
Increase (decrease) in cash, cash equivalents and restricted cash 	(11,412) 	2,593
Cash, cash equivalents and restricted cash at beginning of year 	37,608 	37,077
Cash, cash equivalents and restricted cash at September 30 	26,197 	39,670
Less cash, cash equivalents and restricted cash of discontinued operations at
September 30 	435 	612
Cash, cash equivalents and restricted cash of continuing operations at September 30 	$ 	25,762 	$ 	39,058
2021 3Q FORM 10-Q 	34

-- 34 of 79 --

STATEMENT OF CASH FLOWS (CONTINUED) 	Nine months ended September 30
(UNAUDITED) 	GE Industrial 	GE Capital
(In millions) 	2021 	2020 	2021 	2020
Net earnings (loss) 	$ 	1,042 	$ 	4,355 	$ 	(3,791) 	$ 	(1,449)
(Earnings) loss from discontinued operations 	4 	33 	2,851 	1,039
Adjustments to reconcile net earnings (loss)
to cash provided from operating activities
Depreciation and amortization of property, plant and equipment (Note 7) 	1,372 	1,664 	18 	20
Amortization of intangible assets (Note 8) 	849 	1,028 	11 	8
Goodwill impairments (Note 8) 	— 	877 	— 	—
(Gains) losses on purchases and sales of business interests (Note 23) 	155 	(12,445) 	— 	—
(Gains) losses on equity securities (Note 23) 	(1,010) 	4,761 	(26) 	21
Principal pension plans cost (Note 14) 	1,990 	2,681 	— 	—
Principal pension plans employer contributions 	(232) 	(226) 	— 	—
Other postretirement benefit plans (net) 	(734) 	(675) 	(39) 	(37)
Provision (benefit) for income taxes 	1 	(22) 	(324) 	(566)
Cash recovered (paid) during the year for income taxes 	(1,113) 	(1,805) 	65 	667
Changes in operating working capital:
Decrease (increase) in current receivables 	(1,499) 	(118) 	— 	—
Decrease (increase) in inventories, including deferred inventory costs 	(1,120) 	(385) 	— 	—
Decrease (increase) in current contract assets 	498 	855 	— 	—
Increase (decrease) in accounts payable and equipment project accruals 	(287) 	(3,020) 	8 	(26)
Increase (decrease) in progress collections and current deferred income 	(1,471) 	(1,247) 	— 	—
All other operating activities 	721 	513 	(1,738) 	936
Cash from (used for) operating activities – continuing operations 	(832) 	(3,175) 	(2,963) 	612
Cash from (used for) operating activities – discontinued operations 	5 	34 	2,422 	1,782
Cash from (used for) operating activities 	(827) 	(3,141) 	(541) 	2,394
Additions to property, plant and equipment 	(896) 	(1,302) 	— 	—
Dispositions of property, plant and equipment 	128 	134 	— 	—
Additions to internal-use software 	(76) 	(121) 	(3) 	(5)
Net decrease (increase) in financing receivables 	— 	— 	3,398 	(292)
Proceeds from principal business dispositions 	1 	20,408 	— 	—
Net cash from (payments for) principal businesses purchased 	(27) 	(10) 	— 	—
Sales of retained ownership interests 	2,961 	— 	— 	—
Net (purchases) dispositions of GE Capital investment securities 	— 	— 	(1,158) 	(1,292)
All other investing activities 	124 	210 	1,771 	10,840
Cash from (used for) investing activities – continuing operations 	2,216 	19,318 	4,008 	9,251
Cash from (used for) investing activities – discontinued operations 	(5) 	(39) 	(2,678) 	(1,927)
Cash from (used for) investing activities 	2,211 	19,279 	1,330 	7,324
Net increase (decrease) in borrowings (maturities of 90 days or less) 	(1,304) 	(4,323) 	(118) 	(460)
Newly issued debt (maturities longer than 90 days) 	5 	7,432 	359 	7,020
Repayments and other debt reductions (maturities longer than 90 days) 	(4,156) 	(12,129) 	(6,054) 	(19,857)
Dividends paid to shareholders 	(402) 	(265) 	(41) 	(276)
All other financing activities 	(658) 	(84) 	(1,181) 	(286)
Cash from (used for) financing activities – continuing operations 	(6,514) 	(9,369) 	(7,035) 	(13,859)
Cash from (used for) financing activities – discontinued operations 	— 	1 	101 	(24)
Cash from (used for) financing activities 	(6,514) 	(9,369) 	(6,934) 	(13,883)
Effect of currency exchange rate changes on cash, cash equivalents and restricted cash 	(83) 	(50) 	(53) 	38
Increase (decrease) in cash, cash equivalents and restricted cash 	(5,214) 	6,719 	(6,198) 	(4,126)
Cash, cash equivalents and restricted cash at beginning of year 	23,209 	17,617 	14,400 	19,460
Cash, cash equivalents and restricted cash at September 30 	17,995 	24,337 	8,202 	15,333
Less cash, cash equivalents and restricted cash of discontinued operations at
September 30 	— 	— 	435 	612
Cash, cash equivalents and restricted cash of continuing operations at September 30 	$ 	17,995 	$ 	24,337 	$ 	7,767 	$ 	14,721
2021 3Q FORM 10-Q 	35

-- 35 of 79 --

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS)
(UNAUDITED) Three months ended September
30 	Nine months ended September 30
(In millions, net of tax) 	2021 	2020 	2021 	2020
Net earnings (loss) 	$ 	1,184 	$ 	(1,195) 	$ 	(2,748) 	$ 	2,907
Less net earnings (loss) attributable to noncontrolling interests 	(73) 	(51) 	(72) 	(161)
Net earnings (loss) attributable to the Company 	$ 	1,257 	$ 	(1,144) 	$ 	(2,677) 	$ 	3,068
Currency translation adjustments 	(158) 	55 	81 	133
Benefit plans 	753 	609 	2,372 	2,248
Investment securities and cash flow hedges 	2,151 	32 	2,222 	(140)
Less: other comprehensive income (loss) attributable to noncontrolling interests 	4 	— 	5 	7
Other comprehensive income (loss) attributable to the Company 	$ 	2,742 	$ 	695 	$ 	4,671 	$ 	2,234
Comprehensive income (loss) 	$ 	3,930 	$ 	(499) 	$ 	1,927 	$ 	5,147
Less: comprehensive income (loss) attributable to noncontrolling interests 	(69) 	(50) 	(67) 	(154)
Comprehensive income (loss) attributable to the Company 	$ 	3,999 	$ 	(449) 	$ 	1,994 	$ 	5,302
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS'
EQUITY (UNAUDITED) Three months ended September
30 	Nine months ended September 30
(In millions) 	2021 	2020 	2021 	2020
Preferred stock issued 	$ 	6 	$ 	6 	$ 	6 	$ 	6
Common stock issued 	$ 	15 	$ 	702 	$ 	15 	$ 	702
Beginning balance 	(7,820) 	(10,194) 	(9,749) 	(11,732)
Currency translation adjustments 	(160) 	55 	80 	129
Benefit plans 	751 	609 	2,369 	2,245
Investment securities and cash flow hedges 	2,151 	32 	2,222 	(140)
Accumulated other comprehensive income (loss) 	$ 	(5,078) 	$ 	(9,498) 	$ 	(5,078) 	$ 	(9,498)
Beginning balance 	34,032 	34,292 	34,307 	34,405
Gains (losses) on treasury stock dispositions 	(78) 	(162) 	(571) 	(574)
Stock-based compensation 	109 	104 	322 	319
Other changes 	689 	46 	694 	129
Other capital 	$ 	34,751 	$ 	34,279 	$ 	34,751 	$ 	34,279
Beginning balance 	87,993 	91,188 	92,247 	87,732
Net earnings (loss) attributable to the Company 	1,257 	(1,144) 	(2,677) 	3,068
Dividends and other transactions with shareholders 	(152) 	(139) 	(473) 	(720)
Changes in accounting 	— 	— 	— 	(175)
Retained earnings 	$ 	89,098 	$ 	89,905 	$ 	89,098 	$ 	89,905
Beginning balance 	(81,425) 	(82,320) 	(81,961) 	(82,797)
Purchases 	(4) 	(3) 	(87) 	(25)
Dispositions 	116 	198 	733 	697
Common stock held in treasury 	$ 	(81,314) 	$ 	(82,125) 	$ 	(81,314) 	$ 	(82,125)
GE shareholders' equity balance 	37,477 	33,269 	37,477 	33,269
Noncontrolling interests balance 	1,484 	1,524 	1,484 	1,524
Total equity balance at September 30 	$ 	38,961 	$ 	34,793 	$ 	38,961 	$ 	34,793
2021 3Q FORM 10-Q 	36

-- 36 of 79 --

NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES. 	We present our financial statements in a three-
column format, which allows investors to see our GE industrial operations separately from our financial services operations. We believe that this provides useful
supplemental information to our consolidated financial statements. To the extent that we have transactions between GE Industrial and GE Capital, these
transactions are made on arms-length terms, are reported in the respective columns of our financial statements and are eliminated in consolidation. See Note 22
for further information.
Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles (GAAP), which requires us to make
estimates based on assumptions about current and, for some estimates, future economic and market conditions which affect reported amounts and related
disclosures in our financial statements. Although our current estimates contemplate current and expected future conditions, as applicable, it is reasonably
possible that actual conditions could differ from our expectations, which could materially affect our results of operations and financial position. In particular, a
number of estimates have been and will continue to be affected by the ongoing Coronavirus Disease 2019 (COVID-19) pandemic. The severity, magnitude and
duration, as well as the economic consequences, of the COVID-19 pandemic, are uncertain, rapidly changing and difficult to predict. As a result, our accounting
estimates and assumptions may change over time in response to COVID-19. Such changes could result in future impairments of goodwill, intangibles, long-lived
assets and investment securities, revisions to estimated profitability on long-term product service agreements, incremental credit losses on receivables and debt
securities, a decrease in the carrying amount of our tax assets, or an increase in our insurance liabilities and pension obligations as of the time of a relevant
measurement event.
In preparing our Statement of Cash Flows, we make certain adjustments to reflect cash flows that cannot otherwise be calculated by changes in our Statement of
Financial Position. These adjustments may include, but are not limited to, the effects of currency exchange, acquisitions and dispositions of businesses,
businesses classified as held for sale, the timing of settlements to suppliers for property, plant and equipment, non-cash gains/losses and other balance sheet
reclassifications.
We have reclassified certain prior-period amounts to conform to the current-period’s presentation. Unless otherwise noted, tables are presented in U.S. dollars in
millions. Certain columns and rows may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in
millions. Earnings per share amounts are computed independently for earnings from continuing operations, earnings from discontinued operations and net
earnings. As a result, the sum of per-share amounts may not equal the total. Unless otherwise indicated, information in these notes to the consolidated financial
statements relates to continuing operations. Certain of our operations have been presented as discontinued. We present businesses whose disposal represents
a strategic shift that has, or will have, a major effect on our operations and financial results as discontinued operations when the components meet the criteria for
held for sale, are sold, or spun-off. See Note 2 for further information.
The accompanying consolidated financial statements and notes are unaudited. The results reported in these consolidated financial statements should not be
regarded as necessarily indicative of results that may be expected for the entire year. These consolidated financial statements should be read in conjunction with
the financial statements and notes included in our Annual Report on Form 10-K for the year ended December 31, 2020.
Our significant accounting policies are described in Note 1 of our aforementioned Annual Report.
NOTE 2. BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS. 	In September of 2021, we signed an agreement to exit GE's share of
our boiler manufacturing business in China in our Power segment. In connection with the transaction, we recorded a loss on the planned disposal of this
business of $172 million in Other income in our consolidated Statement of Earnings (Loss). We expect to complete the sale in the fourth quarter of 2021. See
Note 23 for further information.
On March 31, 2020, we completed the sale of our BioPharma business within our Healthcare segment for total consideration of $21,112 million (after certain
working capital adjustments) and incurred $185 million of cash payments directly associated with the transaction. In the first three quarters of 2020, we
recognized a pre-tax gain of $12,362 million ($11,214 million after-tax) in our consolidated Statement of Earnings (Loss).
DISCONTINUED OPERATIONS 	primarily comprise our GE Capital Aviation Services (GECAS) business, our mortgage portfolio in Poland, and other trailing
assets and liabilities associated with prior dispositions. Results of operations, financial position and cash flows for these businesses are reported as discontinued
operations for all periods presented.
GECAS. 	On March 9, 2021 we entered into an agreement with AerCap Holdings N.V. (AerCap) to combine our GECAS business with AerCap (GECAS
transaction). GE will receive total consideration consisting of approximately $22,650 million cash, inclusive of estimated contractual closing adjustments,
111.5 million shares of AerCap common stock (approximately 46% ownership interest) valued at $6,446 million based on AerCap’s closing share price of $57.81
on September 30, 2021 and $1,000 million in AerCap notes. As a result, we have reclassified GECAS' results to discontinued operations for all periods
presented and recognized a non-cash after-tax loss of $3,638 million in discontinued operations for the nine months ended September 30, 2021. Given the
economics of GECAS accrue to AerCap in conjunction with the transaction, the net impact of GECAS (loss on sale and operations) could change materially,
mainly due to fluctuations in AerCap's closing share price. In October 2021, we received final regulatory approvals and are now expecting the transaction to be
completed on November 1, 2021.
After completion of the transaction, we will elect to prospectively measure our investment in AerCap at fair value and expect to have continuing involvement with
AerCap, primarily through our ownership interest and ongoing sales or leases of products and services.
2021 3Q FORM 10-Q 	37

-- 37 of 79 --

Bank BPH. The mortgage portfolio in Poland (Bank BPH) comprises floating rate residential mortgages, 86% of which are indexed to or denominated in foreign
currencies (primarily Swiss francs). At September 30, 2021, the total portfolio had a carrying value of $1,938 million with a 1.96% 90-day delinquency rate and an
average loan to value ratio of approximately 61.1%. The portfolio is recorded at the lower of cost or fair value, less cost to sell, which reflects market yields as
well as estimates with respect to ongoing litigation in Poland related to foreign currency-denominated mortgages and other factors. Earnings from discontinued
operations for the nine months ended September 30, 2021 included $289 million non-cash pre-tax charges, reflecting estimates with respect to ongoing litigation
as well as market yields, primarily in the first quarter of 2021. Future changes in the estimated legal liabilities or market yields could result in further losses
related to these loans in future reporting periods. See Note 21 for further information.
Baker Hughes (BKR). 	We have continuing involvement with BKR primarily through our remaining interest, ongoing purchases and sales of products and
services, transition services that we provide to BKR, as well as an aeroderivative joint venture (JV) we formed with BKR in the fourth quarter of 2019. The JV is a
50-50 joint venture between GE and BKR and is consolidated by GE due to the significance of our investment in BKR.
For the nine months ended September 30, 2021, we had sales of $439 million and purchases of $177 million with BKR for products and services outside of the
JV. We collected net cash of $347 million from BKR related to sales, purchases and transition services.
For the nine months ended September 30, 2021, we had sales of $351 million to BKR for products and services from the JV, and we collected cash of
$423 million. We expect to reduce our investment in BKR to below 20% in the fourth quarter, at which point we will deconsolidate the JV. The deconsolidation of
the JV is not expected to have a material impact on GE Industrial Cash from operating activities (CFOA).
In addition, for the nine months ended September 30, 2021, we received $31 million of repayments on the promissory note receivable from BKR and dividends of
$143 million on our investment.
RESULTS OF DISCONTINUED OPERATIONS Three months ended September
30 	Nine months ended September 30
2021 	2020 	2021 	2020
Operations
GE Capital revenues from services 	$ 	933 	$ 	966 	$ 	2,469 	$ 	3,032
Cost of goods and services sold 	(19) 	(640) 	(394) 	(2,027)
Other income, costs and expenses 	(340) 	(380) 	(1,037) 	(2,090)
Earnings (loss) of discontinued operations before income taxes 	$ 	575 	$ 	(54) 	$ 	1,037 	$ 	(1,085)
Benefit (provision) for income taxes 	(208) 	6 	(287) 	36
Earnings (loss) of discontinued operations, net of taxes(a) 	$ 	367 	$ 	(49) 	$ 	750 	$ 	(1,050)
Disposal
Gain (loss) on disposal before income taxes 	$ 	174 	$ 	(8) 	$ 	(3,661) 	$ 	(22)
Benefit (provision) for income taxes 	62 	(1) 	55 	(1)
Gain (loss) on disposal, net of taxes(b) 	$ 	236 	$ 	(9) 	$ 	(3,606) 	$ 	(23)
Earnings (loss) from discontinued operations, net of taxes 	$ 	602 	$ 	(58) 	$ 	(2,856) 	$ 	(1,072)
(a) Included $490 million and $(38) million from GECAS operations, including zero and $637 million of depreciation and amortization, for the three months ended
September 30, 2021 and 2020, respectively. Included $1,163 million and $(906) million from GECAS operations, including $359 million and $2,020 million of
depreciation and amortization, for the nine months ended September 30, 2021 and 2020, respectively. Depreciation and amortization ceased on March 10,
2021.
(b) Gain for the three months ended September 30, 2021 was primarily driven by GECAS due to an increase in fair value of AerCap common stock to be
received of $736 million, partially offset by an increase in GECAS net assets of $475 million attributable to income from operations.
2021 3Q FORM 10-Q 	38

-- 38 of 79 --

ASSETS AND LIABILITIES OF DISCONTINUED OPERATIONS 	September 30, 2021 	December 31, 2020
Cash, cash equivalents and restricted cash 	$ 	31 	$ 	—
Financing receivables - net 	1,985 	—
Other GE Capital receivables 	1,928 	—
Property, plant, and equipment - net 	29,369 	—
Valuation allowance on disposal group classified as discontinued operations 	(3,560) 	—
All other current assets 	4,029 	—
Total current assets of discontinued operations 	33,782 	—
Cash, cash equivalents and restricted cash 	404 	623
Financing receivables - net 	— 	2,710
Other GE Capital receivables 	50 	1,844
Financing receivables held for sale (Polish mortgage portfolio) 	1,938 	2,461
Property, plant, and equipment - net 	92 	28,429
All other assets 	370 	4,683
Assets of discontinued operations(a) 	$ 	36,637 	$ 	40,749
Deferred income taxes 	$ 	2,242 	$ 	—
Accounts payable and all other liabilities 	2,546 	—
Total current liabilities of discontinued operations 	4,788 	—
Deferred income taxes 	2 	2,172
Accounts payable and all other liabilities(b) 	107 	3,010
Liabilities of discontinued operations(a) 	$ 	4,896 	$ 	5,182
(a) Included $33,782 million and $37,199 million of assets and $4,788 million and $4,997 million of liabilities for GECAS as of September 30, 2021 and
December 31, 2020, respectively.
(b) Included within All other liabilities of discontinued operations at September 30, 2021 and December 31, 2020 are intercompany tax receivables in the amount
of $715 million and $704 million, respectively, primarily related to previously disposed financial services businesses, which are eliminated upon consolidation.
NOTE 3. INVESTMENT SECURITIES. 	All of our debt securities are classified as available-for-sale and substantially all are investment-grade supporting
obligations to annuitants and policyholders in our run-off insurance operations. We have adopted the fair value option for our investment in BKR (comprising
214.0 million shares with approximately 20.5% ownership and a promissory note receivable as of September 30, 2021), which is recorded as Equity securities
with readily determinable fair values. We classify investment securities as current or non-current based on our intent regarding the usage of proceeds from those
investments. Investment securities held within insurance entities are classified as non-current as they support the long-duration insurance liabilities.
September 30, 2021 	December 31, 2020
Amortized
cost
Gross
unrealized
gains
Gross
unrealized
losses
Estimated
fair value
Amortized
cost
Gross
unrealized
gains
Gross
unrealized
losses
Estimated
fair value
Equity (Baker Hughes) 	$ 	5,300 	$ 	— 	$ 	— 	$ 	5,300 	$ 	7,319 	$ 	— 	$ 	— 	$ 	7,319
Current investment securities 	$ 	5,300 	$ 	— 	$ 	— 	$ 	5,300 	$ 	7,319 	$ 	— 	$ 	— 	$ 	7,319
Debt
U.S. corporate 	$ 	24,995 	$ 	5,536 	$ 	(38) 	$ 	30,493 	$ 	23,604 	$ 	6,651 	$ 	(26) 	$ 	30,230
Non-U.S. corporate 	2,489 	349 	(3) 	2,835 	2,283 	458 	(1) 	2,740
State and municipal 	2,848 	643 	(5) 	3,486 	3,387 	878 	(9) 	4,256
Mortgage and asset-backed 	3,771 	159 	(34) 	3,896 	3,652 	171 	(71) 	3,752
Government and agencies 	1,102 	120 	(2) 	1,221 	1,169 	184 	— 	1,353
Other equity 	465 	— 	— 	465 	218 	— 	— 	218
Non-current investment securities 	$ 	35,669 	$ 	6,808 	$ 	(82) 	$ 	42,394 	$ 	34,313 	$ 	8,342 	$ 	(106) 	$ 	42,549
Total 	$ 	40,970 	$ 	6,808 	$ 	(82) 	$ 	47,695 	$ 	41,632 	$ 	8,342 	$ 	(106) 	$ 	49,868
The amortized cost of debt securities as of September 30, 2021 excludes accrued interest of $437 million, which is reported in current Other GE Capital
receivables.
The estimated fair value of investment securities at September 30, 2021 decreased since December 31, 2020, primarily due to the sale of BKR shares and
higher market yields, partially offset by new investments in our Insurance business and the mark-to-market effect on our remaining interest in BKR.
2021 3Q FORM 10-Q 	39

-- 39 of 79 --

Total estimated fair value of debt securities in an unrealized loss position were $2,764 million and $1,765 million, of which $488 million and $165 million had
gross unrealized losses of $(32) million and $(20) million and had been in a loss position for 12 months or more at September 30, 2021 and December 31, 2020,
respectively. Gross unrealized losses of $(82) million at September 30, 2021 included $(38) million related to U.S. corporate securities and $(31) million related
to commercial mortgage-backed securities (CMBS). The majority of our CMBS in an unrealized loss position have received investment-grade credit ratings from
the major rating agencies and are collateralized by pools of commercial mortgage loans on real estate.
Net unrealized gains (losses) for equity securities with readily determinable fair values, which are recorded in Other income within continuing operations, were
$405 million and $(776) million for the three months ended and $1,051 million and $(4,619) million for the nine months ended September 30, 2021 and 2020,
respectively.
Proceeds from debt and equity securities sales, early redemptions by issuers and principal payments on the BKR promissory note totaled $1,745 million and
$833 million for the three months ended and $4,695 million and $3,538 million for the nine months ended September 30, 2021 and 2020, respectively. Gross
realized gains on debt securities were $16 million and $15 million for the three months ended and $59 million and $143 million for the nine months ended
September 30, 2021 and 2020, respectively. Gross realized losses and impairments on debt securities were both insignificant for the three months ended
September 30, 2021 and 2020. Gross realized losses and impairments on debt securities were $(10) million and $(49) million for the nine months ended
September 30, 2021 and 2020, respectively.
Contractual maturities of our debt securities (excluding mortgage and asset-backed securities) at September 30, 2021 are as follows:
Amortized
cost Estimated
fair value
Within one year 	$ 	638 	$ 	647
After one year through five years 	3,290 	3,596
After five years through ten years 	6,264 	7,336
After ten years 	21,241 	26,455
We expect actual maturities to differ from contractual maturities because borrowers have the right to call or prepay certain obligations.
Substantially all our equity securities are classified within Level 1 and our debt securities are primarily classified within Level 2, as their valuation is determined
based on significant observable inputs. Investments with a fair value of $5,845 million and $5,866 million are classified within Level 3, as significant inputs to the
valuation model are unobservable at September 30, 2021 and December 31, 2020, respectively. During the nine months ended September 30, 2021 and 2020,
there were no significant transfers into or out of Level 3.
In addition to the equity securities described above, we hold $366 million and $274 million of equity securities without readily determinable fair values at
September 30, 2021 and December 31, 2020, respectively, that are classified within non-current All other assets in our consolidated Statement of Financial
Position. Fair value adjustments, including impairments, recorded in earnings were both insignificant for the three months ended and $34 million and $(144)
million for the nine months ended September 30, 2021 and 2020, respectively.
NOTE 4. CURRENT AND LONG-TERM RECEIVABLES
CURRENT RECEIVABLES 	Consolidated 	GE Industrial
September 30, 2021 	December 31, 2020 	September 30, 2021 	December 31, 2020
Customer receivables 	$ 	11,890 	$ 	13,459 	$ 	11,359 	$ 	9,841
Sundry receivables(a)(b) 	4,098 	4,395 	4,121 	4,763
Allowance for credit losses(c) 	(1,113) 	(1,164) 	(1,112) 	(1,161)
Total current receivables 	$ 	14,874 	$ 	16,691 	$ 	14,368 	$ 	13,442
(a) Includes supplier advances, revenue sharing programs receivables in our Aviation business, other non-income based tax receivables, primarily value-added
tax related to our operations in various countries outside of the U.S., receivables from disposed businesses, including receivables for transactional services
agreements and certain intercompany balances that eliminate upon consolidation. Revenue sharing program receivables in Aviation are amounts due from
third parties who participate in engine programs by developing and supplying certain engine components through the life of the program. The participants
share in program revenues, receive a share of customer progress payments and share costs related to discounts and warranties.
(b) Consolidated current receivables included a deferred purchase price receivable, which represents our retained risk with respect to current customer
receivables sold to third parties through our active receivables facilities. The balance of the deferred purchase price held by GE Capital as of September 30,
2021 and December 31, 2020 was $484 million and $413 million, respectively.
(c) GE Industrial allowance for credit losses decreased primarily due to write-offs and foreign currency impact, partially offset by net new provisions of
$132 million.
2021 3Q FORM 10-Q 	40

-- 40 of 79 --

Sales of GE Industrial current customer receivables. 	Effective April 1, 2021, the Company discontinued the majority of its factoring programs. The remaining
balance related to these discontinued programs was $720 million as of September 30, 2021, including $530 million retained by GE Capital. Sales to GE Capital
occurring after March 31, 2021 are only in connection with our remaining unconsolidated receivables facility described below. Customer receivables held by GE
Capital and third parties were $3,134 million and $2,582 million, respectively, at March 31, 2021. When GE Industrial sells customer receivables to GE Capital or
third parties, it accelerates the receipt of cash that would otherwise have been collected from customers. In any given period, the amount of cash received from
sales of customer receivables compared to the cash GE Industrial would have otherwise collected had those customer receivables not been sold represents the
cash generated or used in the period relating to this activity. GE Industrial sales of customer receivables to GE Capital or third parties are made on arms-length
terms and any discount related to time value of money is recognized by GE Industrial when the customer receivables are sold. In our Statement of Cash Flows,
receivables purchased and retained by GE Capital are reflected as cash from operating activities at GE Industrial, primarily as cash used for investing activities
at GE Capital and are eliminated in consolidation. Collections on receivables purchased by GE Capital are reflected primarily as cash from investing activities at
GE Capital and are reclassified to cash from operating activities in consolidation. As of September 30, 2021 and 2020, GE Industrial sold approximately 19% and
45%, respectively, of its gross customer receivables to GE Capital or third parties. Activity related to customer receivables sold by GE Industrial is as follows:
2021 	2020
GE Capital 	Third Parties 	GE Capital 	Third Parties
Balance at January 1 	$ 	3,618 	$ 	2,992 	$ 	3,087 	$ 	6,757
GE Industrial sales to GE Capital 	12,890 	— 	24,630 	—
GE Industrial sales to third parties 	— 	765 	— 	699
GE Capital sales to third parties 	(9,933) 	9,933 	(13,757) 	13,757
Collections and other 	(6,144) 	(11,538) 	(9,805) 	(17,755)
Reclassification from long-term customer receivables 	99 	— 	207 	—
Balance at September 30 	$ 	530 	(a) 	$ 	2,152 	(b) 	$ 	4,362 	(a) 	$ 	3,458
(a) At September 30, 2021 and 2020, $240 million and $640 million, respectively, of the current receivables purchased and retained by GE Capital had been sold
by GE Industrial to GE Capital with recourse (i.e., GE Industrial retains all or some risk of default). The effect on GE Industrial CFOA of claims by GE Capital
on receivables sold with recourse was insignificant for the nine months ended September 30, 2021 and 2020.
(b) Included $1,962 million in our active unconsolidated receivables facility at September 30, 2021, ($1,936 million at June 30, 2021 and $1,863 million at March
31, 2021) under which we currently expect to continue sales of GE Industrial receivables.
LONG-TERM RECEIVABLES 	Consolidated 	GE Industrial
September 30, 2021 	December 31, 2020 	September 30, 2021 	December 31, 2020
Long-term customer receivables(a) 	$ 	741$ 	585 	$ 	739$ 	474
Long-term sundry receivables(b) 	1,611 	1,748 	1,795 	2,097
Allowance for credit losses 	(133) 	(142) 	(133) 	(142)
Total long-term receivables 	$ 	2,218$ 	2,191 	$ 	2,401$ 	2,430
(a) As of September 30, 2021 and December 31, 2020, GE Capital held an insignificant amount and $111 million, respectively, of GE Industrial long-term
customer receivables.
(b) Includes supplier advances, revenue sharing programs receivables, other non-income based tax receivables and certain intercompany balances that
eliminate upon consolidation.
UNCONSOLIDATED RECEIVABLES FACILITIES. GE Capital has one active revolving receivables facility, under which customer receivables purchased from
GE Industrial are sold to third parties. The facility has a program size of $2,000 million as of September 30, 2021. Upon the sale of receivables, we receive
proceeds of cash and deferred purchase price and the Company’s remaining risk with respect to the sold receivables is limited to the balance of the deferred
purchase price.
Activity related to our unconsolidated receivables facilities is included in the GE Capital sales to third parties line in the sales of GE Industrial current customer
receivables table above and is as follows:
Nine months ended September 30 	2021 	2020
Customer receivables sold to receivables facilities 	$ 	8,442 	$ 	10,570
Collections and other on receivables sold to receivables facilities 	8,523 	12,146
Total cash purchase price for customer receivables 	7,966 	10,060
Cash collections re-invested to purchase customer receivables 	7,203 	8,865
Non-cash increases to deferred purchase price 	$ 	432 	$ 	446
Cash payments received on deferred purchase price 	362 	388
2021 3Q FORM 10-Q 	41

-- 41 of 79 --

CONSOLIDATED SECURITIZATION ENTITIES. GE Capital consolidates two variable interest entities (VIEs) that purchased customer receivables and long-
term customer receivables from GE Industrial prior to the April 1, 2021 discontinuation of the majority of the Company's factoring programs. At September 30,
2021 and December 31, 2020, these VIEs held current customer receivables of $198 million and $1,489 million and long-term customer receivables of zero and
$93 million, respectively. At September 30, 2021 and December 31, 2020, the outstanding non-recourse debt under their respective debt facilities was zero and
$892 million, respectively.
NOTE 5. FINANCING RECEIVABLES AND ALLOWANCES
Consolidated 	GE Capital
September 30, 2021 	December 31, 2020 	September 30, 2021 	December 31, 2020
Loans, net of deferred income 	$ 	300 	$ 	359 	$ 	1,311 	$ 	4,182
Allowance for losses 	(29) 	(32) 	(11) 	(10)
Current financing receivables – net 	$ 	271 	$ 	326 	$ 	1,300 	$ 	4,172
We manage our GE Capital financing receivables portfolio using delinquency data as key performance indicators. At September 30, 2021 and December 31,
2020, financing receivables over 30 days past due were 0.2% 	and 	2.8% 	and 90 days past due were 0.2% and 	1.7%, respectively.
GE Capital financing receivables that comprise receivables purchased from GE Industrial are reclassified to either Current receivables or All other assets in our
consolidated Statement of Financial Position. To the extent these receivables are purchased with full or limited recourse, they are excluded from the delinquency
above. See Note 4 for further information.
NOTE 6. INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS
September 30, 2021 	December 31, 2020
Raw materials and work in process 	$ 	8,682 	$ 	7,937
Finished goods 	5,583 	5,654
Deferred inventory costs(a) 	2,525 	2,299
Inventories, including deferred inventory costs 	$ 	16,790 	$ 	15,890
(a) Represents cost deferral for shipped goods (such as components for wind turbine assemblies within our Renewable Energy segment) and labor and
overhead costs on time and material service contracts (primarily originating in Power and Aviation) and other costs for which the criteria for revenue
recognition has not yet been met.
NOTE 7. PROPERTY, PLANT AND EQUIPMENT
September 30, 2021 	December 31, 2020
Original cost 	$ 	32,121 	$ 	32,098
Less accumulated depreciation and amortization 	(18,968) 	(18,251)
Right-of-use operating lease assets 	2,720 	2,852
Property, plant and equipment – net 	$ 	15,873 	$ 	16,699
Consolidated depreciation and amortization on property, plant and equipment was $455 million and $744 million for the three months ended September 30, 2021
and 2020, respectively, and $1,390 million and $1,664 million for the nine months ended September 30, 2021 and 2020, respectively.
In the third quarter of 2020, we recognized a non-cash pre-tax impairment charge of $316 million related to property, plant and equipment at our Steam business
within our Power segment due to our announcement to exit the new build coal power market. We determined the fair value of these assets using an income
approach. This charge was recorded by Corporate in Selling, general, and administrative expenses in our consolidated Statement of Earnings (Loss).
Operating Lease Liabilities. 	Our consolidated operating lease liabilities, included in All 	other liabilities 	in our Statement of Financial Position, were $3,004
million and $3,195 million, as of September 30, 2021 and December 31, 2020, respectively, which included GE Industrial operating lease liabilities of $2,948
million and $3,133 million, respectively. Expense on our operating lease portfolio, primarily from our long-term fixed leases, was $287 million and $278 million for
the three months ended September 30, 2021 and 2020, respectively, and $826 million and $857 million for the nine months ended September 30, 2021 and
2020, respectively.
2021 3Q FORM 10-Q 	42

-- 42 of 79 --

NOTE 8. GOODWILL AND OTHER INTANGIBLE ASSETS
GOODWILL 	January 1, 2021 	Acquisitions Currency exchange
and other Balance at
September 30, 2021
Aviation 	$ 	9,247 	$ 	— 	$ 	(126) 	$ 	9,121
Healthcare 	11,855 	45 	(19) 	11,880
Renewable Energy 	3,401 	— 	(88) 	3,313
Power 	146 	— 	— 	145
Corporate 	876 	— 	(1) 	875
Total 	$ 	25,524 	$ 	45 	$ 	(235) 	$ 	25,333
In assessing the possibility that a reporting unit’s fair value has been reduced below its carrying amount due to the occurrence of events or circumstances
between annual impairment testing dates, we consider all available evidence, including (i) the results of our impairment testing from the most recent testing date,
(ii) downward revisions to internal forecasts or decreases in market multiples, if any, and (iii) declines in market capitalization. In the third quarter of 2021, we did
not identify any reporting units that required an interim impairment test. However, we continue to monitor the operating results and cash flow forecasts of our
Additive reporting unit in our Aviation segment as the fair value of this reporting unit was not significantly in excess of its carrying value. At September 30, 2021,
our Additive reporting unit had goodwill of $235 million.
Substantially all other intangible assets are subject to amortization. Intangible assets decreased $484 million during the nine months ended September 30, 2021,
primarily as a result of amortization partially offset by the acquisition of patents and technology and capitalized software mainly at Aviation and Healthcare of
$502 million. Consolidated amortization expense was $272 million and $420 million in the three months ended, and $860 million and $1,036 million in the nine
months ended, September 30, 2021 and 2020, respectively.
In the third quarter of 2020, we recognized a non-cash pre-tax impairment charge of $113 million related to intangible assets at our Steam business within our
Power segment due to our announcement to exit the new build coal power market. We determined the fair value of these intangible assets using an income
approach. This charge was recorded by Corporate in Selling, general, and administrative expenses in our consolidated Statement of Earnings (Loss).
NOTE 9. REVENUES. 	The equipment and services revenues classification in the table below is consistent with our segment Management's Discussion and
Analysis presentation.
EQUIPMENT & SERVICES REVENUES
Three months ended September 30 	2021 	2020
Equipment 	Services 	Total 	Equipment 	Services 	Total
Aviation 	$ 	1,837 	$ 	3,562 	$ 	5,398 	$ 	1,933 	$ 	2,987 	$ 	4,919
Healthcare 	2,187 	2,151 	4,339 	2,538 	2,027 	4,565
Renewable Energy 	3,695 	512 	4,208 	3,771 	754 	4,525
Power 	1,368 	2,658 	4,026 	1,595 	2,430 	4,025
Corporate items and industrial eliminations 	(182) 	33 	(149) 	(212) 	95 	(117)
Total GE Industrial revenues 	$ 	8,905 	$ 	8,916 	$ 	17,821 	$ 	9,625 	$ 	8,293 	$ 	17,918
Nine months ended September 30 	2021 	2020
Equipment 	Services 	Total 	Equipment 	Services 	Total
Aviation 	$ 	5,549 	$ 	9,681 	$ 	15,230 	$ 	6,234 	$ 	9,961 	$ 	16,196
Healthcare 	6,671 	6,429 	13,100 	7,287 	5,899 	13,185
Renewable Energy 	9,844 	1,661 	11,505 	9,068 	2,155 	11,224
Power 	3,680 	8,561 	12,242 	4,589 	7,617 	12,206
Corporate items and industrial eliminations 	(566) 	126 	(439) 	(251) 	268 	17
Total GE Industrial revenues 	$ 	25,178 	$ 	26,459 	$ 	51,637 	$ 	26,928 	$ 	25,901 	$ 	52,828
2021 3Q FORM 10-Q 	43

-- 43 of 79 --

REVENUES Three months ended September
30 	Nine months ended September 30
2021 	2020 	2021 	2020
Commercial Engines & Services 	$ 	3,602 	$ 	3,087 	$ 	10,071 	$ 	10,718
Military 	1,107 	1,137 	3,104 	3,258
Systems & Other 	689 	696 	2,055 	2,220
Aviation 	$ 	5,398 	$ 	4,919 	$ 	15,230 	$ 	16,196
Healthcare Systems 	$ 	3,832 	$ 	4,085 	$ 	11,572 	$ 	11,056
Pharmaceutical Diagnostics 	507 	480 	1,528 	1,300
BioPharma 	— 	— 	— 	830
Healthcare 	$ 	4,339 	$ 	4,565 	$ 	13,100 	$ 	13,185
Onshore Wind 	$ 	3,047 	$ 	3,303 	$ 	8,048 	$ 	7,914
Grid Solutions equipment and services 	759 	936 	2,330 	2,587
Hydro 	190 	160 	549 	490
Offshore Wind and Hybrid Solutions 	211 	127 	577 	232
Renewable Energy 	$ 	4,208 	$ 	4,525 	$ 	11,505 	$ 	11,224
Gas Power 	$ 	2,861 	$ 	2,940 	$ 	8,739 	$ 	8,876
Steam Power 	790 	769 	2,327 	2,340
Power Conversion, Nuclear and other 	376 	316 	1,176 	990
Power 	$ 	4,026 	$ 	4,025 	$ 	12,242 	$ 	12,206
Corporate items and industrial eliminations 	(149) 	(117) 	(439) 	17
Total GE Industrial revenues 	$ 	17,821 	$ 	17,918 	$ 	51,637 	$ 	52,828
Capital 	734 	758 	2,470 	2,455
GE Capital-GE Industrial eliminations 	$ 	(126) 	$ 	(147) 	$ 	(280) 	$ 	(461)
Consolidated revenues 	$ 	18,429 	$ 	18,529 	$ 	53,826 	$ 	54,823
REMAINING PERFORMANCE OBLIGATION. 	As of September 30, 2021, the aggregate amount of the contracted revenues allocated to our unsatisfied (or
partially unsatisfied) performance obligations was $238,505 million. We expect to recognize revenue as we satisfy our remaining performance obligations as
follows: (1) equipment-related remaining performance obligation of $46,666 million, of which 52%, 72% and 97% is expected to be satisfied within 1, 2 and 5
years, respectively; and (2) services-related remaining performance obligation of $191,839 million, of which 11%, 42%, 64% and 81% is expected to be
recognized within 1, 5, 10 and 15 years, respectively, and the remaining thereafter. Contract modifications could affect both the timing to complete as well as the
amount to be received as we fulfill the related remaining performance obligations.
2021 3Q FORM 10-Q 	44

-- 44 of 79 --

NOTE 10. CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME
Contract and other deferred assets 	decreased $296 million in the nine months ended September 30, 2021 primarily due to decreased long-term service
agreements, partially offset by increased customer advances and other and the timing of revenue recognition ahead of billing milestones on long-term equipment
contracts. Our long-term service agreements decreased primarily due to billings of $7,258 million, offset by revenues recognized of $6,810 million, a net
unfavorable change in estimated profitability of $325 million at Aviation and a net favorable change in estimated profitability of $37 million at Power.
September 30, 2021 	Aviation 	Healthcare Renewable
Energy 	Power 	Other 	Total
Revenues in excess of billings 	$ 	2,714 	$ 	— 	$ 	— 	$ 	5,480 	$ 	— 	$ 	8,195
Billings in excess of revenues 	(6,188) 	— 	— 	(1,406) 	— 	(7,594)
Long-term service agreements 	$ 	(3,473) 	$ 	— 	$ 	— 	$ 	4,074 	$ 	— 	$ 	601
Short-term and other service agreements 	341 	177 	97 	91 	20 	725
Equipment contract revenues 	40 	315 	1,349 	1,963 	244 	3,912
Current contract assets 	$ 	(3,092) 	$ 	492 	$ 	1,446 	$ 	6,128 	$ 	264 	$ 	5,238
Nonrecurring engineering costs 	2,467 	31 	30 	14 	— 	2,543
Customer advances and other 	2,596 	135 	— 	846 	— 	3,576
Non-current contract and other deferred assets 	$ 	5,063 	$ 	166 	$ 	30 	$ 	860 	$ 	— 	$ 	6,119
Total contract and other deferred assets 	$ 	1,971 	$ 	658 	$ 	1,476 	$ 	6,988 	$ 	264 	$ 	11,357
December 31, 2020
Revenues in excess of billings 	$ 	3,072 	$ 	— 	$ 	— 	$ 	5,282 	$ 	— 	$ 	8,354
Billings in excess of revenues 	(5,375) 	— 	— 	(1,640) 	— 	(7,015)
Long-term service agreements 	$ 	(2,304) 	$ 	— 	$ 	— 	$ 	3,642 	$ 	— 	$ 	1,338
Short-term and other service agreements 	282 	173 	106 	129 	29 	719
Equipment contract revenues 	59 	306 	1,127 	2,015 	201 	3,707
Current contract assets 	$ 	(1,963) 	$ 	479 	$ 	1,233 	$ 	5,786 	$ 	229 	$ 	5,764
Nonrecurring engineering costs 	2,409 	31 	34 	16 	— 	2,490
Customer advances and other 	2,481 	128 	— 	822 	(32) 	3,398
Non-current contract and other deferred assets 	$ 	4,889 	$ 	159 	$ 	34 	$ 	838 	$ 	(32) 	$ 	5,888
Total contract and other deferred assets 	$ 	2,927 	$ 	638 	$ 	1,268 	$ 	6,623 	$ 	197 	$ 	11,653
Progress collections and deferred income 	decreased $1,424 million primarily due to the timing of revenue recognition in excess of new collections received,
primarily at Renewable Energy and Aviation. Revenues recognized for contracts included in a liability position at the beginning of the year were $12,602 million
and $10,762 million for the nine months ended September 30, 2021 and 2020, respectively.
September 30, 2021 	Aviation 	Healthcare Renewable
Energy 	Power 	Other 	Total
Progress collections on equipment contracts 	$ 	155 	$ 	— 	$ 	1,862 	$ 	5,227 	$ 	— 	$ 	7,244
Other progress collections 	4,245 	480 	2,750 	292 	83 	7,849
Current deferred income 	151 	1,346 	216 	22 	81 	1,816
Progress collections and deferred income 	$ 	4,551 	$ 	1,825 	$ 	4,828 	$ 	5,541 	$ 	163 	$ 	16,909
Non-current deferred income 	963 	564 	188 	118 	6 	1,839
Total Progress collections and deferred income 	$ 	5,514 	$ 	2,389 	$ 	5,015 	$ 	5,659 	$ 	170 	$ 	18,748
December 31, 2020
Progress collections on equipment contracts 	$ 	214 	$ 	— 	$ 	1,229 	$ 	4,918 	$ 	— 	$ 	6,362
Other progress collections 	4,623 	414 	4,604 	458 	152 	10,252
Current deferred income 	132 	1,309 	194 	17 	105 	1,757
Progress collections and deferred income 	$ 	4,969 	$ 	1,724 	$ 	6,028 	$ 	5,393 	$ 	257 	$ 	18,371
Non-current deferred income 	898 	564 	214 	116 	10 	1,801
Total Progress collections and deferred income 	$ 	5,867 	$ 	2,288 	$ 	6,241 	$ 	5,509 	$ 	267 	$ 	20,172
NOTE 11. ALL OTHER ASSETS. 	All other current assets and All other assets primarily include equity method and other investments, long-term customer and
sundry receivables (see Note 4), cash and cash equivalents in our run-off insurance operations and prepaid taxes and other deferred charges. Consolidated All
other non-current assets increased $1,614 million in the nine months ended September 30, 2021, primarily due to increases in pension surplus of $854 million
driven primarily by remeasurement related to freezing the UK pension plans, equity method and other investments of $365 million and Insurance cash and cash
equivalents of $352 million.
2021 3Q FORM 10-Q 	45

-- 45 of 79 --

NOTE 12. BORROWINGS
September 30, 2021 	December 31, 2020
Current portion of long-term borrowings 	$ 	1,002 	$ 	36
Current portion of long-term borrowings assumed by GE Industrial 	2,346 	2,432
Other 	465 	882
Total GE Industrial short-term borrowings 	$ 	3,813 	$ 	3,350
Current portion of long-term borrowings 	$ 	1,696 	$ 	788
Intercompany payable to GE Industrial 	2,346 	2,432
Non-recourse borrowings of consolidated securitization entities 	— 	892
Other 	166 	283
Total GE Capital short-term borrowings 	$ 	4,207 	$ 	4,395
Eliminations 	(2,562) 	(3,033)
Total short-term borrowings 	$ 	5,459 	$ 	4,713
Senior notes 	$ 	13,709 	$ 	18,994
Senior notes assumed by GE Industrial 	13,996 	18,178
Subordinated notes assumed by GE Industrial 	1,765 	1,779
Other 	384 	435
Total GE Industrial long-term borrowings 	$ 	29,854 	$ 	39,386
Senior notes 	$ 	26,918 	$ 	30,132
Subordinated notes 	146 	189
Intercompany payable to GE Industrial 	12,583 	16,780
Other 	511 	483
Total GE Capital long-term borrowings 	$ 	40,158 	$ 	47,584
Eliminations 	(12,583) 	(16,780)
Total long-term borrowings 	$ 	57,429 	$ 	70,189
Total borrowings 	$ 	62,888 	$ 	74,902
At September 30, 2021, the outstanding GE Capital borrowings that had been assumed by GE Industrial as part of the GE Capital Exit Plan was $18,106 million
($2,346 million short-term and $15,761 million long-term), for which GE Industrial has an offsetting Receivable from GE Capital of $14,929 million. The difference
of $3,177 million in long-term borrowings represents the amount of borrowings GE Capital had funded with available cash to GE Industrial via intercompany
loans in lieu of GE Industrial issuing borrowings externally.
At September 30, 2021, total GE Industrial borrowings of $18,738 million comprised GE Industrial-issued borrowings of $15,561 million and intercompany loans
from GE Capital to GE Industrial of $3,177 million as described above.
GE Industrial has provided a full and unconditional guarantee on the payment of the principal and interest on all tradable senior and subordinated outstanding
long-term debt securities issued by GE Capital. This guarantee applied to $27,202 million and $28,503 million of GE Capital debt at September 30, 2021 and
December 31, 2020, respectively.
In the second quarter of 2021, GE Industrial completed a tender offer to purchase $4,114 million in aggregate principal amount of certain GE Industrial
unsecured debt, comprising $201 million of 2.700% Notes due 2022, $752 million of 4.250% Notes due 2040, $377 million of 4.125% Notes due 2042, $311
million of 4.500% Notes due 2044 and $2,473 million of 4.350% Notes due 2050. The total cash consideration paid for these purchases was $4,756 million and
the total carrying amount of the purchased notes was $4,084 million, resulting in a total pre-tax loss of $645 million. In addition to the purchase price, GE
Industrial paid any accrued and unpaid interest on the purchased notes through the date of purchase.
In the second quarter of 2021, GE Capital completed a tender offer to purchase a total of $2,879 million in aggregate principal amount of certain senior
unsecured debt, comprising $23 million of 4.650% Notes due 2021, $56 million of 3.150% Notes due 2022, $75 million of 3.100% Notes due 2023, $503 million
of 6.150% Notes due 2037, $1,400 million of 5.875% Notes due 2038 and $823 million of 6.875% Notes due 2039. The total cash consideration paid for these
purchases was $3,940 million and the carrying amount of the purchased notes was $3,191 million, resulting in a total pre-tax loss of $771 million. In addition to
the purchase price, GE Capital paid any accrued and unpaid interest on the purchased notes through the date of purchase.
See Note 19 for further information about borrowings and associated interest rate swaps.
2021 3Q FORM 10-Q 	46

-- 46 of 79 --

NOTE 13. INSURANCE LIABILITIES AND ANNUITY BENEFITS. 	Insurance liabilities and annuity benefits comprise substantially all obligations to
annuitants and insureds in our run-off insurance operations. Our insurance operations generated revenues of $770 million and $764 million and profit (loss) of
$52 million and $57 million for the three months ended September 30, 2021 and 2020, respectively. For the nine months ended September 30, 2021 and 2020,
revenues were $2,348 million and $2,167 million and profit (loss) was $360 million and $78 million, respectively. 	These operations were supported by assets of
$50,839 million and $50,824 million at September 30, 2021 and December 31, 2020, respectively. A summary of our insurance contracts is presented below:
September 30, 2021 	Long-term care
Structured
settlement
annuities & life 	Other contracts Other
adjustments(a) 	Total
Future policy benefit reserves 	$ 	17,078 	$ 	8,969 	$ 	187 	$ 	3,919 	$ 	30,153
Claim reserves 	4,445 	265 	966 	— 	5,677
Investment contracts 	— 	974 	971 	— 	1,945
Unearned premiums and other 	14 	190 	110 	— 	315
21,538 	10,397 	2,235 	3,919 	38,090
Eliminations 	— 	— 	(385) 	— 	(385)
Total 	$ 	21,538 	$ 	10,397 	$ 	1,851 	$ 	3,919 	$ 	37,705
December 31, 2020 	Long-term care
Structured
settlement
annuities & life 	Other contracts Other
adjustments(a) 	Total
Future policy benefit reserves 	$ 	16,934 	$ 	9,207 	$ 	181 	$ 	8,160 	$ 	34,482
Claim reserves 	4,393 	275 	1,068 	— 	5,736
Investment contracts 	— 	1,034 	1,016 	— 	2,049
Unearned premiums and other 	19 	189 	89 	— 	298
21,346 	10,705 	2,354 	8,160 	42,565
Eliminations 	— 	— 	(374) 	— 	(374)
Total 	$ 	21,346 	$ 	10,705 	$ 	1,980 	$ 	8,160 	$ 	42,191
(a) To the extent that unrealized gains on specific investment securities supporting our insurance contracts would result in a premium deficiency should those
gains be realized, an increase in future policy benefit reserves is recorded, with an after-tax reduction of net unrealized gains recognized through
Accumulated other comprehensive income (loss) (AOCI) in our consolidated Statement of Earnings (Loss). The decrease in Other adjustments of $4,241
million is a result of the decline in unrealized gains on investment securities and the higher margin resulting from the 2021 premium deficiency test.
Claim reserves included incurred claims of $1,264 million and $1,390 million, of which insignificant amounts related to the recognition of adjustments to prior year
claim reserves arising from our periodic reserve evaluation for the nine months ended September 30, 2021 and 2020, respectively. Paid claims were $1,290
million and $1,328 million in the nine months ended September 30, 2021 and 2020, respectively.
Reinsurance recoverables, net of allowances of $1,609 million and $1,510 million, are included in non-current Other GE Capital receivables in our consolidated
Statement of Financial Position, and amounted to $2,613 million and $2,552 million at September 30, 2021 and December 31, 2020, respectively. The vast
majority of our remaining net reinsurance recoverables are secured by assets held in a trust for which we are the beneficiary.
2021 Premium Deficiency Testing. We completed our annual premium deficiency testing in the aggregate across our run-off insurance portfolio in the third
quarter of 2021. These procedures included updating experience studies since our last test completed in the third quarter of 2020, independent actuarial analysis
(principally on long-term care exposures) and review of industry benchmarks. Our 2021 premium deficiency testing started with the positive margin of less than
2% of the recorded future policy benefit reserves that resulted from our 2020 premium deficiency testing. Using updated assumptions, the 2021 premium
deficiency testing results indicated a significant increase in the positive margin to approximately 11% of the related future policy benefit reserves recorded at
September 30, 2021. As a result, the assumptions updated in connection with the premium deficiency recognized in 2019 remain locked-in and will remain so
unless another premium deficiency occurs in the future.
2021 3Q FORM 10-Q 	47

-- 47 of 79 --

The significant increase in the premium deficiency testing margin resulting from our 2021 premium deficiency testing was largely attributable to an increase in the
overall discount rate to a weighted average rate of 6.15% compared to 5.70% in 2020 ($2,216 million). This increase in the discount rate from 2020 reflects
further development of our previously communicated investment portfolio realignment strategy, that includes increased amounts allocated to growth assets,
consisting of private equity, equity-like securities and select high yield credit strategies, from our current target of approximately 8% up to approximately 15%.
These amounts are expected to be funded over the next 5 to 7 years from the remaining projected capital contribution of approximately $5,500 million through
2024 and regular portfolio cash flows while maintaining an overall A-rated fixed income portfolio. The 2021 discount rate assumptions also reflect a lower
expected reinvestment rate on fixed-income investments versus that applied in 2020, due to lower prevailing benchmark interest rates in the U.S, grading to a
lower expected long-term average investment yield over a shorter period and slightly lower actual yields on our fixed-income investment security portfolio. As a
result of this increased allocation to higher-yielding assets, our run-off insurance operations may experience future earnings volatility due to investments carried
at fair value with changes in fair values reported in earnings and changes in the allowance for credit losses and temporary elevated amounts of unfunded
investment commitments.
When results of the premium deficiency testing indicate overall reserves are sufficient, we are also required to assess whether additional future policy benefit
reserves are required to be accrued over time in the future. Such an accrual would be required if profits are projected in earlier future periods followed by losses
projected in later future years (i.e., profits followed by losses). When this pattern of profits followed by losses is projected, we would be required to accrue a
liability in the expected profitable years by the amount necessary to offset projected losses in later future years. We noted our projections as of third quarter 2021
indicate the present value of projected earnings in each future year to be positive, and therefore, no further adjustments to our future policy benefit reserves were
required at this time.
NOTE 14. POSTRETIREMENT BENEFIT PLANS. 	We sponsor a number of pension and retiree health and life insurance benefit plans that we present in
three categories, principal pension plans, other pension plans and principal retiree benefit plans. Please refer to Note 13 to the consolidated financial statements
of our Annual Report on Form 10-K for the year ended December 31, 2020 for a discussion of our postretirement benefit plans.
The components of benefit plans cost other than the service cost are included in the caption Non-operating benefit costs in our consolidated Statement of
Earnings (Loss).
PRINCIPAL PENSION PLANS 	Three months ended September 30 	Nine months ended September 30
2021 	2020 	2021 	2020
Service cost for benefits earned 	$ 	57 	$ 	156 	$ 	179 	$ 	501
Prior service cost amortization 	8 	36 	22 	110
Expected return on plan assets 	(763) 	(747) 	(2,288) 	(2,243)
Interest cost on benefit obligations 	488 	588 	1,464 	1,764
Net actuarial loss amortization 	871 	850 	2,613 	2,549
Benefit plans cost 	$ 	661 	$ 	883 	$ 	1,990 	$ 	2,681
Principal retiree benefit plans income was $43 million and $31 million for the three months ended September 30, 2021 and 2020, and $125 million and
$85 million for the nine months ended September 30, 2021 and 2020, respectively. Other pension plans was $57 million income and $2 million cost for the three
months ended September 30, 2021 and 2020, respectively and $44 million income and $12 million cost for the nine months ended September 30, 2021,and
2020, respectively, which includes a curtailment loss of $77 million in 2021 resulting from the freeze of the UK pension plans announced on June 10, 2021.
We also have a defined contribution plan for eligible U.S. employees that provides employer contributions. Defined contribution plan costs were $99 million and
$71 million for the three months ended September 30, 2021 and 2020 and $321 million and $253 million for the nine months ended September 30, 2021 and
2020, respectively.
NOTE 15. CURRENT AND ALL OTHER LIABILITIES. 	All other current liabilities and All other liabilities primarily includes liabilities for customer sales
allowances, equipment project and commercial liabilities, loss contracts, employee compensation and benefits, income taxes payable and uncertain tax
positions, operating lease liabilities (see Note 7), environmental, health and safety remediations and product warranties (see Note 21). GE Industrial All other
current liabilities decreased $746 million in the nine months ended September 30, 2021, primarily due to decreases in liabilities due to GE Capital of $957 million,
employee compensation and benefit liabilities of $274 million and taxes payable of $220 million. These decreases were partially offset by increased sales
allowances, equipment project and other commercial liabilities of $420 million and the conversion of a redeemable noncontrolling interest of $297 million, in our
Aviation segment, into a mandatorily redeemable instrument and reclassified to All other current liabilities.
2021 3Q FORM 10-Q 	48

-- 48 of 79 --

NOTE 16. INCOME TAXES. 	Our consolidated effective income tax rate was 149.5% and (17.4)% during the nine months ended September 30, 2021 and
2020, respectively. The tax rate for 2021 reflects a tax benefit on a pre-tax loss. The negative rate for 2020 reflects a tax benefit on pre-tax income. The rate for
2021 is higher than the U.S. statutory rate on the loss primarily due to tax benefits associated with internal restructurings to recognize historical losses as a result
of decreases in fair value. This was partially offset by the cost of global activities, including the base erosion and global intangible minimum tax provisions and an
adjustment to increase the 2021 nine-month tax rate to be in-line with the expected full-year rate. The tax benefit for 2020 is primarily due to the lower tax rate on
the sale of our BioPharma business. The tax rate on the BioPharma sale was low because the gain outside the U.S. was taxed at lower than 21% and because
we recorded $633 million of the tax associated with preparatory steps for the transaction in the fourth quarter of 2019. This was partially offset by a non-
deductible goodwill impairment charge associated with our Additive business within our Aviation segment.
The Internal Revenue Service (IRS) is currently auditing our consolidated U.S. income tax returns for 2016-2018.
GE has resolved its dispute with the United Kingdom tax authority, HM Revenue & Customs (HMRC) in connection with interest deductions claimed by GE
Capital for the years 2004-2015. As previously disclosed, HMRC had proposed to disallow interest deductions with a potential impact of approximately
$1,100 million, which included a possible assessment of tax and reduction of deferred tax assets, not including interest and penalties. As part of the settlement,
GE and HMRC agreed that a portion of the interest deductions claimed were disallowed, with no fault or blame attributed to either party. The resolution
concluded the dispute in its entirety without interest or penalties. The adjustments result in no current tax payment to HMRC, but a deferred tax charge of $112
million as part of discontinued operations as a result of a reduction of available tax attributes, which had previously been recorded as deferred tax assets.
NOTE 17. SHAREHOLDERS’ EQUITY
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) Three months ended September
30 Nine months ended September
30
2021 	2020 	2021 	2020
Beginning balance 	$ 	(4,146) 	$ 	(4,743) 	$ 	(4,386) 	$ 	(4,818)
AOCI before reclasses – net of taxes of $5, $(59), $(51) and $(39) 	(158) 	55 	82 	(558)
Reclasses from AOCI – net of taxes of $0, $0, $0 and $0(a) 	— 	— 	— 	691
AOCI 	(158) 	55 	81 	133
Less AOCI attributable to noncontrolling interests 	1 	— 	1 	3
Currency translation adjustments AOCI 	$ 	(4,305) 	$ 	(4,689) 	$ 	(4,305) 	$ 	(4,689)
Beginning balance 	$ 	(3,777) 	$ 	(5,387) 	$ 	(5,395) 	$ 	(7,024)
AOCI before reclasses – net of taxes of $16, $(22), $(5) and $6 	91 	(87) 	264 	58
Reclasses from AOCI – net of taxes of $192, $187, $592 and $613(a) 	662 	695 	2,108 	2,190
AOCI 	753 	609 	2,372 	2,248
Less AOCI attributable to noncontrolling interests 	2 	— 	4 	3
Benefit plans AOCI 	$ 	(3,026) 	$ 	(4,779) 	$ 	(3,026) 	$ 	(4,779)
Beginning balance 	$ 	103 	$ 	(63) 	$ 	32 	$ 	109
AOCI before reclasses – net of taxes of $576, $62, $566 and
$0(b) 	2,152 	65 	2,201 	(116)
Reclasses from AOCI – net of taxes of $3, $(11), $13 and $(17)(a) 	(1) 	(33) 	21 	(24)
AOCI 	2,151 	32 	2,222 	(140)
Investment securities and cash flow hedges AOCI 	$ 	2,254 	$ 	(30) 	$ 	2,254 	$ 	(30)
AOCI at September 30 	$ 	(5,078) 	$ 	(9,498) 	$ 	(5,078) 	$ 	(9,498)
Dividends declared per common share 	$ 	0.08 	$ 	0.08 	$ 	0.24 	$ 	0.24
(a) The total reclassification from AOCI included $836 million, including currency translation of $688 million, net of taxes, for the nine months ended September
30, 2020, related to the sale of our BioPharma business within our Healthcare segment.
(b) Included adjustments of $2,456 million and $(420) million for the three months ended September 30, 2021 and 2020, respectively and $3,350 million and
$(1,382) million for the nine months ended September 30, 2021 and 2020, respectively, related to insurance liabilities and annuity benefits in our run-off
insurance operations to reflect the effects that would have been recognized had the related unrealized investment security gains been realized. See Note 13
for further information.
For information on our preferred stock issuances, please refer to our Annual Report on Form 10-K for the year ended December 31, 2020 and our Quarterly
Report on Form 10-Q for the quarter ended March 31, 2021.
Redeemable noncontrolling interests, presented within All other liabilities in our consolidated Statement of Financial Position, include common shares issued by
our affiliates that are redeemable at the option of the holder of those interests and amounted to $171 million and $487 million as of September 30, 2021 and
December 31, 2020, respectively. The decrease of $316 million was primarily due to a redeemable noncontrolling interest in our Aviation segment, which was
converted into a mandatorily redeemable instrument and reclassified to All other current liabilities.
2021 3Q FORM 10-Q 	49

-- 49 of 79 --

NOTE 18. EARNINGS PER SHARE INFORMATION. 	In the second quarter of 2021, we announced that we would proceed with the 1-for-8 reverse stock
split, as approved by shareholders, and filed an amendment to our certificate of incorporation to effectuate the reverse stock split after the close of trading on
July 30, 2021. GE common stock began trading on a split-adjusted basis on August 2, 2021. Effective this quarter, our shares of outstanding common stock and
earnings per share calculation have been retroactively restated for all periods presented.
Three months ended September 30 	2021 	2020
(Earnings for per-share calculation, shares in millions, per-share amounts in dollars) 	Diluted 	Basic 	Diluted 	Basic
Earnings from continuing operations 	$ 	654 	$ 	654 	$ 	(1,087) 	$ 	(1,087)
Preferred stock dividends 	(52) 	(52) 	(46) 	(46)
Accretion of redeemable noncontrolling interests, net of tax(a) 	(9) 	(9) 	(6) 	(6)
Earnings from continuing operations attributable to common shareholders 	593 	593 	(1,138) 	(1,138)
Earnings (loss) from discontinued operations 	602 	602 	(58) 	(58)
Net earnings (loss) attributable to GE common shareholders 	1,195 	1,195 	(1,196) 	(1,196)
Shares of GE common stock outstanding 	1,098 	1,098 	1,095 	1,095
Employee compensation-related shares (including stock options) 	7 	— 	— 	—
Total average equivalent shares 	1,105 	1,098 	1,095 	1,095
Earnings per share from continuing operations 	$ 	0.54 	$ 	0.54 	$ 	(1.04) 	$ 	(1.04)
Earnings (loss) per share from discontinued operations 	0.54 	0.55 	(0.05) 	(0.05)
Net earnings (loss) per share 	1.08 	1.09 	(1.09) 	(1.09)
Potentially dilutive securities(b) 	37 	61
Nine months ended September 30 	2021 	2020
(Earnings for per-share calculation, shares in millions, per-share amounts in dollars) 	Diluted 	Basic 	Diluted 	Basic
Earnings from continuing operations 	$ 	179 	$ 	179 	$ 	4,129 	$ 	4,129
Preferred stock dividends 	(180) 	(180) 	(280) 	(280)
Accretion of redeemable noncontrolling interests, net of tax(a) 	(9) 	(9) 	(141) 	(141)
Earnings from continuing operations attributable to common shareholders 	(11) 	(11) 	3,707 	3,707
Earnings (loss) from discontinued operations 	(2,856) 	(2,856) 	(1,067) 	(1,067)
Net earnings attributable to GE common shareholders 	(2,866) 	(2,866) 	2,639 	2,639
Shares of GE common stock outstanding 	1,097 	1,097 	1,094 	1,094
Employee compensation-related shares (including stock options) 	— 	— 	1 	—
Total average equivalent shares 	1,097 	1,097 	1,094 	1,094
Earnings from continuing operations 	$ 	(0.01) 	$ 	(0.01) 	$ 	3.39 	$ 	3.39
Loss from discontinued operations 	(2.60) 	(2.60) 	(0.98) 	(0.98)
Net earnings 	(2.61) 	(2.61) 	2.41 	2.41
Potentially dilutive securities(b) 	42 	57
(a) Represents accretion adjustment of redeemable noncontrolling interests in our Additive business within our Aviation segment.
(b) Outstanding stock awards not included in the computation of diluted earnings per share because their effect was antidilutive.
Our unvested restricted stock unit awards that contain non-forfeitable rights to dividends or dividend equivalents are considered participating securities and,
therefore, are included in the computation of earnings per share pursuant to the two-class method. For the three months ended September 30, 2021, application
of this treatment had an insignificant effect. For the three months ended September 30, 2020, as a result of the loss from continuing operations, losses were not
allocated to the participating securities. For the nine months ended September 30, 2021, as a result of the loss from continuing operations, losses were not
allocated to the participating securities. For the nine months ended September 30, 2020, application of this treatment had an insignificant effect.
NOTE 19. FINANCIAL INSTRUMENTS. 	The following table provides information about assets and liabilities not carried at fair value and excludes finance
leases, equity securities without readily determinable fair value and non-financial assets and liabilities. Substantially all of these assets are considered to be
Level 3 and the vast majority of our liabilities’ fair value are considered Level 2.
September 30, 2021 	December 31, 2020
Carrying
amount
(net) Estimated
fair value
Carrying
amount
(net) Estimated
fair value
Assets 	Loans and other receivables 	$ 	2,960 	$ 	3,136 	$ 	2,904 	$ 	3,125
Liabilities 	Borrowings (Note 12) 	62,888 	73,476 	74,902 	86,001
Investment contracts (Note 13) 	1,945 	2,344 	2,049 	2,547
Assets and liabilities that are reflected in the accompanying financial statements at fair value are not included in the above disclosures; such items include cash
and equivalents, investment securities and derivative financial instruments.
2021 3Q FORM 10-Q 	50

-- 50 of 79 --

DERIVATIVES AND HEDGING. 	Our policy requires that derivatives are used solely for managing risks and not for speculative purposes. GE Capital notional
relates primarily to managing interest rate and currency risk between financial assets and liabilities, and GE Industrial notional relates primarily to managing
currency risk.
FAIR VALUE OF DERIVATIVES 	September 30, 2021 	December 31, 2020
Gross Notional All other
assets All other
liabilities 	Gross Notional All other
assets All other
liabilities
Interest rate contracts 	$ 	25,697 	$ 	900 	$ 	44 	$ 	20,500 	$ 	1,912 	$ 	7
Currency exchange contracts 	7,343 	152 	36 	7,387 	164 	125
Derivatives accounted for as hedges 	$ 	33,040 	$ 	1,052 	$ 	81 	$ 	27,886 	$ 	2,076 	$ 	132
Interest rate contracts 	$ 	270 	$ 	6 	$ 	— 	$ 	346 	$ 	8 	$ 	(1)
Currency exchange contracts 	70,072 	677 	798 	65,379 	767 	918
Other contracts 	1,738 	296 	21 	2,036 	218 	71
Derivatives not accounted for as hedges 	$ 	72,080 	$ 	978 	$ 	819 	$ 	67,761 	$ 	993 	$ 	989
Gross derivatives(a) 	$ 	105,120 	$ 	2,030 	$ 	899 	$ 	95,647 	$ 	3,069 	$ 	1,121
Netting and credit adjustments 	$ 	(615) 	$ 	(614) 	$ 	(647) 	$ 	(647)
Cash collateral adjustments 	(773) 	(66) 	(1,935) 	(104)
Net derivatives recognized in statement of financial
position 	$ 	642 	$ 	220 	$ 	487 	$ 	369
Net accrued interest 	$ 	35 	$ 	(19) 	$ 	— 	$ 	—
Securities held as collateral 	(2) 	— 	(2) 	—
Net amount 	$ 	675 	$ 	201 	$ 	484 	$ 	369
(a) Gross notional includes $43,731 million in GE Capital and $61,389 million in GE Industrial, and $45,445 million in GE Capital and $50,202 million in GE
Industrial at September 30, 2021 and December 31, 2020, respectively
It is standard market practice to post or receive cash collateral with our derivative counterparties in order to minimize counterparty exposure. Included in GE
Capital Cash, cash equivalents and restricted cash was total net cash collateral received on derivatives of $1,330 million (comprising $1,963 million received and
$633 million posted) at September 30, 2021 and $3,289 million (comprising $4,203 million received and $914 million posted) at December 31, 2020. Of these
amounts, $959 million and $1,968 million at September 30, 2021 and December 31, 2020, respectively, were received on interest rate derivatives traded through
clearing houses, which are recorded as a reduction of derivative assets.
Also included in total net cash collateral received are amounts presented as cash collateral adjustments in the table above, amounts related to accrued interest
on interest rate derivatives presented as a reduction of Net accrued interest of $180 million and $292 million at September 30, 2021 and December 31, 2020,
respectively, and excess net cash collateral posted of $517 million (comprising $38 million received and $555 million posted) at September 30, 2021, and $802
million (comprising $3 million received and $805 million posted) at December 31, 2020, which are excluded from cash collateral adjustments in the table above.
FAIR VALUE HEDGES. 	At September 30, 2021, the cumulative amount of hedging adjustments of $3,788 million (including $2,579 million on discontinued
hedging relationships) was included in the carrying amount of the hedged liability of $32,679 million. At September 30, 2020, the cumulative amount of hedging
adjustments of $6,203 million (including $2,346 million on discontinued hedging relationships) was included in the carrying amount of the hedged liability of
$33,434 million. The cumulative amount of hedging adjustments was primarily recorded in long-term borrowings.
CASH FLOW AND NET INVESTMENT HEDGES
Gain (loss) recognized in AOCI for the
three months ended September 30
Gain (loss) recognized in AOCI for the
nine months ended September 30
2021 	2020 	2021 	2020
Cash flow hedges(a) 	$ 	(30) 	$ 	121 	$ 	1 	$ 	(139)
Net investment hedges(b) 	191 	(529) 	290 	(461)
(a) Primarily related to currency exchange and interest rate contracts.
(b) The carrying value of foreign currency debt designated as net investment hedges was $4,449 million and $8,175 million at September 30, 2021 and 2020,
respectively. No significant amount was reclassified from AOCI into earnings for both the three and nine months ended September 30, 2021 and 2020,
respectively.
The total amount in AOCI related to cash flow hedges of forecasted transactions was a $39 million gain at September 30, 2021. We expect to reclassify $24
million of gain to earnings in the next 12 months contemporaneously with the earnings effects of the related forecasted transactions. At September 30, 2021, the
maximum term of derivative instruments that hedge forecasted transactions was approximately 14 years.
2021 3Q FORM 10-Q 	51

-- 51 of 79 --

The table below presents the effect of our derivative financial instruments in the consolidated Statement of Earnings (Loss):
Three months ended September 30, 2021 	Three months ended September 30, 2020
Revenues Cost of
sales Interest
Expense(a) 	SG&A Other
Income 	Revenues Cost of
sales Interest
Expense(a) 	SG&A Other
Income
$ 	18,429 	$ 	13,401 	$ 	463 	$ 	2,747 	$ 	491 	$ 	18,529 	$ 	14,042 	$ 	526 	$ 	3,215 	$ 	(517)
Effect of cash flow hedges 	$ 	(14) 	$ 	2 	$ 	(7) 	$ 	— 	$ 	— 	$ 	68 	$ 	(14) 	$ 	(9) 	$ 	6 	$ 	—
Hedged items 	$ 	190 	$ 	311
Derivatives designated as hedging
instruments 	(241) 	(330)
Effect of fair value hedges 	$ 	(52) 	$ 	(19)
Interest rate contracts (a) 	$ 	— 	$ 	— 	$ 	2 	$ 	— 	$ 	— 	$ 	8 	$ 	— 	$ 	(3) 	$ 	— 	$ 	—
Currency exchange contracts 	(177) 	(11) 	(18) 	(66) 	40 	174 	10 	— 	(130) 	35
Other 	— 	— 	— 	1 	41 	— 	— 	— 	48 	50
Effect of derivatives not
designated as hedges 	$ 	(177) 	$ 	(11) 	$ 	(17) 	$ 	(65) 	$ 	81 	$ 	181 	$ 	10 	$ 	(3) 	$ 	(81) 	$ 	85
Nine months ended September 30, 2021 	Nine months ended September 30, 2020
Revenues Cost of
sales Interest
Expense(a) 	SG&A Other
Income 	Revenues Cost of
sales Interest
Expense(a) 	SG&A Other
Income
$ 	53,826 	$ 	39,558 	$ 	2,866 	$ 	8,504 	$ 	1,824 	$ 	54,823 	$ 	42,101 	$ 	1,853 	$ 	9,344 	$ 	8,430
Effect of cash flow hedges 	$ 	(14) 	$ 	(4) 	$ 	(29) 	$ 	1 	$ 	— 	$ 	62 	$ 	(52) 	$ 	(31) 	$ 	1 	$ 	—
Hedged items 	$ 	1,375 	$ 	(2,290)
Derivatives designated as hedging
instruments 	(1,510) 	2,290
Effect of fair value hedges 	$ 	(135) 	$ 	—
Interest rate contracts(a) 	$ 	2 	$ 	— 	$ 	48 	$ 	— 	$ 	(1) 	$ 	(28) 	$ 	— 	$ 	(16) 	$ 	— 	$ 	—
Currency exchange contracts 	226 	(6) 	(18) 	48 	28 	(443) 	39 	— 	29 	14
Other 	— 	— 	— 	113 	162 	— 	— 	— 	(15) 	39
Effect of derivatives not
designated as hedges 	$ 	228 	$ 	(6) 	$ 	30 	$ 	161 	$ 	188 	$ 	(470) 	$ 	39 	$ 	(16) 	$ 	14 	$ 	53
(a) Amounts are inclusive of debt extinguishment costs, the derivative components of which (included in interest rate contracts at total effect of derivatives not
designated as hedges) totaled $48 million and zero for the nine months ended September 30, 2021 and 2020, respectively. There were no debt
extinguishment costs related to derivative components for the three months ended September 30, 2021 and 2020.
COUNTERPARTY CREDIT RISK. 	Our exposures to counterparties (including accrued interest), net of collateral we held, was $572 million and $392 million at
September 30, 2021 and December 31, 2020, respectively. Counterparties' exposures to our derivative liability (including accrued interest), net of collateral
posted by us, was $138 million and $307 million at September 30, 2021 and December 31, 2020, respectively.
NOTE 20. VARIABLE INTEREST ENTITIES. 	In addition to the two VIEs detailed in Note 4, in our consolidated Statement of Financial Position, we have
assets of $1,841 million and $1,733 million and liabilities of $580 million and $657 million, inclusive of intercompany eliminations, at September 30, 2021 and
December 31, 2020, respectively, from other consolidated VIEs. These entities were created to help our customers facilitate or finance the purchase of GE
goods and services and have no features that could expose us to losses that would significantly exceed the difference between the consolidated assets and
liabilities. Substantially all the assets of our consolidated VIEs at September 30, 2021 can only be used to settle the liabilities of those VIEs.
Our investments in unconsolidated VIEs were $4,239 million and $3,230 million at September 30, 2021 and December 31, 2020, respectively. These
investments are primarily owned by GE Capital businesses of which $1,280 million and $1,141 million were owned by EFS, comprising equity method
investments, primarily renewable energy tax equity investments, at September 30, 2021 and December 31, 2020, respectively. In addition, $2,739 million and
$1,833 million were owned by our run-off insurance operations, primarily comprising investment securities at September 30, 2021 and December 31, 2020,
respectively. The increase in investments in unconsolidated VIEs in our run-off insurance operations reflects implementation of our revised reinvestment plan,
which incorporates the introduction of strategic initiatives to invest in higher-yielding asset classes. Our maximum exposure to loss in respect of unconsolidated
VIEs is increased by our commitments to make additional investments in these entities described in Note 21.
2021 3Q FORM 10-Q 	52

-- 52 of 79 --

NOTE 21. COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES
COMMITMENTS. 	GE Capital had total investment commitments of $3,449 million at September 30, 2021. The commitments primarily comprise project financing
investments in thermal and wind energy projects of $532 million and investments by our run-off insurance operations in investment securities and other assets of
$2,917 million, and included within these commitments are obligations to make investments in unconsolidated VIEs of $429 million and $2,834 million,
respectively. See Note 20 for further information.
As of September 30, 2021, in our Aviation segment, we have committed to provide financing assistance of $2,072 million of future customer acquisitions of
aircraft equipped with our engines.
Commitments - Discontinued Operations. 	The GECAS business within discontinued operations has placed multiple-year orders for various Boeing, Airbus
and other aircraft manufacturers with list prices approximating $24,675 million, excluding pre-delivery payments made in advance (including 249 new aircraft with
estimated delivery dates of 11% in 2021, 15% in 2022 and 74% in 2023 through 2027) and secondary orders with airlines for used aircraft approximating
$1,035 million (including 22 used aircraft with estimated delivery dates of 41% in 2021, 45% in 2022 and 14% in 2023) at September 30, 2021. When GECAS
purchases aircraft, it is at contractual price, which is usually less than the aircraft manufacturer's list price. As of September 30, 2021, GECAS has made
$2,615 million of pre-delivery payments to aircraft manufacturers.
GUARANTEES. 	Credit Support and Indemnification Agreements - Continuing Operations. 	For further information on credit support and indemnification
agreements for continuing operations, see our Annual Report on Form 10-K for the year ended December 31, 2020.
Indemnification agreements - Discontinued Operations. 	At September 30, 2021, we have provided specific indemnities to buyers of GE Capital's assets that,
in the aggregate, represent a maximum potential claim of $551 million with related reserves of $64 million.
PRODUCT WARRANTIES. 	We provide for estimated product warranty expenses when we sell the related products. Because warranty estimates are forecasts
that are based on the best available information, mostly historical claims experience, claims costs may differ from amounts provided. The liability for product
warranties was $1,914 million and $2,054 million at September 30, 2021 and December 31, 2020, respectively.
LEGAL MATTERS. 	The following information supplements and amends the discussion of Legal Matters in Note 23 in our Annual Report on Form 10-K for the
year ended December 31, 2020 and Note 21 in our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2021 and June 30, 2021; refer to those
discussions for information about previously reported legal matters that are not updated below. In the normal course of our business, we are involved from time
to time in various arbitrations, class actions, commercial litigation, investigations and other legal, regulatory or governmental actions, including the significant
matters described below that could have a material impact on our results of operations. In many proceedings, including the specific matters described below, it is
inherently difficult to determine whether any loss is probable or even reasonably possible or to estimate the size or range of the possible loss, and accruals for
legal matters are not recorded until a loss for a particular matter is considered probable and reasonably estimable. Given the nature of legal matters and the
complexities involved, it is often difficult to predict and determine a meaningful estimate of loss or range of loss until we know, among other factors, the particular
claims involved, the likelihood of success of our defenses to those claims, the damages or other relief sought, how discovery or other procedural considerations
will affect the outcome, the settlement posture of other parties and other factors that may have a material effect on the outcome. For these matters, unless
otherwise specified, we do not believe it is possible to provide a meaningful estimate of loss at this time. Moreover, it is not uncommon for legal matters to be
resolved over many years, during which time relevant developments and new information must be continuously evaluated.
Alstom legacy matters. 	In November 2015, we acquired the Thermal, Renewables and Grid businesses from Alstom. Prior to the acquisition, the seller was the
subject of two significant cases involving anti-competitive activities and improper payments: (1) in January 2007, Alstom was fined €65 million by the European
Commission for participating in a gas insulated switchgear cartel that operated from 1988 to 2004 (that fine was later reduced to €59 million), and (2) in
December 2014, Alstom pled guilty in the United States to multiple violations of the Foreign Corrupt Practices Act and paid a criminal penalty of $772 million. As
part of GE’s accounting for the acquisition, we established a reserve amounting to $858 million for legal and compliance matters related to the legacy business
practices that were the subject of these and related cases in various jurisdictions. The reserve balance was $653 million and $858 million at September 30, 2021
and December 31, 2020, respectively.
2021 3Q FORM 10-Q 	53

-- 53 of 79 --

Regardless of jurisdiction, the allegations relate to claimed anti-competitive conduct or improper payments in the pre-acquisition period as the source of legal
violations and/or damages. Given the significant litigation and compliance activity related to these matters and our ongoing efforts to resolve them, it is difficult to
assess whether the disbursements will ultimately be consistent with the reserve established. The estimation of this reserve involved significant judgment and
may not reflect the full range of uncertainties and unpredictable outcomes inherent in litigation and investigations of this nature, and at this time we are unable to
develop a meaningful estimate of the range of reasonably possible additional losses beyond the amount of this reserve. Damages sought may include
disgorgement of profits on the underlying business transactions, fines and/or penalties, interest, or other forms of resolution. Factors that can affect the ultimate
amount of losses associated with these and related matters include the way cooperation is assessed and valued, prosecutorial discretion in the determination of
damages, formulas for determining fines and penalties, the duration and amount of legal and investigative resources applied, political and social influences within
each jurisdiction, and tax consequences of any settlements or previous deductions, among other considerations. Actual losses arising from claims in these and
related matters could exceed the amount provided.
Shareholder and related lawsuits. Since February 2018, multiple shareholder derivative lawsuits have been filed against current and former GE executive
officers and members of GE’s Board of Directors and GE (as nominal defendant). Two shareholder derivative lawsuits are currently pending: the Lindsey and
Priest/Tola cases, which were filed in New York state court. These lawsuits have alleged violations of securities laws, breaches of fiduciary duties, unjust
enrichment, waste of corporate assets, abuse of control and gross mismanagement, although the specific matters underlying the allegations in the lawsuits have
varied. The allegations in the Bennett, Lindsey and Priest/Tola cases relate to substantially the same facts as those underlying the Hachem securities class
action described in our Annual Report on Form 10-K for the year ended December 31, 2020, and the allegations in the Cuker case relate to alleged corruption in
China. The plaintiffs seek unspecified damages and improvements in GE’s corporate governance and internal procedures. The Lindsey case has been stayed by
agreement of the parties. GE filed a motion to dismiss the Priest/Tola complaint in March 2021. In July 2021, the court granted GE's motion to dismiss the Cuker
complaint. In October 2021, the Bennett case was voluntarily dismissed by the plaintiff.
In October 2018, a putative class action (the Houston case) was filed in New York state court naming as defendants GE, certain GE subsidiaries and current and
former GE executive officers and employees. It alleges violations of Sections 11, 12 and 15 of the Securities Act of 1933 and seeks damages on behalf of
purchasers of senior notes issued in 2016 and rescission of transactions involving those notes. This case was stayed pending resolution of the motion to dismiss
the Hachem case. In September 2021, following the filing by GE of a motion to dismiss the complaint, the court granted plaintiff’s motion to discontinue the case.
Bank BPH. 	As previously reported, GE Capital’s subsidiary Bank BPH, along with other Polish banks, has been subject to ongoing litigation in Poland related to
its portfolio of floating rate residential mortgage loans, with cases brought by individual borrowers seeking relief related to their foreign currency denominated
mortgage loans in various courts throughout Poland. At September 30, 2021, approximately 86% of the Bank BPH portfolio is indexed to or denominated in
foreign currencies (primarily Swiss francs), and the total portfolio had a carrying value of $1,938 million. We continue to observe an increase in the number of
lawsuits being brought against Bank BPH and other banks in Poland, and we expect this to continue in future reporting periods.
We estimate potential losses for Bank BPH in connection with borrower litigation cases that are pending by recording legal reserves, as well as in connection
with potential future cases or other adverse developments as part of our ongoing valuation of the Bank BPH portfolio, which we record at the lower of cost or fair
value, less cost to sell. At September 30, 2021, the total amount of such estimated losses was $565 million. We update our assumptions underlying the amount
of estimated losses based primarily on the number of lawsuits filed and estimated to be filed in the future, whether liability will be established in lawsuits and the
nature of the remedy ordered by courts if liability is established. The increase in the amount of estimated losses during the third quarter of 2021 was driven by
increases across each of these factors. We expect the trends we have previously reported of an increasing number of lawsuits being filed, more findings of
liability and more severe remedies being ordered against Polish banks (including Bank BPH) to continue in future reporting periods, although Bank BPH is
unable at this time to develop a meaningful estimate of reasonably possible losses associated with active and inactive Bank BPH mortgage loans beyond the
amounts currently recorded. Additional factors may also affect our estimated losses over time, including: potentially significant judicial decisions or binding
resolutions by the European Court of Justice (ECJ) or the Polish Supreme Court, including a new binding resolution anticipated to be considered by the Polish
Supreme Court in the coming months; the impact of any of these or other future or recent decisions or resolutions (including the ECJ decision in April 2021 on a
case involving a Bank BPH mortgage loan, and the Polish Supreme Court binding resolution delivered verbally in May 2021 with written reasoning issued in July
2021) on how Polish courts will interpret and apply the law in particular cases and how borrower behavior may change in response, neither of which are known
immediately upon the issuance of a decision or resolution; uncertainty related to a proposal by the Chairman of the Polish Financial Supervisory Authority in
December 2020 that banks voluntarily offer borrowers an opportunity to convert their foreign currency denominated mortgage loans to Polish zlotys using an
exchange rate applicable at the date of loan origination, and about the settlement strategies or other approaches that Polish banks are adopting or will adopt in
response to this proposal or other factors, and the approaches that regulators and other government authorities will adopt in response; uncertainty arising from
investigations of the Polish Office of Competition and Consumer Protection (UOKiK), including a UOKiK decision in December 2020 which found that certain
foreign exchange clauses that appear in certain of Bank BPH’s mortgage loan agreements are unfair contractual terms under Polish law. Future adverse
developments related to any of the foregoing, or other developments such as actions by regulators or other governmental authorities could have a material
adverse effect on Bank BPH and the carrying value of its mortgage loan portfolio and could result in significant losses beyond the amount that we currently
estimate.
ENVIRONMENTAL, HEALTH AND SAFETY MATTERS. 	For further information about environmental, health and safety matters, see our Annual Report on Form
10-K for the year ended December 31, 2020 and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2021.
2021 3Q FORM 10-Q 	54

-- 54 of 79 --

NOTE 22. INTERCOMPANY TRANSACTIONS. 	Presented below is a walk of intercompany eliminations from the combined GE Industrial and GE Capital
totals to the consolidated cash flows for continuing operations.
Nine months ended September 30, 2021 Nine months ended September 30,
2020
Cash from (used for):
Operating
activities
Investing
activities
Financing
activities
Operating
activities
Investing
activities
Financing
activities
Combined GE Industrial and GE Capital cash flows 	$ 	(3,795) 	$ 	6,224 	$ 	(13,550) 	$ 	(2,563) 	$ 	28,568 	$ 	(23,228)
GE Industrial current receivables sold to GE Capital(a) 	2,423 	(3,069) 	646 	(1,361) 	1,086 	276
GE Industrial long-term receivables sold to GE Capital 	93 	(93) 	— 	210 	(210) 	—
Supply chain finance programs 	135 	(135) 	— 	1,853 	(1,853) 	—
Repayment of GE Capital loans by GE Industrial 	— 	— 	— 	— 	(7,500) 	7,500
Other reclassifications and eliminations 	(384) 	(18) 	401 	(15) 	(423) 	438
Consolidated cash flows 	$ 	(1,527) 	$ 	2,909 	$ 	(12,502) 	$ 	(1,876) 	$ 	19,667 	$ 	(15,014)
(a) 	Included the elimination of $2,957 million and $11,335 million payments to GE Industrial for receivables purchased and retained by GE Capital and the
related reclassification to CFOA of $5,380 million and $9,974 million due to GE Capital collections and other activity in our consolidated statement of cash
flows for the nine months ended September 30, 2021 and 2020, respectively.
Cash payments received on the Receivable facility deferred purchase price are reflected as Cash from investing activities in the GE Capital and Consolidated
columns of our consolidated Statement of Cash Flows. Sales of customer receivables from GE Industrial to GE Capital are classified as Cash from operating
activities in the GE Industrial column of our Statement of Cash Flows. See Note 4 for further information.
NOTE 23. OTHER INCOME
Three months ended September
30 	Nine months ended September 30
2021 	2020 	2021 	2020
Purchases and sales of business interests(a) 	$ 	(153) 	$ 	21 	$ 	(155) 	$ 	12,445
Licensing and royalty income 	54 	44 	141 	117
Equity method income 	42 	(78) 	96 	(9)
Net interest and investment income (loss)(b) 	482 	(582) 	1,523 	(4,259)
Other items 	(5) 	86 	154 	187
GE Industrial 	$ 	420 	$ 	(509) 	$ 	1,760 	$ 	8,481
Eliminations 	71 	(8) 	64 	(50)
Total 	$ 	491 	$ 	(517) 	$ 	1,824 	$ 	8,430
(a) 	Included a pre-tax and after-tax loss of $172 million related to the planned sale of our boiler manufacturing business in China in our Power segment for the
three and nine months ended September 30, 2021. Included a pre-tax gain of $12,362 million ($11,214 million after-tax) on the sale of BioPharma for the nine
months ended September 30, 2020. See Note 2 for further information.
(b) 	Included a pre-tax realized and unrealized gain of $359 million ($282 million after-tax) and a pre-tax unrealized loss of $748 million ($618 million after-tax) for
the three months ended September 30, 2021 and 2020, respectively, and a pre-tax realized and unrealized gain of $1,028 million ($767 million after-tax) and
a pre-tax unrealized loss of $4,613 million ($3,679 million after-tax) for the nine months ended September 30, 2021 and 2020, respectively, related to our
interest in Baker Hughes.
2021 3Q FORM 10-Q 	55

-- 55 of 79 --

EXHIBITS
Exhibit 3. 	The Restated Certificate of Incorporation of General Electric Company 	(Incorporated by reference to Exhibit 3(i) to GE’s Annual Report on Form 10-K
for the fiscal year ended December 31, 2013), as amended by the Certificate of Amendment, dated December 2, 2015 	(Incorporated by reference to Exhibit 3.1
to GE’s Current Report on Form 8-K, dated December 3, 2015), as further amended by the Certificate of Amendment, dated January 19, 2016 (Incorporated by
reference to Exhibit 3.1 to GE’s Current Report on Form 8-K, dated January 20, 2016), as further amended by the Certificate of Change of General Electric
Company (Incorporated by reference to Exhibit 3(1) to GE’s Current Report on Form 8-K, dated September 1, 2016), as further amended by the Certificate of
Amendment, dated May 13, 2019 (Incorporated by reference to Exhibit 3.1 to GE’s Current Report on Form 8-K, dated May 13, 2019), as further amended by
the Certificate of Change of General Electric Company (Incorporated by reference to Exhibit 3.1 to GE’s Current Report on Form 8-K, dated December 9, 2019),
as further amended by the Certificate of Amendment, dated July 30, 2021 (Incorporated by reference to Exhibit 3.1 to GE's Current Report on Form 8-K, dated
July 30, 2021) (in each case, under Commission file number 001-00035).
Exhibit 10(a). 	GE 	2007 	Long-Term Incentive Plan 	(as amended and restated April 26, 2017, as further amended and restated February 15, 2019, 	and as further
amended and 	restated July 30, 2021).
Exhibit 10(b). 	Form of Agreement for Performance Stock Unit 	Grants to Executive Officers in 2021 under the GE 2007 Long-Term Incentive Plan, as amended
July 30, 2021.
Exhibit 10(c). 	Notice of Adjustment to the Performance Share Grant Agreement for H. Lawrence Culp, Jr., effective July 30, 2021.
Exhibit 10(d). 	Notice of Adjustment to the Performance Stock Unit Grant Agreement for Carolina Dybeck Happe, effective July 30, 2021.
Exhibit 11. 	Computation of Per Share Earnings. 	Data is provided in Note 18 of this Report.
Exhibit 31(a). 	Certification Pursuant to Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Amended.
Exhibit 31(b). 	Certification Pursuant to Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Amended.
Exhibit 32. 	Certification Pursuant to 18 U.S.C. Section 1350.
Exhibit 101. 	The following materials from General Electric Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, formatted in
XBRL (eXtensible Business Reporting Language); (i) Statement of Earnings (Loss) for the three and nine months ended September 30, 2021 and 2020, (ii)
Statement of Financial Position at September 30, 2021 and December 31, 2020, (iii) Statement of Cash Flows for the nine months ended September 30, 2021
and 2020, (iv) Consolidated Statement of Comprehensive Income (Loss) for the three and nine months ended September 30, 2021 and 2020, (v) Statement of
Changes in Shareholders' Equity for the three and nine months ended September 30, 2021 and 2020, and (vi) Notes to Consolidated Financial Statements.
Exhibit 104. 	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
FORM 10-Q CROSS REFERENCE INDEX 	Page(s)
Part I – FINANCIAL INFORMATION
Item 1. 	Financial Statements 	28-55
Item 2. 	Management’s Discussion and Analysis of Financial Condition and Results of Operations 	4-27
Item 3. 	Quantitative and Qualitative Disclosures About Market Risk 	17-18, 50-52
Item 4. 	Controls and Procedures 	27
Part II – OTHER INFORMATION
Item 1. 	Legal Proceedings 	53-54
Item 1A. 	Risk Factors 	Not applicable(a)
Item 2. 	Unregistered Sales of Equity Securities and Use of Proceeds 	27
Item 3. 	Defaults Upon Senior Securities 	Not applicable
Item 4. 	Mine Safety Disclosures 	Not applicable
Item 5. 	Other Information 	Not applicable
Item 6. 	Exhibits 	56
Signatures 	56
(a) There have been no material changes to our risk factors since March 31, 2021. For a discussion of our risk factors, refer to our Annual Report on Form 10-K
for the year ended December 31, 2020, and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2021.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
October 26, 2021 	/s/ Thomas S. Timko
Date 	Thomas S. Timko
Vice President, Chief Accounting Officer and Controller
Principal Accounting Officer
2021 3Q FORM 10-Q 	56

-- 56 of 79 --

Exhibit 10(a)
GE 2007 Long-Term Incentive Plan
(as amended and restated April 26, 2017, as further amended and restated February 15, 2019,
and as further Amended and Restated July 30, 2021)
SECTION 1. PURPOSE
The purposes of this GE 2007 Long-Term Incentive Plan (the “Plan”) are to encourage selected Salaried Employees and Directors of General Electric Company
(together with any successor thereto, the “Company”) and its Affiliates (as defined below) to acquire a proprietary interest in the growth and performance of the
Company, to generate an increased incentive to contribute to the Company’s future success and prosperity, thus enhancing the value of the Company for the
benefit of its shareowners, and to enhance the ability of the Company and its Affiliates to attract and retain exceptionally qualified individuals upon whom, in
large measure, the sustained progress, growth and profitability of the Company depend.
SECTION 2. DEFINITIONS
As used in the Plan, the following terms shall have the meanings set forth below:
(a) 	“Affiliate” shall mean (i) any entity that, directly or through one or more intermediaries, is controlled by the Company and (ii) any entity in which the
Company has a significant equity interest, as determined by the Committee.
(b) 	“Award” shall mean any Option, Stock Appreciation Right, Restricted Stock, Restricted Stock Unit, Performance Award, Dividend Equivalent, or Other Stock-
Based Award granted under the Plan.
(c) 	“Award Agreement” shall mean any written agreement, contract, or other instrument or document, including an electronic communication, as may from
time to time be designated by the Company as evidencing any Award granted under the Plan.
(d) 	“Board” shall mean the Board of Directors of the Company.
(e) 	“Code” shall mean the Internal Revenue Code of 1986, as amended from time to time.
(f) 	“Committee” shall mean a committee of the Board, acting in accordance with the provisions of Section 3, designated by the Board to administer the Plan and
composed of not less than three non-employee directors. Unless otherwise determined by the Board, the Management Development and Compensation
Committee of the Board generally serves as the Committee for purposes of the Plan, except that the Governance and Public Affairs Committee of the Board
is responsible for administering the Plan as it relates to any Award provided to a Director.
(g) 	“Director” shall mean any member of the Board who is not a Salaried Employee at the time of receiving an Award under the Plan.
(h) 	“Dividend Equivalent” shall mean any right granted under Section 6(e) of the Plan.
(i) 	“Fair Market Value” shall mean, with respect to any Shares or other securities, the closing price of a Share on the date as of which the determination is being
made or as otherwise determined in a manner specified by the Committee.
(j) 	“Incentive Stock Option” shall mean an option granted under Section 6(a) of the Plan that is intended to meet the requirements of Section 422 of the Code,
or any successor provision thereto.
(k) 	“Non-Qualified Stock Option” shall mean an option granted under Section 6(a) of the Plan that is not intended to be an Incentive Stock Option.
(l) 	“Option” shall mean an Incentive Stock Option or a Non-Qualified Stock Option.
(m) 	“Other Stock-Based Award” shall mean any right, including a Deferred Stock Unit, granted under Section 6(f) of the Plan.
(n) 	“Participant” shall mean a Salaried Employee or Director designated to be granted an Award under the Plan.
(o) 	“Performance Award” shall mean any right granted under Section 6(d) of the Plan.
(p) 	“Performance Criteria” shall mean any quantitative and/or qualitative measures, as determined by the Committee, which may be used to measure the level
of performance of the Company or any individual Participant during a Performance Period, including any Qualifying Performance Criteria.
(q) 	“Performance Period” shall mean any period as determined by the Committee in its sole discretion.
(r) 	“Person” shall mean any individual, corporation, partnership, association, joint-stock company, trust, unincorporated organization, or government or political
subdivision thereof.
(s) 	“Qualifying Performance Criteria” shall mean one or more of the following performance criteria, either individually, alternatively or in any combination,
applied to either the company as a whole or to a business
A-1

-- 57 of 79 --

unit or related company, and measured either annually or cumulatively over a period of years, on an absolute basis or relative to a pre-established target, to
a previous year’s results or to a designated comparison group, in each case as specified by the Committee in the Award: sales and revenue; income, earnings,
profit and margins; earnings per share; return on capital, return on equity and return on investment; cash flow and cash returned to investors; and total
shareowner return, subject to adjustment by the Committee to remove the effect of charges for restructurings, discontinued operations and all items of gain,
loss or expense determined to be unusual in nature or infrequent in occurrence, related to the disposal of a segment or a business, or related to a change in
accounting principle or otherwise.
(t) 	“Restricted Stock” shall mean any award of Shares granted under Section 6(c) of the Plan.
(u) 	“Restricted Stock Unit” shall mean any right granted under Section 6(c) of the Plan that is denominated in Shares.
(v) 	“Salaried Employee” shall mean any salaried employee of the Company or of any Affiliate.
(w) 	“Shares” shall mean the common shares of the Company and such other securities as may become the subject of Awards, or become subject to Awards,
pursuant to an adjustment made under Section 4(b) of the Plan.
(x) 	“Stock Appreciation Right” shall mean any right granted under Section 6(b) of the Plan.
SECTION 3. ADMINISTRATION
Except as otherwise provided herein, the Plan shall be administered by the Committee, which shall have the power to interpret the Plan and to adopt such rules
and guidelines for implementing the terms of the Plan as it may deem appropriate. The Committee shall have the ability to modify the Plan provisions, to the
extent necessary, or delegate such authority, to accommodate any law or regulation in jurisdictions in which Participants will receive Awards.
(a) 	Subject to the terms of the Plan and applicable law, the Committee shall have full power and authority to:
i. 	designate Participants;
ii. 	determine the type or types of Awards to be granted to each Participant under the Plan and grant Awards to such Participants;
iii. 	determine the number of Shares to be covered by (or with respect to which payments, rights, or other matters are to be calculated in connection with)
Awards;
iv. 	determine the terms and conditions of any Award and of Award Agreements, and verify the extent of satisfaction of any performance goals or other
conditions applicable to the grant, issuance, exercisability, vesting and/or ability to retain any Award;
v. 	determine whether, to what extent, and under what circumstances Awards may be settled or exercised in cash, Shares, other securities, or other
Awards, or canceled, forfeited, or suspended, and the method or methods by which Awards may be settled, exercised, canceled, forfeited, or
suspended;
vi. 	determine whether, to what extent, and under what circumstances cash, Shares, other securities, other Awards, and other amounts payable with
respect to an Award under the Plan shall be deferred either automatically or at the election of the holder thereof or of the Committee;
vii. 	interpret and administer the Plan and any instrument or agreement relating to, or Award made under, the Plan;
viii. 	establish, amend, suspend, or waive such rules and guidelines;
ix. 	appoint such agents as it shall deem appropriate for the proper administration of the Plan;
x. 	make any other determination and take any other action that the Committee deems necessary or desirable for the administration of the Plan; and
xi. 	correct any defect, supply any omission, or reconcile any inconsistency in the Plan or any Award in the manner and to the extent it shall deem desirable
to carry the Plan into effect.
(b) 	Unless otherwise expressly provided in the Plan, all designations, determinations, interpretations, and other decisions under or with respect to the Plan or
any Award shall be within the sole discretion of the Committee, may be made at any time, and shall be final, conclusive, and binding upon all Persons,
including the Company, any Affiliate, any Participant, any holder or beneficiary of any Award, any shareowner, and any employee of the Company or of any
Affiliate. Actions of the Committee may be taken by:
A-2

-- 58 of 79 --

i. 	the Chairman of the Committee;
ii. 	a subcommittee, designated by the Committee;
iii. 	the Committee but with one or more members abstaining or recusing himself or herself from acting on the matter, so long as two or more members
remain to act on the matter. Such action, authorized by the Chairman, such a subcommittee or by the Committee (whether upon the abstention or
recusal of such members or otherwise), shall be the action of the Committee for purposes of the Plan; or
iv. 	one or more officers or managers of the Company or any Affiliate, or a committee of such officers or managers whose authority is subject to such terms
and limitations set forth by the Committee, and only with respect to Salaried Employees who are not officers or directors of the Company for purposes
of Section 16 of the Securities Exchange Act of 1934, as amended. This delegation shall include modifications necessary to accommodate changes in the
laws or regulations of jurisdictions outside the U.S.
SECTION 4. SHARES AVAILABLE FOR AWARDS
(a) 	SHARES AVAILABLE. Subject to adjustment as provided in Section 4(b):
i. 	The total number of Shares reserved and available for delivery pursuant to Awards granted under the Plan shall be 134,375,000; of which no more than
28,750,000 may be available for Awards granted in any form provided for under the Plan other than Options or Stock Appreciation Rights. If any Shares
covered by an Award granted under the Plan, or to which such an Award or award relates, are forfeited, or if an Award or award otherwise terminates
without the delivery of Shares or of other consideration, then the Shares covered by such Award or award, or to which such Award or award relates, or
the number of Shares otherwise counted against the aggregate number of Shares available under the Plan with respect to such Award or award, to the
extent of any such forfeiture or termination, shall again be available for granting Awards under the Plan. Notwithstanding the foregoing, but subject to
adjustment as provided in Section 4(b), no more than 134,375,000 Shares shall be available for delivery pursuant to the exercise of Incentive Stock
Options.
ii. 	ACCOUNTING FOR AWARDS. For purposes of this Section 4,
A. 	If an Award (other than a Dividend Equivalent) is denominated in Shares, the number of Shares covered by such Award, or to which such Award
relates, shall be counted on the date of grant of such Award against the aggregate number of Shares available for granting Awards under the Plan;
B. 	Dividend Equivalents denominated in Shares and Awards not denominated, but potentially payable, in Shares shall be counted against the
aggregate number of Shares available for granting Awards under the Plan in such amount and at such time as the Dividend Equivalents and such
Awards are settled in Shares, PROVIDED, HOWEVER, that Awards that operate in tandem with (whether granted simultaneously with or at a
different time from), or that are substituted for, other Awards may only be counted once against the aggregate number of shares available, and the
Committee shall adopt procedures, as it deems appropriate, in order to avoid double counting. Any Shares that are delivered by the Company, and
any Awards that are granted by, or become obligations of, the Company through the assumption by the Company or an Affiliate of, or in
substitution for, outstanding awards previously granted by an acquired company, shall not be counted against the Shares available for granting
Awards under this Plan; and
C. 	Notwithstanding anything herein to the contrary, any Shares related to Awards which terminate by expiration, forfeiture, cancellation, or otherwise
without the issuance of such Shares, are settled in cash in lieu of Shares, or, subject to Section 6(g)(ix), are exchanged with the Committee’s
permission, prior to the issuance of Shares, for Awards not involving Shares, shall be available again for grant under this Plan. Shares subject to an
Award under the Plan may not again be made available for issuance under the Plan if such Shares are: (w) Shares delivered to or withheld by the
Company to pay taxes on Awards other than Options or Stock Appreciation Rights, (x) Shares that were subject to an Option or a stock-settled Stock
Appreciation Right and were not issued upon the net settlement or net exercise of such Option or Stock Appreciation Right, (y) Shares delivered to
or withheld by the
A-3

-- 59 of 79 --

Company to pay the exercise price or the withholding taxes under Options or Stock Appreciation Rights, or (z) Shares repurchased on the open
market with the proceeds of an Option exercise.
iii. 	SOURCES OF SHARES DELIVERABLE UNDER AWARDS. Any Shares delivered pursuant to an Award may consist, in whole or in part, of authorized and
unissued Shares or of treasury Shares.
(b) 	ADJUSTMENTS.
i. 	In the event that the Committee shall determine that any dividend or other distribution (whether in the form of cash, Shares, or other securities),
recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of Shares
or other securities of the Company, issuance of warrants or other rights to purchase Shares or other securities of the Company, or other similar
corporate transaction or event constitutes an equity restructuring transaction, as that term is defined in Accounting Standards Codification Topic 718 (or
any successor thereto) or otherwise affects the Shares, then the Committee shall adjust the following in a manner that is determined by the Committee
to be appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan:
A. 	the number and type of Shares or other securities which thereafter may be made the subject of Awards including the limit specified in Section 4(a)(i)
regarding the number of shares that may be granted in the form of Restricted Stock, Restricted Stock Units, Performance Awards, or Other Stock-
Based Awards;
B. 	the number and type of Shares or other securities subject to outstanding Awards;
C. 	the grant, purchase, or exercise price with respect to any Award, or, if deemed appropriate, make provision for a cash payment to the holder of an
outstanding Award; and
D. 	other value determinations applicable to outstanding awards.
PROVIDED, HOWEVER, in each case, that with respect to Awards of Incentive Stock Options no such adjustment shall be authorized to the extent
that such authority would cause the Plan to violate Section 422(b)(1) of the Code or any successor provision thereto; and PROVIDED FURTHER,
HOWEVER, that the number of Shares subject to any Award denominated in Shares shall always be a whole number.
ii. 	ADJUSTMENTS OF AWARDS UPON CERTAIN ACQUISITIONS. In the event the Company or any Affiliate shall assume outstanding employee awards or the
right or obligation to make future such awards in connection with the acquisition of another business or another corporation or business entity, the
Committee may make such adjustments, not inconsistent with the terms of the Plan, in the terms of Awards as it shall deem appropriate in order to
achieve reasonable comparability or other equitable relationship between the assumed awards and the Awards granted under the Plan as so adjusted.
iii. 	ADJUSTMENTS OF AWARDS UPON THE OCCURRENCE OF CERTAIN UNUSUAL OR NONRECURRING EVENTS. The Committee shall be authorized to make
adjustments in the terms and conditions of, and the criteria included in, Awards in recognition of unusual or nonrecurring events affecting the Company,
any Affiliate, or the financial statements of the Company or any Affiliate, or of changes in applicable laws, regulations, or accounting principles,
whenever the Committee determines that such adjustments are appropriate in order to prevent dilution or enlargement of the benefits or potential
benefits to be made available under the Plan.
SECTION 5. ELIGIBILITY
Any Salaried Employee, including any officer or employee-director of the Company or of any Affiliate, or Director shall be eligible to be designated a Participant.
A-4

-- 60 of 79 --

SECTION 6. AWARDS
(a) 	OPTIONS. The Committee is hereby authorized to grant Options to Participants with the following terms and conditions and with such additional terms and
conditions, in either case not inconsistent with the provisions of the Plan, as the Committee shall determine:
i. 	EXERCISE PRICE. The purchase price per Share purchasable under an Option shall be determined by the Committee; provided, however, and except as
provided in Section 4(b), that such purchase price shall not be less than 100% of the Fair Market Value of a Share on the date of grant of such Option.
ii. 	OPTION TERM. The term of each Option shall not exceed ten (10) years from the date of grant.
iii. 	TIME AND METHOD OF EXERCISE. The Committee shall establish in the applicable Award Agreement the time or times at which an Option may be
exercised in whole or in part, and the method or methods by which, and the form or forms, including, without limitation, cash, Shares, or other Awards,
or any combination thereof, having a Fair Market Value on the exercise date equal to the relevant exercise price, in which, payment of the exercise price
with respect thereto may be made or deemed to have been made.
iv. 	INCENTIVE STOCK OPTIONS. The terms of any Incentive Stock Option granted under the Plan shall be designed to comply in all respects with the
provisions of Section 422 of the Code, or any successor provision thereto, and any regulations promulgated thereunder. For the avoidance of doubt,
Incentive Stock Options shall not be granted to Directors. Notwithstanding anything in this Section 6(a) to the contrary, Options designated as Incentive
Stock Options shall not be eligible for treatment under the Code as Incentive Stock Options (and will be deemed to be Non-Qualified Stock Options) to
the extent that either (1) the aggregate Fair Market Value of Shares (determined as of the time of grant) with respect to which such Options are
exercisable for the first time by the Participant during any calendar year (under all plans of the Company and any subsidiary) exceeds $100,000, taking
Options into account in the order in which they were granted, or (2) such Options otherwise remain exercisable but are not exercised within three
(3) months of termination of employment (or such other period of time provided in Section 422 of the Code).
(b) 	STOCK APPRECIATION RIGHTS. The Committee is hereby authorized to grant Stock Appreciation Rights to Participants. Subject to the terms of the Plan and
any applicable Award Agreement, a Stock Appreciation Right granted under the Plan shall confer on the holder thereof a right to receive, upon exercise
thereof, the excess of (1) the Fair Market Value of one Share on the date of exercise over (2) the grant price of the right as specified by the Committee.
i. 	GRANT PRICE. The grant price per share of each Stock Appreciation Right shall be determined by the Committee, provided, however, and except as
provided in Section 4(b), that such price shall not be less than 100% of the Fair Market Value of one Share on the date of grant of the Stock Appreciation
Right, except that if a Stock Appreciation Right is at any time granted in tandem to an Option, the grant price of the Stock Appreciation Right shall not be
less than the exercise price of such Option.
ii. 	TERM. The term of each Stock Appreciation Right shall not exceed ten (10) years from the date of grant.
iii. 	TIME AND METHOD OF EXERCISE. The Committee shall establish in the applicable Award Agreement the time or times at which a Stock Appreciation
Right may be exercised in whole or in part.
(c) 	RESTRICTED STOCK AND RESTRICTED STOCK UNITS.
i. 	ISSUANCE. The Committee is hereby authorized to grant Awards of Restricted Stock and Restricted Stock Units to Participants.
ii. 	RESTRICTIONS. Awards of Restricted Stock and Restricted Stock Units shall be subject to such restrictions as the Committee may establish in the
applicable Award Agreement (including, without limitation, any limitation on the right to vote a Share of Restricted Stock or the right to receive any
dividend or other right), which restrictions may lapse separately or in combination at such time or times, in such installments or otherwise, as the
Committee may deem appropriate. Unrestricted Shares, evidenced in such manner as the Committee shall deem appropriate, shall be delivered to the
holder of Restricted Stock promptly after such restrictions have lapsed.
A-5

-- 61 of 79 --

iii. 	REGISTRATION. Any Restricted Stock or Restricted Stock Units granted under the Plan may be evidenced in such manner as the Committee may deem
appropriate, including, without limitation, book-entry registration or issuance of a stock certificate or certificates. In the event any stock certificate is
issued in respect of Shares of Restricted Stock granted under the Plan, such certificate shall be registered in the name of the Participant and shall bear an
appropriate legend referring to the terms, conditions, and restrictions applicable to such Restricted Stock.
iv. 	FORFEITURE. Upon termination of employment during the applicable restriction period, except as determined otherwise by the Committee, all Shares of
Restricted Stock and all Restricted Stock Units still, in either case, subject to restriction shall be forfeited and reacquired by the Company.
(d) 	PERFORMANCE AWARDS. The Committee is hereby authorized to grant Performance Awards to Participants. Performance Awards include arrangements
under which the grant, issuance, retention, exercisability, vesting and/or transferability of any Award is subject to such Performance Criteria and such
additional conditions or terms as the Committee may designate. Subject to the terms of the Plan and any applicable Award Agreement, a Performance Award
granted under the Plan:
i. 	may be denominated or payable in cash, Shares (including, without limitation, Restricted Stock), other securities, or other Awards; and
ii. 	shall confer on the holder thereof rights valued as determined by the Committee and payable to, or exercisable by, the holder of the Performance
Award, in whole or in part, upon the achievement of such performance goals during such Performance Periods as the Committee shall establish.
(e) 	DIVIDEND EQUIVALENTS. The Committee is hereby authorized to grant to Participants Awards (other than Options and Stock Appreciation Rights) under
which the holders thereof shall be entitled to receive payments equivalent to dividends or interest with respect to a number of Shares determined by the
Committee, and the Committee may provide that such amounts (if any) shall be deemed to have been reinvested in additional Shares and paid out only on
and when Shares actually vest, are earned or are received under such Awards. Subject to the terms of the Plan and any applicable Award Agreement, such
Awards may have such terms and conditions as the Committee shall determine.
(f) 	OTHER STOCK-BASED AWARDS. The Committee is hereby authorized to grant to Participants such other Awards, including, but not limited to, Deferred Stock
Units, that are denominated or payable in, valued in whole or in part by reference to, or otherwise based on or related to, Shares (including, without
limitation, securities convertible into Shares), as are deemed by the Committee to be consistent with the purposes of the Plan, provided, however, that such
grants must comply with applicable law. Subject to the terms of the Plan and any applicable Award Agreement, the Committee shall determine the terms and
conditions of such Awards. Shares or other securities delivered pursuant to a purchase right granted under this Section 6(f) shall be purchased for such
consideration, which may be paid by such method or methods and in such form or forms, including, without limitation, cash, Shares, other securities, or
other Awards, or any combination thereof, as the Committee shall determine, the value of which consideration, as established by the Committee, and except
as provided in Section 4(b), shall not be less than the Fair Market Value of such Shares or other securities as of the date such purchase right is granted.
(g) 	GENERAL.
i. 	NO CASH CONSIDERATION FOR AWARDS. Awards shall be granted for no cash consideration or for such minimal cash consideration as may be required
by applicable law.
ii. 	AWARDS MAY BE GRANTED SEPARATELY OR TOGETHER. Awards may, in the discretion of the Committee, be granted either alone or in addition to, in
tandem with, or in substitution for any other Award or any award granted under any other plan of the Company or any Affiliate. Awards granted in
addition to or in tandem with other Awards, or in addition to or in tandem with awards granted under any other plan of the Company or any Affiliate,
may be granted either at the same time as or at a different time from the grant of such other Awards or awards.
A-6

-- 62 of 79 --

iii. 	FORMS OF PAYMENT UNDER AWARDS. Subject to the terms of the Plan and of any applicable Award Agreement, payments or transfers to be made by
the Company or an Affiliate upon the grant, exercise, or payment of an Award may be made in such form or forms as the Committee shall determine,
including, without limitation, cash, Shares, rights in or to Shares issuable under the Award or other Awards, other securities, or other Awards, or any
combination thereof, and may be made in a single payment or transfer, in installments, or on a deferred basis, in each case in accordance with rules and
procedures established by the Committee. Such rules and procedures may include, without limitation, provisions for the payment or crediting of
reasonable interest on installment or deferred payments or the grant or crediting of Dividend Equivalents in respect of installment or deferred
payments.
iv. 	LIMITS ON TRANSFER OF AWARDS. Except as provided by the Committee, no Award and no right under any such Award, shall be assignable, alienable,
saleable, or transferable by a Participant otherwise than by will or by the laws of descent and distribution provided, however, that, if so determined by
the Committee, a Participant may, in the manner established by the Committee, designate a beneficiary or beneficiaries to exercise the rights of the
Participant with respect to any Award upon the death of the Participant. Each Award, and each right under any Award, shall be exercisable, during the
Participant’s lifetime, only by the Participant or, if permissible under applicable law, by the Participant’s guardian or legal representative. No Award and
no right under any such Award, may be pledged, alienated, attached, or otherwise encumbered, and any purported pledge, alienation, attachment, or
encumbrance thereof shall be void and unenforceable against the Company or any Affiliate.
v. 	PER-PERSON LIMITATION FOR SALARIED EMPLOYEES. The aggregate dollar value of any Awards granted to a Salaried Employee under the Plan (based on
the grant date fair value of Awards as determined for financial reporting purposes, which shall be calculated based on the target value for any
performance based award) in any fiscal year may not exceed $20,000,000.
vi. 	PER-PERSON LIMITATION FOR DIRECTORS. The aggregate dollar value of (A) any Awards granted to a Director under the Plan (based on the grant date
fair value of Awards as determined for financial reporting purposes) and (B) any cash or other compensation that is not equity-based and that is paid by
the Company with respect to the Director’s service as a Director for any fiscal year may not exceed $1,500,000. The Committee may make exceptions to
the foregoing limit for a Director or committee of Directors, as it may determine in its discretion, provided that (C) the aggregate dollar value of any such
additional compensation may not exceed $1,000,000 for the fiscal year and (D) the Director receiving such additional compensation does not participate
in the decision to award such compensation.
vii. 	CONDITIONS AND RESTRICTIONS UPON SECURITIES SUBJECT TO AWARDS. The Committee may provide that the Shares issued upon exercise of an
Option or Stock Appreciation Right or otherwise subject to or issued under an Award shall be subject to such further agreements, restrictions, conditions
or limitations as the Committee in its discretion may specify prior to the exercise of such Option or Stock Appreciation Right or the grant, vesting or
settlement of such Award, including without limitation, conditions on vesting or transferability and forfeiture or repurchase provisions or provisions on
payment of taxes arising in connection with an Award. Without limiting the foregoing, such restrictions may address the timing and manner of any
resales by the Participant or other subsequent transfers by the Participant of any Shares issued under an Award, including without limitation:
(A) restrictions under an insider trading policy or pursuant to applicable law, (B) restrictions designed to delay and/or coordinate the timing and manner
of sales by Participant and holders of other Company equity compensation arrangements, (C) restrictions as to the use of a specified brokerage firm for
such resales or other transfers and (D) provisions requiring Shares to be sold on the open market or to the Company in order to satisfy tax withholding or
other obligations.
viii. 	SHARE CERTIFICATES. All Shares or other securities delivered under the Plan pursuant to any Award or the exercise thereof shall be subject to
such stop transfer orders and other restrictions as the Committee may deem advisable under the Plan or the rules, regulations, and other requirements
of the Securities and Exchange Commission, any stock exchange upon which such Shares or other securities are then listed, and any applicable Federal,
state, or local securities laws, and the Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to
such restrictions.
ix. 	NO REPRICING. Except in connection with a corporate transaction or adjustment described in Section 4(b) of the Plan, the terms of outstanding Options,
Stock Appreciation Rights or other Stock-Based Awards encompassing rights to purchase Shares that have an exercise or purchase price in excess of the
Fair
A-7

-- 63 of 79 --

Market Value of a Share may not be amended to reduce the exercise or purchase price of such Awards, and any such outstanding Options, Stock
Appreciation Rights or other Stock-Based Awards encompassing rights to purchase Shares may not be exchanged for cash or property, other Awards, or
Options, Stock Appreciation Rights or other Stock-Based Awards encompassing rights to purchase Shares with an exercise or purchase price that is less
than the exercise or purchase price of the original Awards, in each case unless approved by shareowners.
x. 	RECOUPMENT. The Plan will be administered in compliance with Section 10D of the Securities Exchange Act of 1934, as amended, any applicable rules or
regulations promulgated by the Securities and Exchange Commission or any national securities exchange or national securities association on which the
Shares may be traded, and any Company policy adopted with respect to compensation recoupment. This Section 6(g)(x) will not be the Company’s
exclusive remedy with respect to such matters.
SECTION 7. AMENDMENT AND TERMINATION
Except to the extent prohibited by applicable law and unless otherwise expressly provided in an Award Agreement or in the Plan:
(a) 	AMENDMENTS TO THE PLAN. The Board may amend, alter, suspend, discontinue, or terminate the Plan, in whole or in part; provided, however, that without
the prior approval of the Company’s shareowners, no material amendment shall be made if shareowner approval is required by law, regulation, or stock
exchange, and; PROVIDED, FURTHER, that, notwithstanding any other provision of the Plan or any Award Agreement, no such amendment, alteration,
suspension, discontinuation, or termination shall be made without the approval of the shareowners of the Company that would:
i. 	increase the total number of Shares available for Awards under the Plan, except as provided in Section 4 hereof; or
ii. 	amend Section 6(g)(ix) or, except as provided in Section 4(b), permit Options, Stock Appreciation Rights, or other Stock-Based Awards encompassing
rights to purchase Shares to be repriced, replaced, or exchanged as described in Section 6(g)(ix).
(b) 	AMENDMENTS TO AWARDS. Subject to Section 6(g)(ix), the Committee may waive any conditions or rights under, amend any terms of, or amend, alter,
suspend, discontinue, or terminate, any Awards theretofore granted, prospectively or retroactively. No such amendment or alteration shall be made which
would impair the rights of any Participant, without such Participant’s consent, under any Award theretofore granted, provided that no such consent shall be
required with respect to any amendment or alteration if the Committee determines in its sole discretion that such amendment or alteration either (i) is
required or advisable in order for the Company, the Plan or the Award to satisfy or conform to any law or regulation or to meet the requirements of any
accounting standard, or (ii) is not reasonably likely to significantly diminish the benefits provided under such Award.
SECTION 8. GENERAL PROVISIONS
(a) 	NO RIGHTS TO AWARDS. No Salaried Employee, Participant or other Person shall have any claim to be granted any Award under the Plan, or, having been
selected to receive an Award under this Plan, to be selected to receive a future Award, and further there is no obligation for uniformity of treatment of
Salaried Employees, Participants, or holders or beneficiaries of Awards under the Plan. The terms and conditions of Awards need not be the same with
respect to each recipient.
(b) 	WITHHOLDING. The Company or any Affiliate shall be authorized to withhold from any Award granted or any payment due or transfer made under any Award
or under the Plan the amount (in cash, Shares, other securities, or other Awards) of taxes required or permitted to be withheld (up to the maximum statutory
tax rate in the relevant jurisdiction) in respect of an Award, its exercise, or any payment or transfer under such Award or under the Plan and to take such
other action as may be necessary or appropriate in the opinion of the Company or Affiliate to satisfy withholding taxes.
(c) 	NO LIMIT ON OTHER COMPENSATION ARRANGEMENTS. Nothing contained in the Plan shall prevent the Company or any Affiliate from adopting or
continuing in effect other or additional compensation arrangements, and such arrangements may be either generally applicable or applicable only in specific
cases.
A-8

-- 64 of 79 --

(d) 	NO RIGHT TO EMPLOYMENT. The grant of an Award shall not constitute an employment contract nor be construed as giving a Participant the right to be
retained in the employ of the Company or any Affiliate. Further, the Company or an Affiliate may at any time dismiss a Participant from employment, free
from any liability, or any claim under the Plan, unless otherwise expressly provided in the Plan or in any Award Agreement.
(e) 	GOVERNING LAW. The validity, construction, and effect of the Plan and any rules and regulations relating to the Plan shall be determined in accordance with
the laws of the State of New York and applicable Federal law without regard to conflict of law.
(f) 	SEVERABILITY. If any provision of the Plan or any Award is or becomes or is deemed to be invalid, illegal, or unenforceable in any jurisdiction, or as to any
Person or Award, or would disqualify the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or
deemed amended to conform to applicable laws, or if it cannot be so construed or deemed amended without, in the determination of the Committee,
materially altering the intent of the Plan or the Award, such provision shall be stricken as to such jurisdiction, Person, or Award, and the remainder of the
Plan and any such Award shall remain in full force and effect.
(g) 	NO TRUST OR FUND CREATED. Neither the Plan nor any Award shall create or be construed to create a trust or separate fund of any kind or a fiduciary
relationship between the Company or any Affiliate and a Participant or any other Person. To the extent that any Person acquires a right to receive payments
from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured general creditor of the Company or
any Affiliate.
(h) 	NO FRACTIONAL SHARES. No fractional Shares shall be issued or delivered pursuant to the Plan or any Award, and the Committee shall determine whether
cash, or other securities shall be paid or transferred in lieu of any fractional Shares, or whether such fractional Shares or any rights thereto shall be canceled,
terminated, or otherwise eliminated.
(i) 	HEADINGS. Headings are given to the Sections and subsections of the Plan solely as a convenience to facilitate reference. Such headings shall not be deemed
in any way material or relevant to the construction or interpretation of the Plan or any provision thereof.
(j) 	INDEMNIFICATION. Subject to requirements of New York State law, each individual who is or shall have been a member of the Board, or a Committee
appointed by the Board, or an officer or manager of the Company to whom authority was delegated in accordance with Section 3, shall be indemnified and
held harmless by the Company against and from any loss, cost, liability, or expense that may be imposed upon or reasonably incurred by him or her in
connection with or resulting from any claim, action, suit, or proceeding to which he or she may be a party or in which he or she may be involved by reason of
any action taken or failure to act under this Plan and against and from any and all amounts paid by him or her in settlement thereof, with the Company’s
approval, or paid by him or her in satisfaction of any judgment in any such action, suit, or proceeding against him or her, provided he or she shall give the
Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his/her own behalf,
unless such loss, cost, liability, or expense is a result of his/her own willful misconduct or except as expressly provided by statute. The foregoing right of
indemnification shall not be exclusive of any other rights of indemnification to which such individuals may be entitled under the Company’s Certificate of
Incorporation or Bylaws, as a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them harmless.
(k) 	COMPLIANCE WITH SECTION 409A OF THE CODE. Except to the extent specifically provided otherwise by the Committee, Awards under the Plan are intended
to be exempt from or satisfy the requirements of Section 409A of the Code (and the Treasury Department guidance and regulations issued thereunder) so as
to avoid the imposition of any additional taxes or penalties under Section 409A of the Code. If the Committee determines that an Award, Award Agreement,
payment, distribution, deferral election, transaction or any other action or arrangement contemplated by the provisions of the Plan would, if undertaken,
cause a Participant to become subject to any additional taxes or other penalties under Section 409A of the Code, then unless the Committee specifically
provides otherwise, such Award, Award Agreement, payment, distribution, deferral election, transaction or other action or arrangement shall not be given
effect to the extent it causes such result and the related provisions of the Plan and/or Award Agreement will be deemed modified, or, if necessary,
suspended in order to comply with the requirements of Section 409A of the Code to the extent determined appropriate by the Committee, in each case
without the consent of or notice to the Participant.
A-9

-- 65 of 79 --

(l) 	NO REPRESENTATIONS OR COVENANTS WITH RESPECT TO TAX QUALIFICATION. Although the Company may endeavor to (i) qualify an Award for favorable
U.S. or foreign tax treatment (e.g., incentive stock options under Section 422 of the Code or French qualified stock options) or (ii) avoid adverse tax
treatment (e.g., under Section 409A of the Code), the Company makes no representation to that effect and expressly disavows any covenant to maintain
favorable or avoid unfavorable tax treatment. The Company shall be unconstrained in its corporate activities without regard to the potential negative tax
impact on holders of Awards under the Plan.
(m) 	AWARDS TO NON-U.S. EMPLOYEES. The Committee shall have the power and authority to determine which Affiliates shall be covered by this Plan and which
employees outside the U.S. shall be eligible to participate in the Plan. The Committee may adopt, amend or rescind rules, procedures or sub-plans relating to
the operation and administration of the Plan to accommodate the specific requirements of local laws, procedures, and practices. Without limiting the
generality of the foregoing, the Committee is specifically authorized to adopt rules, procedures and sub-plans with provisions that limit or modify rights on
death, disability or retirement or on termination of employment; available methods of exercise or settlement of an award; payment of income, social
insurance contributions and payroll taxes; the withholding procedures and handling of any stock certificates or other indicia of ownership which vary with
local requirements. The Committee may also adopt rules, procedures or sub-plans applicable to particular Affiliates or locations.
(n) 	COMPLIANCE WITH LAWS. The granting of Awards and the issuance of Shares under the Plan shall be subject to all applicable laws, rules, and regulations,
and to such approvals by any governmental agencies or stock exchanges on which the Company’s securities are listed as may be required. The Company shall
have no obligation to issue or deliver evidence of title for Shares issued under the Plan prior to:
i. 	obtaining any approvals from governmental agencies that the Company determines are necessary or advisable; and
ii. 	completion of any registration or other qualification of the Shares under any applicable national or foreign law or ruling of any governmental body that
the Company determines to be necessary or advisable or at a time when any such registration or qualification is not current, has been suspended or
otherwise has ceased to be effective.
The inability or impracticability of the Company to obtain or maintain authority from any regulatory body having jurisdiction, which authority is deemed by
the Company’s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the
failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.
SECTION 9. EFFECTIVE DATE OF THE PLAN
The Plan, as hereby amended and restated, shall be effective as of the date of its approval by the Board or, to the extent that such amendment and restatement
is submitted for shareowner approval, the date of its approval by shareowners of the Company.
SECTION 10. TERM OF THE PLAN
No Award shall be granted under the Plan after the date of the Annual Meeting of the Company in 2027. However, unless otherwise expressly provided in the
plan or in an applicable Award Agreement, any Award theretofore granted may extend beyond such date, and the authority of the Committee to amend, alter,
adjust, suspend, discontinue, or terminate any such Award, or to waive any conditions or rights under any such Award, and the authority of the Board to amend
the Plan, shall extend beyond such date.
A-10

-- 66 of 79 --

Exhibit 10(b)
March 1, 2021 Equity Grant Agreement
GE 2007 Long-Term Incentive Plan
(as amended and restated April 26, 2017, as further amended and restated February
15, 2019, and as further amended and restated July 30, 2021)
GE Performance Stock Unit Grant Agreement (“Grant Agreement”)
For <<Employee Name>> (“Grantee”)
Grant Date PSUs Granted Vesting Date
March 1, 2021 	<<number>>*
(target)
March 1, 2024
*Actual number of Shares delivered to be between 0% and 175% of target
based on performance as defined below.
1. 	Grant. 	The Management Development and Compensation Committee (“Committee”) of the Board of Directors of
General Electric Company (“Company”) has granted the above number of Performance Stock Units (“PSUs”) to the
individual named in this Grant Agreement (“Grantee”), subject to the terms of this Grant Agreement. Without limiting
any condition of this PSU award, the award is subject to cancellation and forfeiture if the Grantee does not confirm
acceptance within 45 days of the Grant Date. Once vested, each PSU entitles the Grantee to receive from the
Company (i) one Share of Company common stock, par value $0.01 per share and (ii) a cash payment in respect of
Dividend Equivalents (described below), each in accordance with the terms of this Grant Agreement, the GE 2007
Long-Term Incentive Plan as amended and restated April 26, 2017, as further amended and restated February 15,
2019, and as further amended and restated July 30, 2021 (“Plan”), and any rules, procedures and sub-plans
(including country addenda) adopted by the Committee.
2. 	Vesting. 	A PSU shall become vested only upon satisfaction of the performance criteria described in Section 2(a) and
the 	employment criteria described in Section 2(b).
a. 	Performance Criteria. 	Subject to satisfying the employment criteria, the number of PSUs to be vested shall be a
percentage of the number of PSUs Granted (as shown above), determined as follows:
1

-- 67 of 79 --

i. 	Financial Goals Percentage. 	A percentage based on 2021 performance against the Earnings Per Share and
Free Cash Flow targets shown below (the “Financial Goals Percentage”) shall be calculated. The Financial
Goals Percentage equals the sum of the Earnings Per Share Factor plus the Free Cash Flow Factor, with each
such Factor weighted 50% of the total as shown in the table below. If performance for a Factor is below the
threshold level, that factor will be 0%. If performance for a Factor is above the maximum level, that Factor will
be capped at 50% of 175%, or 87.5%. If performance is between the threshold and target, or between the
target and maximum, the percentage will be determined by interpolation.
Factor 	Weight 	Threshold 	Target 	Maximum
Earnings Per Share 	50% 	$1.36 	$1.68 	$2.00
Free Cash Flow ($MM) 	50% 	$2,880 	$3,600 	$4,320
Percentage 	25% 	100% 	175%
ii. 	TSR Adjustment. 	The Financial Goals Percentage shall be adjusted based on relative Total Shareholder
Return for the three-year period of 2021-2023 (the “TSR Adjustment”) as follows:
A. 	If the Company’s Total Shareholder Return (“Company TSR”) is equal to or below the 35th percentile
(“threshold”) of the Total Shareholder Return for the S&P 500 Industrial Index Companies (“S&P
Industrials TSR”), then the Financial Goals Percentage will be multiplied by 80%.
B. 	If the Company TSR is equal to the 55th percentile (“target”) of the S&P Industrials TSR, then the
Financial Goals Percentage will be multiplied by 100%.
C. 	If the Company TSR is equal to or exceeds the 80th percentile (“maximum”) of the S&P Industrials TSR,
then the Financial Goals Percentage will be multiplied by 120%.
If the Company TSR is between the threshold and target, or between the target and maximum, TSR
Adjustment shall be determined by interpolation. 	However, in no event will the PSUs be adjusted to provide
more than 175% of the PSUs Granted in total.
All determinations regarding performance (both for the Financial Goals Percentage and TSR Adjustment) shall be
made solely by the Committee in accordance with the customary accounting and financial reporting practices
used by the Company for external reporting, and shall include adjustment for any recapitalization, split-up, spinoff,
reorganization, restructuring or other similar corporate transaction as determined by the Committee to prevent
dilution or enlargement of intended benefits.
2

-- 68 of 79 --

b. 	Employment Criteria. 	In order to vest in a PSU with respect to which the performance criteria are satisfied, the
Grantee must be continuously employed by the Company and its Affiliates from the Grant Date through the
Vesting Date listed above. All unvested PSUs shall be immediately cancelled upon termination of employment for
any reason before the Vesting Date, except as specifically provided below:
i. 	Death or Disability. 	If the Grantee’s employment with the Company and its Affiliates terminates prior to the
Vesting Date as a result of the Grantee’s death or disability, then the employment criteria shall be deemed
satisfied. For this purpose, “disability” shall have the same definition as provided in the long-term disability plan
sponsored by the Company or an Affiliate in which the Grantee is eligible to participate.
ii. 	Retirement Eligibility. 	If, on or after the first anniversary of the Grant Date (and prior to the Vesting Date),
the Grantee attains age 60 and completes 5 years of continuous employment with the Company and its
Affiliates, then the employment criteria shall be deemed satisfied.
3. 	Dividend Equivalents. 	The Company will establish an amount for each PSU equal to the per Share quarterly
dividend payments made to Shareholders during the period beginning on the Grant Date and ending on the date that
such PSU vests or is cancelled (“Dividend Equivalents”). The Company shall accumulate Dividend Equivalents and,
upon vesting of the related PSU, will pay the Grantee a single lump sum cash amount equal to the Dividend
Equivalents on the same date that Shares are delivered with respect to such PSU, as described in Section 4 of this
Grant Agreement. Any accumulated and unpaid Dividend Equivalents attributable to a PSU that is cancelled are
immediately forfeited upon cancellation and will not be paid.
4. 	Delivery and Tax Withholding. 	As soon as practicable after the Vesting Date and during the 2024 calendar year,
the Company shall deliver to the Grantee a number of Shares equal to the number of vested PSUs and the Dividend
Equivalent cash amount with respect to each vested PSU (in each case net of applicable tax withholding and fees).
Delivery shall be electronic, through the brokerage account established by the Company for the Grantee, or in such
other medium as is determined by the Company. The Grantee is ultimately responsible for any and all applicable
taxes, regardless of the amount withheld or reported. Notwithstanding the foregoing, the date of issuance or delivery
of Shares may be postponed by the Company for such period as may be required for it with reasonable diligence to
comply with any applicable listing requirements of any national securities exchange and requirements under any law
or regulation applicable to the issuance or transfer of such Shares to the extent such postponement is permissible
under Section 409A of the Code.
3

-- 69 of 79 --

5. 	Holding Period. 	Shares paid to the Grantee pursuant to this Grant Agreement must be held for at least one year
following the delivery date (except for such Shares used to satisfy any tax withholding obligation or fees) and may be
used to satisfy any Company stock ownership requirements imposed by the Company.
6. 	Data Security and Privacy.
a. 	Data Collection, Processing and Usage. 	Personal data collected, processed and used by the Company in
connection with Awards granted under the Plan includes the Grantee’s name, home address, email address,
telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job
title, any Shares or directorships held in the Company, and details of all Awards granted, cancelled, exercised,
vested, or outstanding. In granting Awards under the Plan, the Company will collect the Grantee’s personal data
for purposes of allocating Shares in settlement of the Awards and implementing, administering and managing the
Plan. The Company collects, processes and uses the Grantee’s personal data in compliance with 	GE's
Employment Data Protection Standards 	and the 	Uses of Employment Data for GE Entities. The Grantee may
exercise rights to access, correction, or restriction or deletion where applicable, by contacting the Grantee’s local
HR manager or initiating a request through 	www.onehr.ge.com.
b. 	Administrative Service Provider. 	The Company transfers the Grantee’s personal data to UBS Financial
Services, which assists with the implementation, administration and management of the Plan (the “Third-Party
Administrator”). In the future, the Company may select a different Third-Party Administrator and share the
Grantee’s personal data with another company that serves in a similar manner. The Third-Party Administrator will
open an account for the Grantee to receive and trade Shares acquired under the Plan. The Grantee will be asked
to agree on separate terms and data processing practices with the Third-Party Administrator, which is a condition
to the Grantee’s ability to participate in the Plan. The privacy policy of the Third-Party Administrator may be
reviewed 	here.
7. 	Non-solicitation, Non-competition and Compliance with Agreements. 	During the Grantee’s employment with the
Company or its Affiliate, and for the one-year period following termination of such employment (the “Restriction
Period”), the Grantee will not, without prior written approval from the Senior Human Resources Manager of the
Grantee’s Company business segment: (a) whether on his or her own behalf or in conjunction with any other person
or third party, directly or indirectly solicit or encourage any person who is a Lead Professional Band or higher
employee of the Company or any of its Affiliates (a “Restricted Person”) to terminate his or her employment
relationship with, or accept any other employment outside of, the Company and its Affiliates; (b) directly hire, or
recommend or cause to be hired by an entity for which the Grantee works, or with which the Grantee is otherwise
associated or owns more than a 1% ownership interest, any person who is, or was within one year before or after the
Grantee’s termination of employment with the
4

-- 70 of 79 --

Company and its Affiliates, a Restricted Person (this restriction does not apply where legally impermissible, such as
California); or (c) provide any non-public information regarding any Restricted Person, including, but not limited to,
compensation data, performance evaluations, skill sets or qualifications, etc., to any external person in connection
with employment outside the Company and its Affiliates, including, but not limited to, recruiters and prospective
employers. The above restrictions do not apply once a Restricted Person has been formally notified of his or her
impending layoff from the Company or any of its Affiliates.
In addition, 	the Grantee agrees that during the Restriction Period, the Grantee will not, without prior written approval
from the Senior Human Resources Manager of the Grantee’s Company business segment, whether directly or
indirectly, perform activities or services in the Restricted Area for any Competitive Company which: (a) are similar in
nature to the activities and services the Grantee performed for the Company or its Affiliate (or gained confidential
information about, as described in the Employee Innovation and Proprietary Information Agreement or 	“EIPIA”) during
the last two years of Grantee’s employment; and/or (b) will include Grantee working on products or services that are
competitive with the products or services the Grantee worked on during the last two years of Grantee’s employment
with the Company or its Affiliate. The term “Competitive Company” means any company or other third party that
provides products and services that are competitive with the Company or its Affiliates. The term “Restricted Area”
means the country in which the Grantee is based. Grantee agrees that the foregoing Restriction Period and
Restricted Area are reasonable and appropriate to protect the Company’s legitimate business interests and goodwill
because (i) the Company or its Affiliate has material business operations in the Restricted Area as of the Grantee’s
termination of employment and (ii) the Grantee has provided services in, had a material presence or influence in,
and/or has received confidential information about (as described in the EIPIA) the Restricted Area during the last two
years of the Grantee’s employment with the Company or its Affiliate. 	The 	foregoing restrictions do not apply where
legally impermissible (such as California). To the extent the Grantee is subject to an existing non-competition
agreement with the Company or any of its affiliates (the “Prior Agreement”), the Prior Agreement shall be
incorporated herein by reference and the Prior Agreement and this Grant Agreement shall be read together;
provided, however, that where the provisions are inconsistent, the more restrictive covenant shall apply.
Furthermore, during the Grantee’s employment with the Company or its Affiliate, and for all periods thereafter, the
Grantee will not breach his or her EIPIA or otherwise disclose the Company’s or Affiliate’s non-public information.
The Grantee agrees that any breach by him or her of the foregoing obligations inevitably would cause substantial and
irreparable damage to the Company and its Affiliates for which money damages may not be an adequate remedy.
Accordingly, the Grantee agrees that the Company and its Affiliates will be entitled to an injunction and/or other
equitable relief, without the necessity of posting security, to
5

-- 71 of 79 --

prevent the breach of such obligations. The Grantee also agrees to indemnify and hold the Company and its Affiliates
harmless from any loss, claim or damages, including, without limitation, all reasonable attorneys’ fees, costs and
expenses incurred in enforcing its rights under this Grant Agreement, as well as repay any payments made
hereunder (regardless of whether the PSUs are vested), except to the extent that such reimbursement is prohibited
by law.
The Grantee agrees that the payment and benefits provided for in the Grant Agreement constitute fair and
reasonable consideration for Grantee’s compliance with this section.
8. 	Additional Requirements. 	The Company reserves the right to impose other requirements on the Award, Shares
acquired pursuant to the Award, and the Grantee's participation in the Plan to the extent the Company determines, in
its sole discretion, that such other requirements are necessary or advisable in order to comply with local law or to
facilitate the operation and administration of the Award and the Plan. Without limiting the generality of the foregoing,
the Company may require the Grantee to sign any agreements or undertakings that may be necessary to accomplish
the foregoing.
9. 	Alteration/Termination. 	Under the express terms of this Grant Agreement, the Committee shall have the right at
any time in its sole discretion to amend, alter, suspend, discontinue or terminate any PSUs without the consent of the
Grantee. Furthermore, if the Company determines in its sole discretion that the Grantee has engaged in conduct that
(a) constitutes a breach of this Grant Agreement, the EIPIA or any other confidentiality, non-solicitation, or non-
competition agreement with the Company or its Affiliates, (b) results in (or has the potential to cause) material harm
financially, reputationally, or otherwise to the Company or its Affiliates or (c) occurred prior to 	the Grantee’s
termination of employment and would give rise to a termination for Cause (regardless of whether such conduct is
discovered before or after the Grantee’s termination of employment), any unvested PSUs shall be cancelled
immediately, and any amounts previously conveyed under this Grant Agreement shall be subject to recoupment. In
any event, the PSUs provided under this Grant Agreement shall be further subject to the Company’s policy with
respect to compensation recoupment, as in effect and amended from time to time. The Grantee agrees that the
Company may take any such actions as are necessary to effectuate recoupment or applicable law without further
consent or action being required by the Grantee, including issuing instructions to any Third-Party Administrator to (i)
hold the Grantee’s Shares and other amounts acquired under the Plan and/or (ii) reconvey, transfer, or otherwise
return such Shares and other assets to the Company. Also, the PSUs shall be null and void to the extent the grant of
PSUs or the vesting thereof is prohibited under the laws of the country of residence of the Grantee.
6

-- 72 of 79 --

For this purpose, “Cause” shall be determined by the Company in its sole discretion and includes: (a) breach of the
Employee Innovation and Proprietary Information Agreement or any other confidentiality, non-solicitation, or non-
competition agreement with the Company or Affiliate, or breach of a material term of any other agreement with the
Company or Affiliate; (b) engagement in conduct that results in, or has the potential to cause, material harm
financially, reputationally, or otherwise to the Company or its Affiliate; (c) commission of an act of dishonesty, fraud,
embezzlement or theft; (d) conviction of, or plea of guilty or no contest to a felony or crime involving moral turpitude;
or (e) failure to comply with the Company’s or Affiliate’s policies and procedures, including, but not limited to, The
Spirit and Letter.
10. 	Plan Terms and Definitions. 	Except to the extent that the context clearly provides otherwise, all terms used in this
Grant Agreement have the same meaning as given such terms in the Plan. This Grant Agreement is subject to the
terms and provisions of the Plan, which are incorporated by reference. In the event of any conflict between the
provisions of this Grant Agreement and those of the Plan, the provisions of the Plan shall control.
11. 	Interpretation and Construction. 	This Grant Agreement and the Plan shall be construed and interpreted by the
Committee, in its sole discretion. Any interpretation or other determination by Committee (including correction of any
defect or omission and reconciliation of any inconsistency) shall be binding and conclusive. All determinations
regarding enforcement, waiver or modification of the cancellation and rescission and other provisions of this Grant
Agreement shall be made in the Committee’s sole discretion. Determinations made under this Grant Agreement and
the Plan need not be uniform and may be made selectively among individuals, whether or not such individuals are
similarly situated.
12. 	Severability. 	The invalidity or unenforceability of any provision of the Plan or this Grant Agreement will not affect the
validity or enforceability of any other provision of the Plan or this Grant Agreement, and each provision of the Plan
and this Grant Agreement will be severable and enforceable to the extent permitted by law.
13. 	Shareholder Rights. 	The Grantee shall not have any voting or other Shareholder rights unless and until Shares are
actually delivered to the Grantee.
14. 	No Employment Rights. 	The grant of the Award described in this Grant Agreement does not give the Grantee any
rights in respect of employment with the Company or any of its Affiliates.
15. 	Discretionary Award, Extraordinary Benefit. 	Awards under the Plan are granted to employees of the Company
and its Affiliates in the Committee’s sole discretion. The Award described in this Grant Agreement is a one-time
benefit and does not create any contractual or other right to receive other Awards under the Plan or other benefits in
lieu thereof. Future grants, if any, will be at the sole discretion of the Committee. The Grantee’s participation in the
Plan is voluntary. This Award (and each other Award, if any, granted under the Plan) constitutes an extraordinary
item
7

-- 73 of 79 --

of compensation and is not part of the Grantee’s normal or expected compensation for purposes of calculating any
severance, retirement, or other benefit rights (unless otherwise expressly provided in an applicable benefit plan).
16. 	No Transfer or Assignment. 	No rights under this Award shall be assignable or transferable by the Grantee, except
to the extent expressly permitted by the Plan.
17. 	Successors and Assigns. 	The Company may assign any of its rights under this Grant Agreement. This Grant
Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to
the restrictions on transfer set forth herein, this Grant Agreement will be binding upon the Grantee and the Grantee's
beneficiaries, executors or administrators.
18. 	Section 409A. 	To the extent applicable, this Grant Agreement shall be construed and administered consistently with
the intent to comply with or be exempt from the requirements of Section 409A of the Code (“Section 409A”) and any
state law of similar effect (i.e., applying the “short-term deferral” rule described in Treas. Reg. § 1.409A-1(b)(4) and/or
another exemption). Where the Grant Agreement specifies a window during which a payment may be made, the
payment date within such window shall be determined by the Company in its sole discretion.
19. 	Entire Agreement. 	This Grant Agreement, the Plan, and any rules, procedures and sub-plans (including country
addenda) adopted by the Committee contain all of the provisions applicable to the PSUs. No other statements,
documents or practices may modify, waive or alter such provisions unless expressly set forth in writing, signed by an
authorized officer of the Company and delivered to the Grantee.
By acknowledging this Grant Agreement, the Grantee acknowledges and confirms that the Grantee has read this
Grant Agreement and the Plan (including applicable addenda), and the Grantee accepts and agrees to the provisions
therein.
20. 	Electronic Delivery. 	The Company may, in its sole discretion, decide to deliver any documents related to this or
other Awards under the Plan by electronic means. The Grantee hereby consents to receive such documents
electronically and agrees to participate in the Plan through an on-line or electronic system established and
maintained by the Company or a third party designated by the Company.
21. 	Global Addendum. 	Notwithstanding any provisions in this document to the contrary, the PSUs will also be subject to
the special terms and conditions set forth on Appendix A for Grantees who reside outside of the United States.
Moreover, if a Grantee is not a resident of any of the countries listed on Appendix A as of the Grant Date, but
relocates to one of the listed countries at any point thereafter, the special terms and conditions for such country will
apply to the Grantee, to the extent the Company determines that the application of such terms and conditions is
necessary or advisable in order to comply with local law or facilitate the administration of the Plan. Appendix A
constitutes part of this Grant Agreement.
8

-- 74 of 79 --

Exhibit 10(c)
NOTICE OF ADJUSTMENT TO THE
GE PERFORMANCE SHARE GRANT AGREEMENT
This NOTICE OF ADJUSTMENT TO THE GE PERFORMANCE SHARE GRANT AGREEMENT (this “Notice”) is hereby
given that, effective July 30, 2021 (the "effective date"), certain adjustments were made to the GE Performance Share Grant
Agreement between General Electric Company (the “Company”) and H. Lawrence Culp, Jr., dated August 18, 2020 (the “Award
Agreement”), which documents the grant of certain performance shares by the Company to Mr. Culp.
This Notice is to advise Mr. Culp that proportional adjustments have been made to the Award Agreement to reflect the
reverse stock split of the Company’s common stock at a ratio of 1-for-8 (the “reverse stock split”), which was completed on the
effective date. The adjustments described herein are made in accordance with the anti-dilution provisions of the Award
Agreement and the 2007 Long-Term Incentive Plan, as amended and restated, and are consistent with the adjustments made for
shareholders generally.
1. 	Adjustments:
a. 	The number of performance shares granted at target is adjusted from 9,295,352 to 1,161,919.
b. 	The reference to par value shall mean $0.01 per share.
c. 	The Reference Stock Price is adjusted from $6.67 to $53.36.
d. 	The closing price per Share used to calculate the Highest Average Price shall be adjusted for any day prior to and
including the effective date of this Notice to reflect the reverse stock split.
2. 	Effect of Notice. Except as set forth in this Notice, the terms of the Award Agreement shall remain in full force and
effect.
IN WITNESS WHEREOF, this Notice has been duly given by and on behalf of the Company.
General Electric Company
By: 	/s/ L. Kevin Cox
Name: 	L. Kevin Cox
Title: 	Chief Human Resource Officer

-- 75 of 79 --

Exhibit 10(d)
NOTICE OF ADJUSTMENT TO THE
GE PERFORMANCE STOCK UNIT GRANT AGREEMENT
This NOTICE OF ADJUSTMENT TO THE GE PERFORMANCE STOCK UNIT GRANT AGREEMENT (this “Notice”) is
hereby that, effective July 30, 2021 (the "effective date"), certain adjustments were made to the GE Performance Share Grant
Agreement between General Electric Company (the “Company”) and Carolina Dybeck Happe, dated September 3, 2020 (the
“Award Agreement”), which documents the grant of certain performance stock units by the Company to Ms. Dybeck Happe.
This Notice is to advise Ms. Dybeck Happe that proportional adjustments have been made to the Award Agreement to
reflect the reverse stock split of the Company’s common stock at a ratio of 1-for-8 (the “reverse stock split”), which was
completed on the effective date. The adjustments described herein are made in accordance with the anti-dilution provisions of
the Award Agreement and the 2007 Long-Term Incentive Plan, as amended and restated, and are consistent with the
adjustments made for shareholders generally.
1. 	Adjustments:
a. 	The number of performance shares granted at target is adjusted from 1,093,920 to 136,740.
b. 	The reference to par value shall mean $0.01 per share.
c. 	The Reference Stock Price is adjusted from $6.67 to $53.36.
d. 	The closing price per Share used to calculate the Highest Average Price shall be adjusted for any day prior to and
including the effective date of this Notice to reflect the reverse stock split.
2. 	Effect of Notice. Except as set forth in this Notice, the terms of the Award Agreement shall remain in full force and
effect.
IN WITNESS WHEREOF, this Notice has been duly given by and on behalf of the Company.
General Electric Company
By: 	/s/ L. Kevin Cox
Name: 	L. Kevin Cox
Title: 	Chief Human Resource Officer

-- 76 of 79 --

Exhibit 31(a)
Certification Pursuant to
Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Amended
I, H. Lawrence Culp, Jr., certify that:
1. 	I have reviewed this quarterly report on Form 10-Q of General Electric Company;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and have:
a) 	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;
b) 	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles;
c) 	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) 	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant’s internal control over financial reporting; and
5. 	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) 	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) 	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control
over financial reporting.
Date: October 26, 2021
/s/ H. Lawrence Culp, Jr.
H. Lawrence Culp, Jr.
Chairman & Chief Executive Officer

-- 77 of 79 --

Exhibit 31(b)
Certification Pursuant to
Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Amended
I, Carolina Dybeck Happe, certify that:
1. 	I have reviewed this quarterly report on Form 10-Q of General Electric Company;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and have:
a) 	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;
b) 	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles;
c) 	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) 	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant’s internal control over financial reporting; and
5. 	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) 	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) 	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control
over financial reporting.
Date: October 26, 2021
/s/ Carolina Dybeck Happe
Carolina Dybeck Happe
Chief Financial Officer

-- 78 of 79 --

Exhibit 32
Certification Pursuant to
18 U.S.C. Section 1350
In connection with the Quarterly Report of General Electric Company (the “registrant”) on Form 10-Q for the period ended September 30, 2021, as filed with the
Securities and Exchange Commission on the date hereof (the “report”), we, H. Lawrence Culp, Jr. and Carolina Dybeck Happe, Chief Executive Officer and Chief
Financial Officer, respectively, of the registrant, certify, pursuant to 18 U.S.C. § 1350, that to our knowledge:
(1) 	The report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) 	The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the registrant.
October 26, 2021
/s/ H. Lawrence Culp, Jr.
H. Lawrence Culp, Jr.
Chairman & Chief Executive Officer
/s/ Carolina Dybeck Happe
Carolina Dybeck Happe
Chief Financial Officer

-- 79 of 79 --